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Abstract 
Methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa are 
the main multi-drug resistant pathogens associated with deep wound infections which 
then may cause septicaemia. Treatment is problematic and re-infection is quite 
common. Free Living Amoebae (FLA), such as Acanthamoeba, are widely distributed 
in the environment and may also contaminate wounds. It is well known that 
Acanthamoeba feed on and protect bacteria. The role of Acanthamoeba in wound 
infections is not very well understood. It is possible that the presence of Acanthamoeba 
in wounds is one of the key factors for such re-infections. 
In this study, 140 wound swabs were collected to check for the presence of 
Acanthamoeba spp. Only one sample was positive for Acanthamoeba spp. Sequencing 
of the highly variable DF3 region of 18S rRNA gene for the sample showed that this 
isolate belongs to genotype T4. 
In addition, clinical isolates of MRSA and Pseudomonas from wound infections were 
used in this study. The results showed that MRSA and Pseudomonas were able to bind 
with, invade, survive and multiply inside Acanthamoeba species. One of the essential 
compounds for microorganisms to grow is iron. The role of iron chelators, including 
deferiprone and selected novel compounds based on hydroxyl pyridine moiety, was 
studied. Findings revealed that all novel iron chelators have an antimicrobial activity 
against both bacteria. In addition, all novel iron chelators were able to kill 
Acanthamoeba. Cytotoxic effects of MRSA, P. aeruginosa and Acanthamoeba were 
investigated using the KB epithelial cell line and mesenchymal stem cells (MSC) using 
a general caspase inhibitor. The results revealed that the ability of live bacteria to induce 
cell death was higher compared with heat-killed bacteria, bacteria conditioned medium 
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(BCM) and Acanthamoeba conditioned media (CM). The exact trigger for the cell death 
in this study was not investigated but the relative contributions of apoptosis and necrosis 
were investigated using fluorescent technique, caspase inhibition and LDH assay. 
In conclusion, presence of Acanthamoeba in wounds could be the reason of prolong 
treatment and reinfection in wounds. 
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Chapter 1 : Literature Review 
1.1 Structure of skin 
Skin is the largest organ of the human body, where it covers an area approximately 1.8 
square meters, and it is equivalent to one-sixth of body weight. Each 6 square 
centimetres of human skin contains roughly 1500 nerve receptors, 3.6 metres of nerves, 
4.6 metres of blood vessels, 100 sebaceous glands, and about 350 sweat (Marieb and 
Hoehn, 2007). It includes two different tissue structures,  the epidermis and the dermis, 
with thickness from 100 µm and 1-4 mm respectively (Figure 1.1).  
Skin provides several physiological functions including regulation of body temperature 
and reduction of harmful effect of ultra violet light (UV). However, the most important 
function is to provide a protective barrier against harmful microorganisms, mechanical 
trauma, thermal burn and physical injury. 
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Figure 1.1 Structure of skin. 
Non-hairy (right) and hairy regions (left). The epidermal invaginations are called rete ridges. 
(By Madhero88 and M.Komorniczak - https://en.wikipedia.org/wiki/File:Skin_layers.png, CC 
BY-SA 3.0, https://commons.wikimedia.org/w/index.php?curid=21986708 from Wikipedia 
commons, May 2016).  
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1.1.1 Structure of the epidermis 
The epidermis is part of the first physical barrier of the skin. The thickness of epidermis 
varies from one part of the body to another. The thinnest epidermis layer is in the 
eyelids, and the thickest layer is on the palms of the hand and the soles of the feet. Cells 
in the epidermis layer are constantly renewed from the basal layer below. This part of 
skin comprises five layers of cells from the basement membrane (BM) to the surface of 
the skin (Figure 1.2).  
1.1.1.1 Stratum germinativum 
Stratum germinativum (SG) layer is the first layer after BM, and it is the lowest one of 
the epidermis. It is comprised mainly of the proliferating and non-proliferating 
keratinocytes, and some of the melanocyte cells. Within this layer, proliferative 
keratinocytes play role in the continuous regeneration of the epidermis. The new cells 
will push up the cells in the layers above them which will take about 28-30 days. 
Although the majority of cells in this layer are keratinocytes, a low number of 
melanocytes and Merkel cells are present (Borghi and Nelson, 2009; Maricich et al., 
2009). 
1.1.1.2 Stratum spinosum 
The Spinosus layer comprises cells which migrate towards the surface of the skin. They 
are created from the basal cells of the SG layer. Cells in this layer are characterised as 
polyhedral-shaped containing large nuclei. These cells are able to synthesise proteins, 
therefore, they are able to produce large amount of the intermediate filament 
cytokeratin. In addition to the keratinocytes which are the main cells in this layer, it also 
contains star-shaped immune cells known as Langerhans cells. The function of these 
cells is to uptake the antigens which have entered the epidermis, then take them to T-
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cells of the regional lymph nodes (Romani et al., 2010). 
1.1.1.3 Stratum granulosum 
The keratinocytes moved up from the spinosus layer to create the stratum granulosum, 
which contains between three to five layers of keratinocytes. Cells in this layer are in a 
late stage of differentiation, and they start to lose their polyhedral morphology, then as a 
result, they become more flattened. Keratinocytes in this stage start to produce proteins 
required for cornification, such as K1 keratin filaments. In addition, they begin lose 
their nuclei, and granulation appears in their cytoplasm (Candi et al., 2005; Palmer et 
al., 2006). 
1.1.1.4 Stratum lucidum 
This layer is found in the thick skin only, such as on the palms of the hand and the soles 
of the feet. Cells in this layer do not contain nuclei; and they are flat (Marieb and 
Hoehn, 2007). 
1.1.1.5 Stratum corneum 
Stratum corneum (SC) cells compose the outer part of the epidermis. This layer consists 
of 20-30 layers of corneocytes, and forms up to 3/4 of the epithelium thickness (Marieb 
and Hoehn, 2007). Corneocytes are the most differentiated keratinocytes, which are 
characterised as polyhedral, nucleated, flattened, dead cells. This type of cell is 
surrounded by a cornified envelope of cross-linked proteins, and they have an 
intracellular matrix of hydrophobic non-polar lipids (Candi et al., 2005). The cornified 
envelope is the principle barrier to inhibit penetration of damaging agents such as 
chemicals and microbes. It is capable of withstanding mechanical forces and provides 
the water impermeability of the skin (Madison, 2003). 
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1.1.2 Structure of the dermis 
The dermis is an extensive layer of specialised connective tissue. The main function of 
this layer is to support the epidermis, however it also provides essential mechanical 
protection. The dermis is comprised of an extracellular matrix (ECM) that contains 
glycosaminoglycans, elastins and collagen fibres (Marieb and Hoehn, 2007). The 
reticular layer is the deepest area of the dermis, which contains nerve endings, sweat 
glands and oil (sebaceous) glands, hair follicles, and blood vessels (Figure 1.1).  
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Figure 1.2 Composition of the Epidermis. 
The stratum lucidium is a thin translucent layer of dead keratinocytes that is only present in 
areas of thick skin where it helps to reduce friction and shear forces between the stratum 
corneum and the stratum granulosum (By BruceBlaus. When using this image in external 
sources it can be cited as:Blausen.com staff. "Blausen gallery 2014". Wikiversity Journal of 
Medicine. DOI:10.15347/wjm/2014.010. ISSN 20018762. - Own work, CC BY 3.0, 
https://commons.wikimedia.org/w/index.php?curid=30871437 from Wikipedia commons, May 
2016).  
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1.2 Wound and wound healing  
The skin provides a natural protective barrier, thus any breach happening in the skin, 
such as wounds, must be rapidly and expeditiously repaired. To get to this end, skin has 
the ability to heal itself after any injury or tissue damage. Wound healing is a complex 
phenomenon which can be described in four distinguishable and overlapping phases 
(Figure 1.3) (Shechter and Schwartz, 2013). 
1.2.1 Haemostasis  
This phase starts immediately after the injury of the skin. Wounds cause disruption to 
the blood vessels which lead to bleeding. As a quick response for the local haemorrhage 
after endothelial cell injury, the blood platelets get activated and the coagulation process 
starts. As a result, blood clotting leads to plugging and termination of the bleed. 
That would make a temporary barrier to the external environment, and provides a 
provisional matrix for the invasion of new capillaries within 4 days of the injury 
(Shechter and Schwartz, 2013). The clot contains platelets and a mesh of fibres derived 
from the plasma proteins and cleaved by thrombin enzyme (Clark, 2001). Platelets are 
activated when they aggregate and attach to the collagen surfaces. This activation lets 
the platelets release chemokines and growth factors such as platelet-derived growth 
factor (PDGF) and epidermal growth factor (EGF), proteases and vasoactive agents. At 
the end, fibroblasts get activated by these growth factors to produce collagen. 
Chemokines have a role in attracting inflammatory cells to the injury area, that leads to 
the following phase of wound healing (Bauer et al., 1985; Brissett and Hom, 2003). 
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Figure 1.3 Phases of wound healing. 
Wound healing is a complex phenomenon which can be described in four distinguishable and 
overlapping phases: (i) Haemostasis, starts immediately after the injury; (ii) Inflammatory 
phase, starts within haemostasis up to 3 weeks; (iii) Proliferative phase, starts within 1 week up 
to 6 weeks; (iv) Remodelling phase, starts after 6 weeks up to 2 years. 
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1.2.2 Inflammatory phase 
The Inflammatory phase begins within the haemostasis phase. In this phase, 
inflammation is a controlled vascular and cellular response to the injury. The 
inflammation process is essential to set up the tissue regeneration by clearing the dead 
cells, foreign materials and germs (Velnar et al., 2009). The response of this phase is 
characterised by raising the vasopermeability, vessel dilation, and leukocyte permeation 
(Stadelmann et al., 1998). In addition to the white blood cells, such as granulocytes and 
monocytes, which infiltrate and are regulated by different types of chemo-attractants, 
e.g. the cleavage products produced by fibrin and fibrinogen. There are other chemo-
attractive agents attracted to a wound site which act as key factors for the inflammatory 
response, including clotting factors, cytokines, leukotriene, elastin and collagen 
breakdown products (Velnar et al., 2009).    
Granulocytes are a group of leukocytes including neutrophils, which are the first 
leukocyte cells to arrive at the wound site. They have a protective role in the wound 
against infections, by killing bacteria via producing toxic reactive oxygen species 
(ROS). Moreover, they also produce lysosomal enzymes and proteases to debride the 
injury site. In addition, monocytes attach to blood vessel endothelial cells and infiltrate 
to ECM. This action protects the wound from contamination via phagocytosis by 
macrophages (Segre, 2006). 
Macrophages are essential cells for wound healing. They release collagenases and 
elastases, which break down injured tissue, and release cytokines. In addition, 
macrophages encourage and activate other types of leukocytes to promote the 
inflammation process. Macrophages have a role in enhancing the apoptosis of 
irrecoverable cells, and then phagocytosing them. Additionally, they provide many 
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tissue growth factors, such as transforming growth factor alpha and beta TGF-α, TGF-β, 
heparin binding epidermal growth factor, fibroblast growth factor (FGF), and 
collagenase, which activate keratinocytes, fibroblasts and endothelial cells to enhance 
the healing via regeneration and proliferation of cells (Mosser and Edwards, 2008; 
Velnar et al., 2009; Guo and Dipietro, 2010).  
The last type of leukocytes to enter wounds during the inflammatory phase is 
lymphocytes. Their number will increase till the end of the proliferative phase and the 
beginning of remodelling phase (Swift et al., 2001). The lymphocytes are attracted to 
the injury site by the action of interleukin-1 (IL-1), which also takes part in collagenase 
regulation. The collagenase is needed later for remodelling collagen, that is a main 
component of ECM (Velnar et al., 2009).  
1.2.3 Proliferative phase 
The proliferative phase begins 2-3 days post-injury and takes approximately two weeks. 
This phase is characterised by the appearance of fibroblasts in the extracellular matrix, 
which exchange with the provisional network composed of fibrin and fibronectin. 
Formation of granulation tissue is the main event in this phase, and that can be seen 
clearly under the microscope. The fibrocytes produce fibroblasts in the connective 
tissue; however, there is some evidence of the contribution of bone marrow stem cells in 
producing these fibroblasts (Opalenik and Davidson, 2005). Fibroblasts form an 
amorphous gel made from glycosaminoglycans (GAGs) and proteoglycans, which play 
a role in the aggregation of collagen fibres. Fibroblasts migrate and proliferate as a 
response to different factors, including fibronectin, PDGF, fibroblast growth factor, and 
TGF-β; thereafter they are dedicated to the synthesis of extracellular collagen. One-
week post-injury, some of the fibroblasts will be transformed into myofibroblasts, 
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which will connect with each others forming strong contractile tissue to connect wound 
edges together (Shechter and Schwartz, 2013).   
Because of the increase of metabolic demand by the new tissue, the angiogenesis 
process starts within the proliferation phase, which will be supportive to the provisional 
matrix. Thereafter, angiogenesis is enhanced by some different growth factors which are 
produced by macrophages, keratinocytes and vascular endothelial cells such as, basic 
fibroblast growth factor (FGF-2), vascular endothelial growth factor (VEGF), and TGF-
β. Therefore, the flow of blood to the new tissue will increase, thus the healing factors 
increase as well. These vessels will disappear by apoptosis when the demand for them is 
reduced (Velnar et al., 2009).  
Within hours after the injury, re-epithelialisation will be established by a series of 
processes such as mobilisation, mitosis, and differentiation of epidermal cells. 
Keratinocytes in the edge of the wound lose their basal polarity and make pseudopodia 
from the sides, therefore they interface between clot and healthy dermis to discard the 
eschar from the viable tissue. When the gap of the wound is closed, the migration of 
keratinocytes stops and the BM starts to form (Figure 1.4) (Shechter and Schwartz, 
2013). 
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Figure 1.4 The late inflammatory/ early proliferative phase of wound healing. 
The granulation tissue is rich in newly sprouted blood vessels, and fibroblasts begin to 
proliferate and synthesise collagen and ECM components. Keratinocytes of the leading-edge 
(shown in yellow), begin to re-epithelialise by firstly migrating underneath the eschar to 
separate it from the underlying regenerating tissue. Figure adapted from (Martin and Parkhurst, 
2004). 
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1.2.4 Remodeling phase 
In the remodelling or maturation phase, the collagen fibres are reorganised into a 
specific structure. Three weeks post-injury, remodelling starts and continues for up to 
two years. The wound during this phase continues to increase in tensile strength. 
Collagen type III, which was laid down in the early stage of the wound healing, is 
replaced by collagen type I until a 4:1 ratio of collagen I to III is reached; similarly the 
GAGs are decreased until they reach the normal value. High numbers of new blood 
vessels, myofibroblasts and fibroblasts are degraded through endothelial cell apoptosis. 
In the end, the newly produced epidermal layer becomes gradually thinner (Velnar et 
al., 2009). 
1.2.5 Chronic wounds (non-healing wounds) 
Chronic wounds are those which fail to the respond to the wound healing process, 
resulting in unrepaired wounds. There are many reasons leading to chronic wounds, 
such as diabetes, pressure, vascular insufficiency, burns, and vasculitis. For example, 
venous leg ulcers are a common chronic wound that have a high impact on the life 
quality of the patient and the treatment is not cheap. About 15 to 18 per thousand people 
in the United Kingdom (UK) have venous leg ulcers, which cost the National Health 
Service (NHS) between £300 and £600 million per annum (Watson et al., 2011; 
Hodgson et al., 2014). Many factors can disrupt the process of wound healing, which 
prolong one or more of the wound healing phases, including types of infection, tissue 
hypoxia, necrosis, exudates, and excess levels of inflammatory cytokines. Prolongation 
of the inflammatory phase in the wound produces a cascade that conserves a non-
healing state. One of the biological markers of chronic wounds is the excessive 
infiltration of neutrophils to the wound site, and that could be the cause of chronic 
inflammation. This type of leukocyte produces high amounts of enzymes, notably 
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collagenase and elastase which break down the ECM and destroy growth and healing 
factors. It is difficult to treat these wounds unless they respond well to treatment 
(Maxson et al., 2012). For that reason, researchers are trying to find alternative methods 
to induce wound healing processes to close wounds. Many studies suggest the 
possibility of using mesenchymal stem cells (MSCs) in tissue regeneration and wound 
healing. The presence of MSCs in normal skin and their role in wound healing propose 
the promise of using exogenous MSCs to treat non-healing wounds (Paquet-Fifield et 
al., 2009; Zahorec et al., 2015). 
1.2.6 Mesenchymal stem cells 
MSCs have the potential to differentiate into different tissue-forming cell lineages, e.g. 
osteoblasts, adipocytes, chondrocytes, tenocytes, and myocytes. Moreover, they can be 
grown extensively ex vivo for several transfers without losing their features and self-
renewal capacity (Hocking and Gibran, 2010). MSCs also have the ability to regenerate 
themselves and control the immune and inflammatory responses. These features give a 
therapeutic possibility of treating cases with an inflammatory component. In addition, 
MSCs also have the ability to enhance the surrounding cells’ production of biologically 
active molecules which have a direct effect on cell migration, proliferation, and survival 
by paracrine signalling. In clinical settings, therapeutic applications of MSCs have 
shown good results through their role in wound healing phases. Therefore, involvement 
of MSCs in the wound healing process is very important, especially in these cases of 
chronic non-healing wounds (Figure 1.5) (Sorrell and Caplan, 2010; O’Loughlin et al., 
2013). 
Although bone marrow is considered the most common source of MSCs, they are also 
isolated from different parts of the body, such as adipose tissue, periosteum, tendon, 
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muscle, synovial membrane, skin, and others. There are some differences in the gene 
expression and cytokines from different origins, but the expression of the main genes 
are conserved (Chen et al., 2012), and the features of MSCs are shared between all 
MSCs from different sources. Moreover, it is still not decided which origin is better for 
wound healing and other clinical applications. Human placentae become a target for the 
researcher recently as a source for MSCs. In addition, there are minimal differences of 
cell phenotype, differentiation and immunomodulative features, between bone marrow-
derived MSCs and placental-derived MSCs (Jiang et al., 2012; Mulder et al., 2012). 
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Figure 1.5 Differentiation capacity of MSCs. 
Figure adapted from (Claros et al., 2011).  
  
Chapter 1 
   
  
18 
1.2.7 Role of MSC’s in wound healing 
MSCs’ roles are associated with all wound healing phases (Figure 1.6). They show the 
ability to enhance cells’ progress to beyond the inflammatory phase and not develop a 
chronic state. The presence of MSCs in wounds reduces the production of the 
proinflammatory cytokines tumour necrosis factor-α (TNF-α) and interferon-γ (IFN-γ), 
whereas the interleukin-10 (IL-10) and IL-4 will increase (Aggarwal and Pittenger, 
2005). Therefore, these features of MSCs give an advantage in treating chronic wounds. 
In addition, the MSCs have direct and indirect antimicrobial activity. The direct 
mechanism is through releasing antimicrobial factors (e.g. LL-37), whereas the indirect 
mechanism is via releasing immunomodulatory factors which have the role of bacterial 
killing and phagocytosis by the immune cells (Figure 1.6) (Krasnodembskaya et al., 
2010; Mei et al., 2010). In vivo, MSCs can migrate to the injury site in response to the 
chemotactic signals of inflammation, then repair the damaged tissue and help in tissue 
regeneration. Moreover, MSCs improve tissue repair via two mechanisms: 
differentiation and participation in regeneration of damaged tissue, and paracrine 
signalling that regulates the cellular response in the injury site (Gnecchi et al., 2008; 
Chen et al., 2009). The analysis of MSCs’ conditioned medium showed their ability to 
produce many known factors that contribute in tissue repair, such as growth factors, 
cytokines, and chemokines (Gnecchi et al., 2008). Many cell types e.g. epithelial cells, 
endothelial cells, keratinocytes, and fibroblasts are responsive to the MSCs paracrine 
signalling. These responses include cell survival, proliferation, migration, and gene 
expression (Hocking and Gibran, 2010). In addition, MSCs and MSC-conditioned 
medium have a role in promoting dermal fibroblasts which speed up wound closure. 
MSCs enhance dermal fibroblasts to release more collagen type I and alter gene 
expression (Smith et al., 2010).  
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Figure 1.6 Mesenchymal stem cell roles in each phase of the wound-healing process. 
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1.3 Wound infections 
Microbial infection is a serious problem in wounds resulting in increasing the length of 
treatment, exudate and pain. In chronic infections, it might result in serious 
consequences such as osteomyelitis, amputation, sepsis and death. In addition, wound 
infections are the most common cause of morbidity and mortality in patients after 
operations and also with burns (Melling et al., 2001; Church et al., 2006). Full 
microbial identification is very important for effective treatment. This is becoming more 
difficult with the increased number of multi-drug resistant bacteria notably, Methicillin-
Resistant Staphylococcus aureus (MRSA) (Gray et al., 2005; Soong et al., 2015).  
1.3.1 Epidemiology and burden of wounds and wound infections 
The accurate global burden of wounds and wound infections is still not completely 
known. The full picture given by international statistics is difficult to understand, due to 
regional, national and local specificities for some countries. However, in the developed 
countries the epidemiology and economic burden of wounds and wound infections is 
well documented. In North America, there are between 6-7 million patients with 
wounds each year. About 2.5 million persons in the United States have burns each year. 
More than 100,000 of these patients are hospitalized, and the mortality  is about 12,000 
per year  (Weinstein and Mayhall, 2003). Another study in the UK showed that 3.55 per 
1000 population are patients with wounds. The majority of wounds were surgical 48 %, 
leg/foot (28 %) and ulcers (21 %) (MacDonald, 2009).  
Wound infections could lead to severe circumstances and increased morbidity and 
mortality among patients. The burden of high cost on health-care is increasing 
(Zoutman et al., 1998). In the UK, the cost was estimated about £9.89 million between 
2006 and 2007, including dressing, full-time nurses and hospital beds. This is a huge 
amount of money spent on wound infections only. Moreover, the cost of surgical 
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wounds has proved difficult to estimate (Lynch et al., 1992), however, hospital costs 
alone could be over £1500 per patient (Zoutman et al., 1998). 
A study in the USA among paediatric patients with and without surgical wound 
infections showed that wound infections prolonged hospital stay by 10.6 days, and that 
costs patient care about US$ 27288 per patient (Sparling et al., 2007). Similar study by 
Bond and Raehl showed that hospitalised patients over 65 years old with wounds were 
three times more likely to die compared with healthy people (Bond and Raehl, 2007). 
1.3.2 Pathogenesis of wound infections 
Bacteria (e.g. Pseudomonas aeruginosa), fungi (e.g. Aspergillus), protist (e.g. 
Balamuthia mandrillaris) or viruses (e.g. human immunodeficiency virus (HIV)) may 
enter any wound through a break in the skin. This could happen through external 
sources such as, direct contact (e.g. transfer from hands of a carer or equipment), 
environment (e.g. microorganism from the surrounding air), and self-contamination 
(e.g. from the patient’s own skin (Sibbald, 2004; Sibbald et al., 2007). The host immune 
system will be triggered when the microorganism establishes, proliferates and releases 
enzymes and toxins that lead to local inflammation.  As a result, there will be some 
signs and symptoms that characterize wound infection, including erythema, oedema, 
elevated temperature, pain, unusual wound odour and/or purulent exudates. Local 
infection may become systemic if host defence mechanisms are not enough to eradicate 
the infection or the therapy used is inappropriate (Nichols, 1985). 
The presence of pathogens in wounds does not always lead to wound infections 
(Thomson and Smith, 1994). Wound healing and infection are affected by the 
relationship between the virulence of pathogen and the host resistance to control the 
growth of bacteria in wound (Sibbald et al., 2007). Three important factors are 
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associated with infection or/and wound healing. They are: infectious dose, pathogen 
virulence and host resistance (Dow et al., 1999). Therefore, should the microorganisms 
invade and multiply inside tissues to cause an infection,  that can be apparent clinically 
by the presence of toxins, intracellular replication or antigen-antibody response (Sibbald 
et al., 2007). 
1.3.3 Classification of wounds with bacterial imbalance  
Classification of wounds in a continuum has been used to provide guidance on the route 
to administer systemic antibiotics. Schultz et al. (2003) described four levels of 
microbial interaction (Figure 1.7): 
1.3.3.1 Colonised 
This level has a very low number of microorganisms, and this wound is considered to 
be progressing normally. The main signs of this level are no necrotic tissue, presence of 
low number of pathogens on the surfaces, and there may be pink-purple epithelial tissue 
(Sibbald et al., 2007; Gray et al., 2010). 
1.3.3.2 Critically colonised 
In this level, the number of microorganisms is increased, and this wound is considered 
to be not responding to appropriate therapy. The main signs in this level are a wet 
wound, no new necrotic tissue, wound easily bleed with any touch and the tissue may be 
unhealthy with a dark colour (Gray et al., 2010). 
1.3.3.3 Locally infected 
Number of pathogens in this level is high, and wound has some cellulitis on the adjacent 
skin or around the wound about 2 cm from the wound edge (Dow et al., 1999). In this 
level, microorganisms are present within a wound and in deeper tissue, there are 
necrotic tissues in the absence of cellulitis, tissue may be an unhealthy deep red colour, 
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wound bleeding with any slight touch. Moreover, wound in this level is wetter than 
wound in critically colonised (Kingsley, 2001). 
1.3.3.4 Spreading infection 
Number of microorganisms in this level is very high. They are found on the surface of 
wound and in deeper tissue. The wound is surrounded by cellulitis about 2 cm from the 
edge. The main signs in this level are similar to those in locally infected. Furthermore, 
odour may be offensive, and there may be pyrexia, lymphangitis or lymphadenitis or 
bacteraemia (Schultz et al., 2003; Sibbald et al., 2003; Gray et al., 2010). 
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Figure 1.7 Classification of wounds continuum. 
Four levels of microbial interaction with wounds, starts with colonisation that shows low 
number of bacteria and no signs or symptoms of infection, then critical colonisation that shows 
an increasing  number of bacteria with no signs and symptoms, next stage is local infection that 
shows an increasing number of bacteria with ability to invade the tissue and presence of signs 
and symptoms, next stage is spreading infection that shows a very high number of bacteria and 
could lead to bacteraemia.   
  
Number of bacteria. 
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1.3.4 Common wound pathogens 
 Wounds may be infected by numerous microorganisms including bacteria, fungi, 
protist and viruses. Bacteria are the most common pathogens that lead to wound 
infection (Table 1.1). Some bacteria have a positive effect on wound healing, such as 
the skin commensal Staphylococcus epidermidis (SE) found as flora on the skin 
(Schultz et al., 2003; Rajan, 2012). 
Sibbald et al. (2003) reported that wounds infected of less than a month duration post-
infection seems to have a high percentage of Gram-positive bacteria, while wounds that 
have been infected for more than a month post-infection tend to have Gram-negative 
bacteria present followed by anaerobes. Another study showed that delayed wound 
healing is not dependent on one specific microorganism or group of bacteria, but is 
caused by the presence of four or more different species of microorganisms (Trengove 
et al., 1996). In addition, wounds are considered as infected when about 105 colony-
forming units (CFUs) is present in one gram of viable tissues (Gardner et al., 2001; 
Percival et al., 2012; McCarty and Percival, 2013).  
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Most Common Bacteria Causing Wound Infections 
 
 
 
 
 
 
 
Table 1.1 The most common bacteria that cause wound infection. 
Table adapted from (Rajan, 2012). 
 
  
Species Total isolates 
Percentage of 
isolates 
Staphylococcus aureus 2602 44.6 
Pseudomonas aeruginosa 648 11.1 
Enterococcus spp 542 9.3 
Escherichia coli 422 7.2 
Enterobacter spp 282 4.8 
Klebsiella pneumoniae 248 4.2 
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Each bacterial strain can have a quite different approach to cause disease or change its 
sensitivity to antibiotics. Because of the overuse and misuse of antibiotics, new 
multidrug resistant strains are emerging. Most of these antibiotic-resistant bacteria are 
hospital-acquired. 
Most common antibiotic-resistant pathogens in wound infections are (Serra et al., 
2015): 
1.3.4.1 Methicillin-resistant Staphylococcus aureus (MRSA) 
Staphylococcus aureus are Gram-positive cocci. Staphylococci were observed and 
cultured for the first time by Pasteur and Koch, but Ogston in 1881 and Rosenbach in 
1884 made more studies on them (Ogston, 1881). The cocci are usually arranged in 
grape-like clusters. Staphylococci may be found as part of the normal flora of other 
specific sites such as the upper respiratory tract, and are commonly present on animals. 
The major pathogen within the genus is Methicillin-sensitive Staphylococcus aureus 
(MSSA), and they cause a wide range of hospital-acquired and community-acquired 
infections notably skin and wound infection (Creech et al., 2015).  
Methicillin-resistant Staphylococcus aureus (MRSA) were described directly after the 
introduction methicillin in 1961 in the UK. Methicillin was introduced to solve the 
problem of penicillin-resistant strains that became high during 1950s. The presence of 
MRSA in many hospitals has become a major public health issue, with concern 
expressed by patients and members of the public about the clinical implications 
(Bukharie, 2010). 
Resistance to methicillin in S. aureus is mediated by PBP-2a, a penicillin binding 
protein, encoded by the mecA gene (Mulligan et al., 1993; Ben-David et al., 2008). The 
gene which is located on the staphylococcal chromosome cassette (SCCmec), permits 
the organism to grow and replicate in the presence of methicillin and other β-lactam 
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antibiotics (Hiramatsu et al., 2001; Peacock and Paterson, 2015). There are two 
mechanisms responsible for resistance of S. aureus to β-lactam antibiotics. The first one 
is the low affinity of PBP-2a to β-lactam, and the second is the releasing of β-
lactamases that damage the antibiotics (Mulligan et al., 1993; Edgeworth, 2011). 
1.3.4.1.1 Virulence factors 
Staphylococcus aureus strains have a large number of surface-associated and 
extracellular factors, such as enterotoxins serotype A (SEA), toxic shock syndrome 
toxin-1 (TSST-1), cytolytic toxins (α and β haemolysins) exfoliative toxins, Panton-
Valentine leukocidin (PVL), protein A, and several enzymes (Table 1.2.) (Vandenesch 
et al., 2003). Those factors probably play an important role in the ability of the 
organism to overcome the body's defences and cause infections (Table 1.2.). They bind 
to tissues and secrete exotoxins, however the entire process is not fully understood 
(Patel et al., 2012). 
Enterotoxins, types A-E, G, H, I and J, are commonly produced by up to 65 % of 
staphylococcus strains. These toxic proteins are heat stable, withstanding exposure to 
100°C for several minutes (Greenwood et al., 1992). The enterotoxins and the TSST-1 
cause toxic shock and related illnesses through induction of massive cytokine release, 
from both macrophages and T lymphocytes (McCormick et al., 2001). The recent 
community-acquired MRSA (CA-MRSA) isolation rate has shown evidence of 
increased virulence resulting in increased prevalence of toxic shock cases and more 
severe soft-tissue infections and in many cases increased mortality. However, TSST-1 
can be produced by hospital-acquired MRSA (HA-MRSA) as well as MSSA strains 
and, therefore, TSST-1 production should not be considered a hallmark of CA-MRSA 
strains. The absence of circulating antibodies to TSST-1 is a factor in the pathogenesis 
of this syndrome (Fey et al., 2003; Bukharie, 2010). 
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Another important virulence factor in S. aureus is PVL, a member of the recently 
described family of synergohymenotropic toxins. PVL damages the membranes of host 
defence cells through the synergistic activity of two separately secreted but non-
associated proteins, LukS-PV and LukF-PV, causing tissue necrosis (Lina et al., 1999). 
Although some investigators have suggested that PVL expression does not correlate 
directly with polymorphonuclear leukocyte lysis (Saïd-Salim et al., 2005), PVL 
producing CA-MRSA isolates has been increasingly associated with necrotizing 
pneumonia and necrotizing cutaneous infections (Lina et al., 1999; Francis et al., 2005; 
Bukharie, 2010). 
The other virulence factor are epidermolytic toxins (ETs). Two kinds of epidermolytic 
toxin (ET-A and ET-B) are commonly produced by S. aureus, which cause blistering 
diseases (Greenwood et al., 1992). ET allows S. aureus to proliferate and spread 
beneath the skin. These toxins induce intra-epidermal blisters at the granular cell layer. 
The most dramatic manifestation of ET is the scalded skin syndrome in young children, 
where the toxin spreads systemically in individuals who lack neutralizing antitoxin 
(Ladhani et al., 2001). 
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Virulence Factors Of Staphylococcus aureus 
Virulence factor Activity 
Cell wall polymers 
Peptidoglycan Inhibits inflammatory response; endotoxin-
like activity 
Teichoic acid Phage adsorption; reservoir of bound 
divalent cations 
Cell surface proteins 
Protein A Binds to  Fc region of IgG 
Clumping factor Binds to fibrinogen 
Fibronectin-binding protein Binds to fibronectin 
Exoproteins 
α-Lysin Impairment of membrane permeability; 
cytotoxic effects on phagocytic and tissue 
cells 
β-Lysin 
γ-Lysin 
δ-Lysin 
Panton-Valentine 
leucocidin 
Dermo-necrotic 
Epidermolytic toxins Cause blistering of skin 
Toxic shock syndrome 
toxin 
Induces multi-system effects; super antigen 
effects 
Enterotoxins Induce vomiting and diarrhoea; super antigen 
effects 
Coagulase Converts fibrinogen to fibrin in plasma 
Staphylokinase Degrades fibrin 
Lipase Degrades lipid 
Deoxyribonuclease Degrades DNA 
 
Table 1.2 Some virulence factors of S. aureus and their activities. 
Table adapted from (Greenwood et al., 2012). 
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1.3.4.1.2 Treatment 
S. aureus and other staphylococci are inherently sensitive to many antimicrobial agents. 
Among the most active benzylpenicillin, about 90 % of strains found in hospitals are 
now resistant. Resistance to penicillin depends on production of the enzyme 
penicillinase, a b-lactamase that cleaves the b-lactamase ring. MRSA strains are resistant 
to all b-lactam agents, and often to other agents such as the aminoglycosides and 
fluoroquinolones. Glycopeptides (vancomycin or teicoplanin) are the agents of choice in 
the treatment of MRSA infection, but these agents are expensive and may be toxic. 
Currently, there are four approved antibiotics for the treatment of MRSA infections, 
including vancomycin, linezolid, daptomycin and tigecycline (Boucher, 2008; Van Hal 
et al., 2011). 
1.3.4.2 Pseudomonas aeruginosa 
Pseudomonas aeruginosa is a Gram-negative, aerobic bacillus belonging to the family 
pseudomonadaceae. Almost all strains are motile by one or two polar flagella. 
Pseudomonas aeruginosa is a free-living bacterium, it could be found in soil and water. 
It is a typical species of its group that contains 12 other members. Most of the clinical 
cases caused by P. aeruginosa can be associated with the immunocompromise such as 
patients with burns. Many cases of P. aeruginosa infection can be attributed to general 
immunosuppression (e.g. AIDS patients) (Wu et al., 2011; Percival et al., 2012; 
McCarty and Percival, 2013).  
1.3.4.2.1 Virulence factors 
As mentioned earlier, P. aeruginosa can be found in different environments, which 
enables the bacteria to grow and survive in almost any environment. However, P. 
aeruginosa rarely causes community-acquired infections in immunocompetent patients. 
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Virulence factors of Pseudomonas are classified into two main groups, cell-associated 
and extracellular virulence factors (Castillo-Juárez et al., 2015).  
Moreover, up to 50 % of hospitalised patients are at high risk of P. aeruginosa 
colonisation (Van Delden and Iglewski, 1998). An important virulence factor of P. 
aeruginosa that is probably responsible for the association of this bacterium to 
epithelium is type 4 pili. There are several other non-pilus adhesions responsible for the 
binding to host epithelial cells which have been described, but their role in infection is 
still unclear. Another virulence factor is flagella, which are primarily responsible for 
motility, and it may also have a role in adhesion to epithelial cells (Alborzi et al., 2009). 
Most Pseudomonas strains produce two exotoxins (exotoxin A and exoenzyme S), and a 
variety of cytotoxic substances including proteases, phospholipases, rhamnolipids and 
the blue pigment pyocyanin (De Bentzmann et al., 2000). Exotoxin A is responsible for 
local tissue damage and bacterial invasion (Vidal et al., 1993). Purified exotoxin A is 
fatal for mice, and that supports its role as a main systemic virulence factor of P. 
aeruginosa. Exoenzyme S is responsible for direct tissue destruction in lung infection 
and may be important for bacterial dissemination (Van Delden and Iglewski, 1998). 
There are other enzymes which are produced by P. aeruginosa, such as haemolysins, 
phospholipase C and rhamnolipid. These factors may work together to break down 
lipids and lecithin. Moreover, both may contribute to tissue invasion by their cytotoxic 
effects. 
Production of fluorescein in vivo allows P. aeruginosa to compete with mammalian 
iron-binding proteins such as transferrin. In association with pyocyanin, it gives rise to 
the characteristic blue-green pus of pseudomonas-infected wounds and hence the old 
species name pyocyanea (Wu et al., 2011; Greenwood et al., 2012). 
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1.3.4.2.2 Treatment 
Pseudomonas aeruginosa is normally resistant to many antimicrobial agents. Among β-
lactam compounds, piperacillin, ticarcillin, ceftazidime and carbapenems are usually 
active, as are aminoglycosides such as gentamicin and tobramycin. Aminoglycosides 
are often used in combination with a β-lactam antibiotic. This provides the potential for 
antibacterial synergy and reduced antibiotic resistance, but there is little evidence of 
clinical superiority. Monotherapy with broad-spectrum β-lactam agents such as 
ceftazidime and imipenem is used, but resistance to these agents occurs. 
Fluoroquinolones such as ciprofloxacin exhibit good activity against P. aeruginosa and 
penetrate well into most tissues, but resistance may develop. Polymyxins are usually 
active, but they are toxic and generally reserved for topical application (Estahbanati et 
al., 2002; Kucisec-Tepes et al., 2006; Kucisec-Tepes and Antolić, 2014). 
Passive vaccination may be useful for the treatment of septicaemia and burn infections 
due to P. aeruginosa, which are associated with a high mortality rate. Active 
vaccination to prevent pulmonary colonisation would be desirable for patients with 
cystic fibrosis and several conjugate vaccines are in clinical trial (Estahbanati et al., 
2002). 
1.3.5 Cell death  
Cell death can be natural as a normal process of the cell cycle developing an organ’s 
tissue and preventing sickness or functional disorder. However, cell death can also be 
induced by pathogens such as bacteria, viruses (DeLeo, 2004; Shao et al., 2004), fungi 
(Glass and Dementhon, 2006) and protist (Lee et al., 2002; Raina and Kaur, 2012).  
Host cell death is a defence response to the host-microbe interaction process. Specific 
chemical signals in a particular stage of infection are expressed to activate specific 
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molecules that are responsible, leading to cell death. The virulence factors produced by 
bacteria have the main role in host cell damage. Past and recent studies have 
demonstrated two different types of cell death; these are apoptosis and necrosis. Those 
two cell death types are widely connected with bacterial infection. Therefore, the trying 
of understanding the pathways of cell death that induced by bacterial infection have 
been shown a significant attention for the researchers (Hossain, 2012) 
1.3.5.1 Characteristics of apoptosis and necrosis 
Both apoptosis and necrosis are forms of cell death, however, there are significant 
differences between them. Apoptosis is considered as a programmed cell death which is 
required for the growth and the survival of multicellular organisms. Apoptosis is 
triggered by two different pathways, receptor-mediated (extrinsic pathway) and 
mitochondria-mediated (intrinsic pathway). However, necrosis occurs by ROS 
production or danger signals, such as lysosomal destabilization, releasing non-
lysosomal cysteine proteases (calpain), and reduction of Adenosine triphosphate (ATP), 
that are induced by bacterial infection or physical damage. In comparison with the 
necrosis, apoptosis does not enhance inflammatory responses which are induced with 
the necrosis process, with the removal process of discrete cells (Rathmell and 
Thompson, 2002). Furthermore, the apoptotic bodies of apoptotic cells exist as vesicles 
containing the cellular content, such as mitochondria, lysosomes and Golgi bodies. In 
contrast, the necrotic cell’ membrane is lysed and ruptured, therefore all the cell 
contents are released to cause inflammatory responses. Moreover, apoptosis is an active 
process of individual cell death, whereas necrosis is a passive accidental cell death 
happening along with inflammatory cellular response caused by environmental 
disturbance (Figure 1.8) (Negroni et al., 2015).  
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Figure 1.8 Cell death pathways induced by bacterial infection. 
Bacteria have the ability to induce host cell death via different mechanisms including apoptosis 
and necrosis. Apoptosis can be stimulated by two different pathways, the intrinsic 
(mitochondria-mediated) pathway and extrinsic (receptor-mediated) pathway. All caspases are 
activated in apoptosis except caspase-1. At the morphological level, apoptosis can be 
characterised by membrane blebbing, cell shrinkage, DNA fragmentation and mitochondrial 
permeability. Then, apoptotic bodies start to appear containing bacteria which are engulfed by 
macrophages. Necrosis is type of inflammatory cell death which can be morphologically 
characterised by membrane rupture, nuclear swelling, and the release of cellular contents. 
Necrosis occurs by producing ROS or danger signals, such as lysosomal destabilization, calpain 
release, and depletion of ATP. These actions are induced by bacterial infection or physical 
damage. Figure adapted from (Ashida et al., 2011).  
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Apoptosis is considered as a general pathway to remove old and infected cells. It is also 
involves the replacement of dead cells with new ones via mitosis to keep the stability of 
the cell population within the tissue. Therefore, cells are genetically programmed to 
contain the metabolic elements responsible to activate cell death (Ashida et al., 2011). 
Moreover, cells swell during the necrosis process and then the plasma membrane is 
destroyed which leads to cell lysis. In contrast, cells shrink and identical DNA 
condensation occurs firstly within the apoptosis process, then the cell contents and 
damaged nuclei appear enclosed in the apoptotic bodies. The apoptotic bodies get 
phagocytised by phagocytes, however if they are not phagocytised, the content would 
lead to necrosis (Elmore, 2007). 
1.3.5.2 Mechanisms of host cell death induced by bacterial infections  
The interaction between eukaryotic host cells and prokaryotic cells (bacteria) is a 
complex process which involves different factors including bacterial virulence factors 
and cell innate immune defence factors (Lin et al., 2010). Apoptosis is not the only 
process related to the stability of the immune system and renewing the functionally 
faulty cells. It also has a role in the immune response to infections. As well as that, 
intracellular pathogens may be killed by the apoptosis process. However, pathogens 
have developed different strategies to protect themselves against the host immune 
response. One of these strategies is to enhance apoptosis in immune cells such as T and 
B cells, neutrophils and phagocytes, thus pathogens secure their ability to survive, 
replicate and cause the infection. For example, exotoxin T produced by P. aeruginosa 
interferes with phagocyte functions (Galle et al., 2012a, 2012b). Moreover, alpha toxin 
produced by S. aureus is able to induce the apoptosis in T cells by making pores in its 
membrane (Hossain, 2012). Furthermore, these toxins have the ability to lyse host cells 
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which allows the intracellular bacteria to spread and invade other cells through 
apoptosis (Broquet and Asehnoune, 2015). That would cause significant damaged in the 
extracellular matrix or cell plasma membrane of the host cells. This damage caused by 
bacterial toxins might occur through enzymatic or pore development (Hossain, 2012). 
Protist as well use the same strategy to cause apoptosis in lymphocytes, granulocytes 
and phagocytes by the extrinsic pathway (Sitjà-Bobadilla, 2008), which will be 
mentioned in chapter four. 
Balamuthia mandrillaris is a Free-Living Amoeba (FLA) which cause skin lesions as 
well as a fatal disease called Granulomatous Aamoebic Encephalitis (GAE) (Cabello-
Vílchez et al., 2014a). In addition, Acanthamoeba can cause the same disease through 
its haematogenous spread. It is believed that skin lesion is the main entry route for 
Acanthamoeba to enter blood stream and interact with the blood brain barrier (BBB) 
(D’Auria et al., 2012)   
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1.4  Acanthamoeba  
Acanthamoeba are FLA that can cause human infections such as keratitis and 
encephalitis. In the last two decades, Acanthamoeba species have become recognised as 
one of the important microbes. They could play an important role as carriers and 
reservoirs for prokaryotes.  
1.4.1 History and classification 
Protists are eukaryotic organisms, and amoebozoa is one of the largest group belong to 
them (Scamardella, 1999; Khan, 2001). Amoebae were considered for a while as 
harmless microorganisms in the environment. However, later on researchers confirmed 
that amoebae could cause a fatal disease to human and animals, such as Acanthamoeba 
Granulomatous Encephalitis (AGE) (Winiecka-Krusnell and Linder, 2001). In 1930, 
Castellanii discovered amoeba as an eukaryotic cell culture contaminant from a fungus 
culture plate. In 1931, the genus Acanthamoeba was discovered by Volkonsky (Figure 
1.9) (Khan, 2009). 
In 1970s, Acanthamoeba was first established as a cause of human disease.  
Acanthamoeba cause two well studied diseases in human: AGE and amoebic keratitis 
(AK) (Marciano-Cabral and Cabral, 2003).  
The pathogenic species of Acanthamoeba include Acanthamoeba castellanii, 
Acanthamoeba polyphaga, Acanthamoeba culbertsoni, Acanthamoeba palestinensis, 
Acanthamoeba hatchetti, Acanthamoeba rhysodes, Acanthamoeba divionensis, 
Acanthamoeba lugdunensis, and Acanthamoeba griffini. 
In the past, Acanthamoeba were classified in different groups based on the morphology 
of their cysts (Pussard and Pons, 1977). They divided Acanthamoeba into three groups 
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based on the cyst size and number of arms within a single cyst. According to their 
study, Group I have large cysts with diameter at least ≥18 µm; and the endocysts and 
ectocysts are widely separated. Species belonging to this group have between 6-14 
arms. Acanthamoeba belonging to group II have cysts with diameter of ≤18 µm, with an 
ovoid, stellate, globular, or polyhedric endocyst and thick or thin ectocyst, while 
Acanthamoeba which were classified as group III have cysts with diameters of <18 µm 
with globular or ovoid endocysts, and thin ectocysts (Khan, 2009). 
However, the ionic concentration of the growth media can have an effect on the 
morphology of the cyst, which would cause a variation in this morphological 
characteristic (Sawyer, 1971; Stratford and Griffiths, 1978). As a result, the 
morphological taxonomy criteria have been challenged as a main classification method 
(Moura et al., 1992). Isolation, cultivation and microscopy were the main methods of 
Acanthamoeba identification, but due to the difficulty of interpretation, it has now been 
suspended. The discovery of molecular techniques led to work in classification of the 
genus Acanthamoeba based on sequences of Diagnostic Fragment 3 (DF3) of 18S 
rDNA. The Polymerase Chain Reaction (PCR) is one of these techniques which is used 
to amplify a region of deoxyribonucleic acid (DNA). This sequences is highly 
conserved, precise, reliable and informative (Schroeder et al., 2001). Sequences of both 
nuclear 18S rRNA gene (rDNA) and mitochondrial 16S rRNA gene (rDNA) are 
suitable to classify Acanthamoeba isolates (Gast et al., 1996; Chung et al., 1998; Khan, 
2009). Based on 18S rDNA sequences, genus Acanthamoeba is divided into 20 different 
genotypes (T1-T20). In addition, T2/T6 and T4 genotypes are divided to different 
subgroups (Siddiqui and Khan, 2012; Fuerst, 2014; Corsaro et al., 2015). 
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Figure 1.9 The classification scheme of protists, based on their genetic relatedness. 
Figure adapted from (Marciano-Cabral and Cabral, 2003). 
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1.4.2 Ecology 
 Free-living amoebae are widely distributed in the environment, and they have been 
isolated from different sources, such as soil and air (Khan, 2009). Acanthamoeba can 
live in harsh conditions, such as frozen and salty environments (Dudley et al., 2005). In 
addition, there are some virulence differences between Acanthamoeba isolated from 
different environments. For example, Acanthamoeba isolated from thermally-polluted 
factory discharges is more virulent than Acanthamoeba isolated from water surface. 
Furthermore, Acanthamoeba has been isolated from hospital settings and clinical 
samples, such as lung tissues, skin lesions, skin wounds and human faeces (De 
Jonckheere, 1991; Siddiqui and Khan, 2012). 
1.4.3 Life cycle 
Acanthamoeba has two main different stages in its life. The active stage of 
Acanthamoeba is called the trophozoite stage. The dormant stage of Acanthamoeba is 
the cyst stage. Growth conditions are very important in changing the stage of 
Acanthamoeba from active to dormant. The necessary conditions for trophozoites 
include an abundant food supply, temperature and neutral pH. The trophozoite varies in 
size from 25 to 40 µm and feeds on bacteria, algae, and yeast in the environment but also 
can exist axenically on nutrients in liquid taken up through pinocytosis. The 
reproduction of Acanthamoeba is asexual, that is it occurs via binary fission; and two 
new genetically identical Acanthamoeba will be the result of any division. This active 
stage contains the typical content of a eukaryotic cell, including cytoplasm, Golgi, free 
ribosomes and a nucleus. The trophozoite is characterized by the presence of 
acanthopodia, which are just found in the trophozoite stage but not in the cyst stage 
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(Siddiqui and Khan, 2012; Castrillón and Orozco, 2013). The cyst stage is characterized 
by the double walls called the endocyst and exocyst (Page, 1967). 
The favourable conditions of pH, temperature, osmolarity and food are very important to 
keep the Acanthamoeba in the active stage; otherwise Acanthamoeba will change to be 
in a dormant stage, cyst (Figure 1.10) (Dudley et al., 2005). The cyst stage can survive 
more than 20 years until exposed to a source of food when they excyst (Lloyd, 2014). 
The cyst stage is crucial in Acanthamoeba pathogenesis due to its ability to resist 
antimicrobial agents and physical treatments. Cysts can be airborne playing a significant 
role in Acanthamoeba distribution in the environment (Siddiqui and Khan, 2012; Lloyd, 
2014). 
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Figure 1.10 The life cycle of Acanthamoeba spp.  
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1.4.4 Feeding 
Amoeba growth and survival depends on the amoeba feeding preferences (Bottone et 
al., 1992, 1994) and bacterial density (Marciano-Cabral and Cabral, 2003). 
Acanthamoeba showed high amoebic yields upon digestion of low densities of Gram-
negative bacteria. Examples of bacteria which serve as excellent food for 
Acanthamoeba include Escherichia coli K-12 (Huws et al., 2005; Alsam et al., 2006), 
and Klebsiella pneumoniae (Weekers et al., 1993).  
Acanthamoeba feeding occurs by phagocytosis and pinocytosis (Chambers and 
Thompson, 1976). Phagocytosis is a contact dependent process whereas pinocytosis is a 
non-binding process characterized by surface invaginations and vesiculations that takes 
up solutes and food particles (Bowers, 1980). Phagocytosis usually occurs by 
pseudopodia or by food cup formation. Acanthamoeba surrounds the food particles 
within its plasma membrane or pseudopodial projections into a membrane-enclosed 
particle that buds off into the cytoplasm. The membrane-enclosed particle called a 
phagosome subsequently fuses with a lysosome that contains a variety of hydrolytic 
enzymes (Alsam et al., 2005a; Lorenzo-Morales et al., 2015). 
1.4.5 Diseases caused by Acanthamoeba 
Acanthamoeba is a harmful pathogen that can cause fatal diseases, such as AGE, and 
corneal infection known as AK. Furthermore, Acanthamoeba could cause some 
infections (e.g. cutaneous, skin and bone infections) in immunosuppressed patients 
(Graffi et al., 2013).  
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1.4.5.1 Acanthamoeba granulomatous encephalitis (AGE) 
In 1972, AGE was identified as a human disease for the first time (Ringsted et al., 1976). 
This disease mostly occurs in immunocompromised patients, such as HIV/AIDS and 
malnourished patients. AGE can be fatal and occurs in the central nervous system 
(CNS), where it may develop as a chronic disease spanning from several weeks to 
months. There are different entry routes for Acanthamoeba to cause this disease 
including lower respiratory tract, olfactory neuroepithelium, and skin lesions (Figure 
1.11)  (Garajová and Mrva, 2011). However, the incubation time of Acanthamoeba to 
cause AGE is still unknown, and it is assumed to be more than 10 days. Nowadays, the 
number of human immunodeficiency syndrome HIV/AIDS patients has increased; 
therefore, AGE has become a serious concern for human health (Figure 1.12) (Cuevas et 
al., 2006).  
1.4.5.1.1 Pathophysiology and treatment 
There are many characteristic symptoms of AGE including confusion, stiff neck, 
headache, lethargy, ataxia, vomiting, aphasia, nausea, seizures, cranial nerve palsies, 
increased intracranial pressure, coma and death in the end (Bloch and Schuster, 2005). It 
is difficult to diagnose AGE, because of the similarities in its signs and symptoms with 
viral encephalitis and bacterial meningitis. However, scans by Magnetic Resonance 
Imaging (MRI) or cranial Computed Tomography (CT) may help in diagnoses and could 
reveal contrast enhancement areas indicating brain abscess or tumours (Figure 1.13) 
(Miltner and Bermudez, 2000). 
There are some different drugs to treat AGE, such as trimethoprim-sulfamethoxazole, 
ketokonazole, amphotericin-B, rifampicin, fluconazole, sulfadiazine and albendazole 
(Kaushal et al., 2008; Zamora et al., 2014).  
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Figure 1.11 The haematogenous routes of Acanthamoeba entry into the CNS. 
Acanthamoeba may pass through the lower respiratory tract or through skin injury then to blood 
brain barrier (BBB) via bloodstream.  
  
Chapter 1 
   
  
47 
 
Figure 1.12 Coronal section. 
Coronal section of the cerebral hemispheres with cortical and subcortical necrosis from a fatal 
human case of AGE (Marciano-Cabral and Cabral, 2003). 
 
 
Figure 1.13 RMI of normal and infected brain with AGE. 
(A) Normal brain MRI. (B) MRI of a patient’s brain with AGE showing a hemorrhagic lesion in 
the right front lobe (Meersseman et al., 2007). 
  
Chapter 1 
   
  
48 
1.4.5.1.2 Immunology of AGE 
Haematogenous spread is a pre-requisite in AGE infections and complement activation 
is the inducer of the first line of defence. There are three pathways of complement 
activation, 1) classical pathway activated by antibody recognion of antigens on the 
surface of Acanthamoeba; 2) alternative pathway activated by C3 binding and auto-
catalytically cleaved, then the attached C3b act as an opsonin; and 3) mannose-binding 
lectin bound  by Acanthamoeba surface (Ferrante and Rowan-Kelly, 1983; Marciano-
Cabral and Toney, 1998; Pumidonming et al., 2011).  
Normal human serum is effective against Acanthamoeba by activation of the alternative 
pathway of the complement system through the attachment of Acanthamoeba with C3 
(Pumidonming et al., 2011). Different proteins (C5, C6, C7, C8 and C9) in complement 
system in human body could kill Acanthamoeba by the damaging of amoeba membrane; 
or it could be killed by phagocytic cell following opsonisation by C3b (Ferrante and 
Rowan-Kelly, 1983). Overall, the immune system response against Acanthamoeba 
infections is not fully understood, and more studies are required to identify the factors 
that lead to this fatal infection (Marciano-Cabral and Cabral, 2003; Malla et al., 2014).   
1.4.5.2 Acanthamoeba keratitis (AK) 
The reports showed that the first recognised cases of ocular infection were in 1973 in the 
UK and USA (Illingworth et al., 1995), and the first case of AK was described in 1975 
(Naginton et al., 1974). There are eight species of Acanthamoeba which can cause AK, 
they are Acanthamoeba castellanii, Acanthamoeba culbertsoni, Acanthamoeba hatchetii, 
Acanthamoeba polyphaga, Acanthamoeba rhysodes, Acanthamoeba lugdunensis, 
Acanthamoeba quina and Acanthamoeba griffini (Logar and Kraut, 1997) (Ledee et al., 
1996; Omaña-Molina et al., 2015). AK infection often affects the users of unsterile 
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solution for their contact lenses, and also affects the people who are swimming or 
bathing while wearing contact lenses (Ibrahim et al., 2007). Moreover, this infection 
could affect non-lens users by exposure to contaminated water and soil (Dart et al., 
2009).  
1.4.5.2.1 Pathophysiology and treatments 
Acanthamoeba keratitis takes few days to several weeks to be cleared, but it depends on 
the route of amoeba’s entry. The development of infection occurred by contaminated 
contact lenses is a much slower process, while it is rapid in the case of corneal trauma. 
The main symptoms of AK are represented by photophobia, pain, epithelial defects, and 
inflammation with redness and tearing that leads to epitheliopathy, perineural infiltrates, 
ring infiltrates, ulceration, abscess formation, hypopyon, scleritis, glaucoma, cataract, 
corneal perforation and posterior segment inflammation (Figure 1.14) (Alsam et al., 
2008; Lorenzo-Morales et al., 2015). 
A wide range of topical antimicrobial agents currently used for AK treatment. However, 
a combination of agents is used against cyst form as it is highly resistance to therapy. 
Low concentration of PolyHexaMethylene Biguanide (PHMB) is effective against both 
forms of Acanthamoeba, but is unfortunately toxic to human corneal cells. 
Chlorhexidine is an effective agent against both forms, and is not toxic on cornial 
epithelial cells. A combination of chlorhexidine, propamidine isethionate, 
dibromopropamidine, hexamidine and neomycin, have been used to treat AK, and is 
showing great results (Lorenzo-Morales et al., 2015). 
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Figure 1.14 Acanthamoeba-infected eye. 
(A) Early presentation of Acanthamoeba keratitis (B) Improvement of Acanthamoeba keratitis 
after 6 months’ treatment with polyhexamethylene biguanide, propamidine-isethionate and 
neomycin. Figure adapted from (Alsam et al., 2008). 
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1.4.5.2.2 Immunology of AK 
The first defense line against AK is ocular surface, tear fluid and the eyelid. The tear 
fluid contains several compounds possessing antimicrobial and immunological 
properties (e.g. lysozyme, lactoferrin, β-lysins, secretory immunoglobulin A and 
prostaglandins). There are no significant effects of lysozyme and lactoferrin on 
Acanthamoeba binding to and cytotoxicity of human corneal epithelial cells (Dudley et 
al., 2007; Alsam et al., 2008). 
The adherence of trophozoites to corneal epithelial cells is prevented by the conjunctiva 
being coated with secretory IgA. Previous studies proved that the mechanism of anti-
Acanthamoeba IgA antibodies protect against AK by inhibiting the adherence of 
trophozoites to corneal epithelial cells without effecting the viability of Acanthamoeba 
trophozoites. Mannose-Induced Protein (MIP-133) is produced when trophozoites 
adhere to corneal epithelium (Hurt et al., 2003). Repeated  oral vaccination with both 
MIP-133 and cholera toxin elicit generation of IgA antibodies which block cytopathic 
effects in corneal cells in vitro, and that strongly supports its ability to be used as an anti-
disease vaccine (Alizadeh et al., 2005; Bouheraoua et al., 2014; Lorenzo-Morales et al., 
2015). 
Conjunctiva macrophage cells can be activated by interferon gamma (INF-γ) and 
lipopolysaccharide (LPS), and this activation could kill Acanthamoeba trophozoites 
(Alizadeh et al., 2005). 
1.4.6 Acanthamoeba pathogenesis 
Several studies were conducted on the pathogenicity of Acanthamoeba infections. These 
studies were mainly conducted on the strains that cause corneal disease rather than that 
causing CNS disease. The pathogenicity of Acanthamoeba infections is a complex 
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process that involves many determinants grouped in contact-dependent and contact-
independent factors (Baig, 2015; Lorenzo-Morales et al., 2015). 
1.4.6.1 Contact-dependent mechanisms 
1.4.6.1.1 Binding 
Binding of Acanthamoeba to the host cell is an important step in Acanthamoeba 
pathogenesis. Studies show that Mannose Binding Protein (MBP) is very important for 
Acanthamoeba to bind to both corneal epithelial cells and human brain microvascular 
endothelial cells, while mannose containing glycoproteins are present on  the surface of 
corneal epithelium (Yang et al., 1997; Shin et al., 2001; Alsam et al., 2003) (Panjwani, 
2010; Yoo and Jung, 2012). 
The transepithelial resistance of cell monolayers interacting with Acanthamoeba is 
reduced, which indicate the role of MBP as contact-dependent cytolysis (González-
Robles et al., 2006; Lorenzo-Morales et al., 2015). As binding assays showed 
Acanthamoeba perfectly bind to collagen, laminin and fibronectin. Acanthamoeba 
invade and destruct host tissue after the association (Gordon et al., 1993). 
1.4.6.1.2 Phagocytosis 
The pseudopodia of Acanthamoeba trophozoites are responsible of making contact with 
target cells in the presence of calcium channels and cytoskeletal elements. The binding 
of Acanthamoeba with epithelial cells is dependent on the induction of the host cell’s 
signalling pathway and cytotoxic substances. Epithelial cells will be severely ulcerated 
and penetrated when incubating them together for 12 h at 35 ˚C. Acanthamoeba cause 
cytopathic effects in host cells through cytolysis and phagocytosis (Alsam et al., 2005a; 
Siddiqui and Khan, 2012). 
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1.4.6.2 Contact-independent mechanisms 
1.4.6.2.1 Extracellular proteases 
Proteases such as, cysteine, serine and metalloprotease are produced by viruses, bacteria 
and protist. It is represented by cysteine, serine and metalloprotease. Pathogenic 
Acanthamoeba show high activity of extracellular protease. The relation between 
pathogenicity and the high activity of extracellular proteases propose that pathogenic 
Acanthamoeba use proteases to invade host cells. Some pathogenic Acanthamoeba spp. 
produce serine proteases, with range of molecular weights from 20 to 200 kDa (Alsam et 
al., 2005b). Serine proteases are produced by Acanthamoeba trophozoites but not 
Acanthamoeba cysts. Proteases produced by Acanthamoeba has been identified as 
degraded enzyme which degrade fibronectin, fibrinogen, IgG, IgA, albumin, 
haemoglobin, protease inhibitors, IL-1, chemokines and cytokines. The main component 
of corneal stroma matrix is type I collagen, which can be degraded by Acanthamoeba 
proteases (e.g. serine, cysteine and metalloprotease). Moreover, the production of 
metalloprotease was shown to exhibit degradation of ECM (extracellular matrix) 
components such as collagen and laminin (Alizadeh et al., 2007; Rocha-Azevedo et al., 
2010; Tripathi et al., 2012).  
1.4.6.2.2 Phospholipases 
Phospholipases enzymes are classified into five major classes A1, A2, B, C and D, and 
their role is to catalyse the hydrolysis of phospholipids into fatty acids and other 
lipophilic substances. However, a few studies referred to the presence of phospholipases 
in Acanthamoeba infections. Overall, each of these factors presented have a crucial role 
in invasion of Acanthamoeba trophozoites and development of disease. However, their 
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precise roles remain to be determined in further studies (Khan, 2008; Lorenzo-Morales 
et al., 2015). 
1.4.7 Indirect virulence factors 
Acanthamoeba ability to initiate any infection in the human body is a complicated 
process depending on direct and indirect factors. Some of these factors are 
Acanthamoeba cell morphology (e.g. the active stage, trophozoite), temperature (e.g. 
the suitable temperature for Acanthamoeba to grow from 12-37 °C), osmolarity ranging 
between 50-80 mosmol, pH ranging between 4-12, phenotype switching, drug resistance 
(Acanthamoeba elicit resistance against most of the drugs used), ubiquity 
(Acanthamoeba found in diverse environments), and biofilms (biofilms are suitable 
niches to provide nutrition for Acanthamoeba) (Alsam et al., 2008; Khan, 2008). 
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1.5 Alternative therapeutic techniques 
The increase in multidrug-resistant bacteria has been widely reported. Different 
resistance modes could be present in a bacterial strain, and that could be related to 
increasing virulence leading to increased morbidity and mortality in patients (Bax and 
Griffin, 2012). Several factors are associated with the increased antimicrobial resistance 
in bacteria, such as the overuse and improper uses of antimicrobial agents (Spellberg et 
al., 2008; Juul et al., 2016). This could happen through several mechanisms such as, 
some microorganisms develop the ability to neutralize the antibiotic, and others can 
change the target attack site, rendering the antibiotic ineffective. Mutations are not 
uncommon in bacterial genetic material and also, resistance could increase through the 
transfer of resistance determinants intra and inter species (Bozdogan et al., 2003; 
Aminov and Mackie, 2007; Li and Nikaido, 2009; Wegener, 2012). MRSA and P. 
aeruginosa are just examples of antibiotic-resistant bacteria, which often cause wound 
infections. These antibiotic-resistant bacteria are difficult to treat, often associated with 
prolonged hospital stay, and they could cause complications and can increase the risk of 
death (Sawa et al., 2014; Duerden et al., 2015). In addition, Acanthamoeba have two 
stages in their life cycle, trophozoite and cyst forms. Acanthamoeba trophozoites turn to 
cyst in harsh conditions notably, presence of medications. Some studies showed that 
bacteria have the ability to survive and multiply inside both forms of Acanthamoeba 
(Alsam et al., 2006; Thomas et al., 2010; Cardas et al., 2012). Other studies concluded 
that the protected bacteria inside Acanthamoeba become more resistant to antibiotics 
(Spellberg et al., 2008). With this increased resistance, the need for new antimicrobial 
agents (e.g. iron chelators) is urgent (Lamb, 2015; Rangel-Vega et al., 2015). 
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1.5.1 Importance of iron for pathogens 
Iron is one of the essential elements required for the growth of all bacteria (Lewin, 
1984). Iron has many different functions in bacterial cells. It has an effect on the 
synthesis of the cell structures, proteins, enzymes, DNA and RNA, in addition to its 
influence on the metabolism process. Those functions, also showed the main important 
role of iron for the bacteria to enhance the interaction of bacteria with the host cells 
which would include the pathogenicity (see table 1.3) (Messenger and Barclay, 1983; 
Yamaji et al., 2004).  
 
Table 1.3 Role of iron in microorganisms. 
Table adapted from (Messenger and Barclay, 1983). 
  
Affected Area Effects 
Cell structure and 
contents 
Shortage of iron can cause: growth inhibition, decrease 
in RNA and DNA synthesis, changes in morphology of 
cells  
Metabolism and  
Metabolic products 
Examples of metabolism processes requiring iron: 
tricarboxylic acid cycle, oxidative phosphorylation, 
nitrogen fixation, aromatic biosynthesis  
Some of metabolic products which regulated by 
increased or decreased the iron element: porphyrins, 
toxins, hydroxamates, cytochromes, siderophores, 
aromatic compounds, DNA and RNA 
Proteins and 
enzymes 
Examples of proteins and enzymes required iron: 
Peroxidase, superoxide dismutase, nitrogenase, hydro- 
genase, glutamate 
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Iron roles are considered to be catalytic rather than regulatory roles. Iron is required to 
activate the responsible enzymes for the oxidative metabolism of the tricarboxylic acid 
cycle, such as aconitase, which is an iron-sulphur protein that catalyses the 
interconversion of citrate and isocitrate. Although iron is important for the metabolism 
through tricarboxylic acid cycle, the aerobic and facultative anaerobic bacteria are able 
to metabolise through glycolysis using glycolytic enzymes which do not require iron 
element (Braun and Hantke, 2011; Ledala et al., 2014). As a result, phosphorylation 
would be the main source of energy rather than oxidative phosphorylation. However, 
the shortage of iron would lead to reduced DNA and RNA levels in bacteria. The DNA 
synthesis will fail as a result of the dysfunction of ribonucleoside diphosphate which is 
responsible for deoxyribonucleotide synthesis (Hammer and Skaar, 2011). Moreover, 
the deficiency in the amount of iron could make a significant change in the structure of 
tRNA. Some of nitrogen assimilation stages need iron as an essential element. For 
example, nitrogenase enzyme in bacteria consists of an iron-molybdenum protein and 
an iron-protein (Miller et al., 2009). The intracellular iron in the host cells is not 
available for the extracellular bacteria. In addition, the amount of free iron in the serum 
is very low, as it is conjugated with high affinity iron-binding proteins. Therefore, 
conjugated iron in the host is a natural immunity of the host to limit the growth of 
pathogens. This limitation of iron leads the microorganisms to improve their strategies 
to obtain the iron required for growth and survival within the host body (Crosa and 
Payne, 2004; Cassat and Skaar, 2013; Ledala et al., 2014). 
1.5.2 Mechanisms of iron acquisition 
The iron in form of Fe3+ is almost insoluble, but it is toxic with the formation of oxygen 
radicals which could damage the DNA and proteins. Iron is mostly found as bound 
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element with proteins such as transferrin, lactoferrin and hemoglobin. To get the iron 
they need, microorganisms have developed several mechanisms. They can use their own 
siderphores or other siderophores of other microorganisms to release the iron compound 
and then transport the iron into their cytoplasm through specific transport systems. Or, 
they can get the iron from the host heme in blood and iron binding proteins. They can 
deal with the shortage of iron via enhancing gene transcription encoding iron-transport 
proteins. They are able to synthesize different iron transport systems according to iron 
available in any infection of the human body (Hider and Kong, 2010).  
1.5.2.1 Iron acquisition in S. aureus 
Staphylococcus aureus responds to the shortage of iron in the host by activating the 
ferric uptake regulator (Fur). In most Gram-negative bacteria, Fur regulates iron 
metabolism to precisely control cytoplasmic iron levels. Although Fur regulation 
involves the binding of Fur-Fe2+ to the promoter region as a repressor and can function 
as an activator even without an iron cofactor in some pathogenic bacteria (Deng et al., 
2012). Staphylococci obtain the iron through siderophores and heme acquisition 
systems (Torres et al., 2010). There are two types of carboxylate siderophores in S. 
aureus such as, staphyloferrin A and staphyloferrin B. Staphyloferrins are characterised 
by two receptors, HtsA specific for staphyloferrin A and SirA, specific for 
staphyloferrin B (Cheung et al., 2009; Cotton et al., 2009; Grigg et al., 2010). In 
addition, S. aureus has another receptor for iron known as Fhu transporter, which is 
responsible for transfering Fe3+ hydroxamates to inside bacteria (Beasley et al., 2011; 
Hammer and Skaar, 2011). Furthermore, S. aureus secretes haemolysins which lyse red 
blood cells resulting in acquisition of the hemoglobin. This is followed by a sequence of 
steps to extract the heme from hemoglobin by using some proteins in the S. aureus cell 
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wall and plasma membrane ending with internalization of heme by using the Isd system. 
Two receptors within the Isd system are colocalized on the cell surface and both are 
important for the virulence of S. aureus, namely IsdB (haemoglobin receptor) and IsdA 
(heme receptor). In the cytoplasm, S. aureus produces a heme-oxygenase enzyme 
(staphylobilin), which extract the iron from the porphyrin ring by degrading the heme 
via IsdG and IsdI (Mazmanian et al., 2003; Muryoi et al., 2008; Hammer and Skaar, 
2011). 
1.5.2.2 Iron acquisition in P. aeruginosa 
There are four different strategies of iron uptake used by P. aeruginosa. The first and 
main strategy is via siderophore production, including pyoverdine and pyochelin, and 
through TonB-dependent receptors (TBDR) in the cytoplasmic membrane protein 
(Schalk et al., 2012; Schalk and Guillon, 2013). P. aeruginosa pyoverdine is a high 
affinity siderophore which is needed in the case of acute infections. Pyoverdine is a 
complex siderophore containing a chromophore and a peptide chain. This type of 
siderophore is characterised by fluorescent pigment produced by grown P. aeruginosa 
in low iron conditions (Visca et al., 2007). Pyoverdines have the ability to separate iron 
from transferrin, and their production is required to cause infection in a burnt mouse 
model (Imperi et al., 2013), whereas, TonB protein mutation is avirulent in this mouse 
model (Takase et al., 2000). Along with the pyoverdine role as a siderophore, it acts 
also in molecular signalling to enhance two extracellular virulence factors, the protease 
PrpL and the exotoxin A (Cornelis, 2010). The other siderophore of P. aeruginosa is 
pyochelin which has a very low affinity for iron, and can be produced by all strains of 
P. aeruginosa (Brandel et al., 2012). Pyochelin is firstly produced by P. aeruginosa 
however, in the case of a shortage of iron, bacteria switch into pyoverdine production 
Chapter 1 
   
  
60 
(Dumas et al., 2013). Pyochelin can be found in chronic infections, as it plays a role in 
the inflammatory response by damaging the host tissues (Lyczak et al., 2002).  
Furthermore, P. aeruginosa use Has and Phu systems to uptake the heme from the 
hemoproteins (Ochsner et al., 2000). P. aeruginosa Has system secretes heme-binding 
hemophore protein in order to extract the heme from the hemoproteins such as 
hemoglobin, while the heme is extracted directly in the Phu system via an outer 
membrane TBDR. In order to internalize the heme, periplasmic binding protein will 
bind with heme and transport it to the cytoplasm via ABC transporter followed by 
degrading the heme by heme oxygenase to extract the iron (Barker et al., 2012; O’Neill 
et al., 2012). 
Other strategy used by P. aeruginosa to obtain iron is xenosiderophore. The ability of P. 
aeruginosa to use several different types of xenosiderophores could help it to compete 
with other microorganisms to uptake the available iron. However, the importance of 
xenosiderophore iron-uptake strategies in infections has not been determined. They 
could be important in the case of polymicrobial infections, by making P. aeruginosa 
have an advantage in the presence of other microbes at the site of infection. P. 
aeruginosa has the ability to take up siderophores produced by other microorganisms 
(siderophore piracy) (Traxler et al., 2012; Cornelis and Dingemans, 2013). 
1.5.2.3 Iron acquisition in Acanthamoeba 
A few reports have described the mechanisms of iron-uptake by the protozoa and the 
role of protozoan proteases in the degradation of iron-binding proteins. However, one of 
the main pathogenicity factors of Acanthamoeba is protease production. Acanthamoeba 
like other organisms need iron to survive and multiply (Siddiqui and Khan, 2012). 
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Proteases have been determined as factors used by protozoa to degrade iron-binding 
proteins in the host, such as hololactoferrin, transferrin, and hemoglobin (Serrano-Luna 
et al., 1998; León-Sicairos et al., 2005; Reyes-López et al., 2011). Cysteine proteases 
produced by Acanthamoeba castellanii and other protozoa have been suggested to be 
the responsible factor in degrading iron-binding proteins. These proteases could be 
involved in iron uptake and may represent a virulence factor to initiate different diseases 
caused by Acanthamoeba (Reyes-López et al., 2011; Martínez-Castillo et al., 2015; 
Ramírez-Rico et al., 2015). Similar to the mammalian cells, transferrin receptors (Tfr) 
in the protozoa membranes are responsible for the transport and uptake of iron by 
endocytosis, however, there is little information about the signals and pathways induced 
by this mechanism to obtain iron (Reyes-López et al., 2015). 
1.5.3 Iron chelation techniques 
The aim of chelation therapy is to reduce the iron level in the area. Chelation therapy 
has been established to treat patients with thalassemia in the 1980's (Borgna-Pignatti et 
al., 2004). The aim of using this therapy in thalassemia patients is to remove the 
overload of iron and therefore reduce the complications related to iron burden. Many 
iron chelators have been reported in the literature, such as deferoxamine (DFO) and 
deferiprone (DFP) (Poggiali et al., 2012). 
DFP is one of hydroxypyridinone iron chelators synthesized by Dr. Kontoghiorghes in 
the early to mid 1980s in the laboratory of Professor R. Hider at the University of 
Essex, United Kingdom (Kontoghiorghes, 1985). The medicinal chemists in this 
laboratory were researching a molecule that could be taken orally, bind iron in 
conditions of iron overload, such as thalassemia, and excrete it from the body (Victor 
Hoffbrand, 2005). Moreover, the excitement over the discovery of a potentially 
Chapter 1 
   
  
62 
effective oral iron chelator led the investigators to initiate a development program of 
animal studies that would lead them to the most rapid route to a trial in humans. The 
first publication of the use of DFP in man was published in 1987 (Kontoghiorghes et al., 
1987). 
The affinity of a selective iron chelator is very important when the high-affinity ones 
can easily be taken up by microbes. So, the affinity of iron chelator agents must be very 
high, enabling them to compete efficiently with siderophores. Moreover, topical 
application of chelators may be used in different ways such as cosmetic application, or 
in wound healing and in the treatment of wound infections (Qiu et al., 2011). 
There are some recent studies showing the antimicrobial effect of DFP, DFO and other 
developed iron chelators on microorganisms, such as E. coli, S. aureus and P. 
aeruginosa (Qiu et al., 2011; Xu et al., 2011; Thompson et al., 2012; Zhou et al., 2015). 
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1.6 Aim and objective(s) 
MRSA and P. aeruginosa are the main multi-drug resistant pathogens associated with 
deep wound infections and then septicaemia. Treatment is problematic and re-infection 
is quite common. As well as bacteria, wounds can be colonised with protozoan 
microorganisms such as Acanthamoeba which feed on bacteria. The wide distribution of 
Acanthamoeba in the environment and its role as a Trojan horse for different bacterial 
strains suggest they may play an important role in wounds, acting as a protector for the 
intracellular bacteria against the treatment. As well as that, episodes of wound infection 
and healing periods could be attributed to the presence of Acanthamoeba. However, 
there is no single report showing the presence of Acanthamoeba in infected wounds. 
The main questions of this thesis are: does Acanthamoeba occur in wounds and does it 
have any role in wound infections?  
To this end, many aspects and objectives have been investigated.  
1- The ability of MRSA and P. aeruginosa strains to interact with and survive 
inside a human skin cell line and in different Acanthamoeba strains. 
2- To examine new alternative therapies against these multi-drug resistant 
microorganisms. 
3-  To study the role and pathway of these microorganisms in inducing cell death 
by using the human skin cell line and stem cells that can be used to speed up 
wound healing. 
4- To look for the presence of Acanthamoeba in clinical samples obtained from 
infected wounds. 
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Chapter 2 : The interaction of MRSA and Pseudomonas with skin 
epithelial cells and Acanthamoeba in wound infections 
2.1 Introduction 
Wound infections are the second common amongst health care associated infections 
such as urinary tract infection in hospitals, accounting for 10–16 % of all nosocomial 
infections (Kingsley, 2001; Frescos and Rando, 2008). There are many factors that 
could affect the progress of wound infections and make them more complicated. Large 
numbers of different microorganisms will enter the wound and the inflammatory 
response will result, as the integrity and protective function of the skin is breached. That 
would be clear and easy to diagnose by the classic signs of inflammation, such as 
redness, pain, fever and swelling. The process of the body’s response is to restore the 
stability of the interdependence of the elements to return homeostasis in the infected 
area (Calvin, 1998; Sibbald et al., 2003). 
All wounds are colonised with different types of microbes (Bryant and Nix, 2012). In 
fact, these microorganisms are not all harmful and they are naturally found as flora on 
the skin’s surface. Although the intact skin acts as a natural barrier against these 
microbes, a wound can significantly compromise this defence mechanism and allow 
microbes to enter and cause infections. The target layer of the skin for pathogenic 
microbes to cause infection is the underlying tissue, where there are suitable conditions 
and nutrients for microbes to colonise, grow and multiply. These microorganisms 
include bacteria, fungi, protist and viruses. MRSA and P. aeruginosa are the most 
common causes of wound infections and are isolated from both chronic and acute 
wounds (Gardner et al., 2001). There are some studies which show their prevalence in 
different wound sites, such as surgical sites, penetrating trauma, burn wounds and ulcers 
(Gomez et al., 2009; Keen et al., 2010). The presence of bacteria in chronic and non-
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healing wounds is to some extent high. Other studies show that the presence of MRSA 
and P. aeruginosa as polymicrobial infection in wound can lead to increased 
antimicrobial resistance (Pfaller et al., 1989). Therefore, MRSA and P. aeruginosa were 
selected for this study. 
2.1.1 MRSA 
MRSA is a common opportunistic pathogen, which causes the majority superficial skin 
infections, thus increasing morbidity and mortality. MRSA-associated infections in both 
acute and chronic wounds have been reported and well-documented. Virulence factors 
and toxins produced by MRSA play a main role in its pathogenicity. These virulence 
factors include a-hemolysin (Hla), staphyloccal protein A (spa), and Panton-Valentine 
leukocidin (PVL). Surface proteins of MRSA have multi functions in the pathogenesis. 
In addition to their functions in the metabolism of the bacterial cell wall, they have a 
main role in the binding to the host cells and biofilm formation (Foster and Höök, 1998; 
Pastar et al., 2013). MRSA surface binding proteins that interact with human skin 
matrix molecules may play a role in the MRSA colonisation and then infection, 
especially when the matrix proteins are exposed through breaching the superficial tissue 
layers. Together, S. aureus proteins G and X (SasG, SasX) and clumping factor B has 
been shown to have a role in binding to nasal epithelial cells (O’Brien et al., 2002; 
Roche et al., 2003; Corrigan et al., 2009). SasX protein has been shown as an important 
binding protein, as it is linked to an MRSA epidemic. This protein is encoded on a 
Mobile Genetic Element (MGE) that often occurs in ST239 MRSA strains, which are 
considered as the common source of MRSA infection in Asia (Li et al., 2012).  
2.1.2  Pseudomonas aeruginosa 
P. aeruginosa is another pathogen, which can cause serious nosocomial infections, such 
as surgical-site infection that could develop to be a chronic wound infection. Similar to 
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other pathogens, cellular and extracellular virulence factors (e.g. exoenzyme S) play a 
role in the pathogenesis. These factors help the microorganism to colonise, invade then 
survive inside the host cells (Rocha et al., 2003; Harmsen et al., 2010). P. aeruginosa 
virulence factors could be classified into two main types. Firstly, virulence factors 
within acute infections, which could be either surface proteins (e.g. pili) or secreted 
enzymes (e.g. exotoxin A) (Ben et al., 2011). Pili are one of these surface factors which 
are responsible for the binding of bacteria to host epithelial cells (Hahn, 1997). 
Exoenzyme S (ExoS) is another factor that reinforces adhesion to epithelial cells via 
disruption of normal cytoskeleton. In addition, ExoS motivates ADP-ribosyltransferase 
activity of Ras family proteins. Expression of the ADP-ribosyltransferase domain also 
inhibits Pseudomonas internalization by epithelial cells and macrophages (Shaver and 
Hauser, 2004). Secondly, virulence factors occur within chronic infections, such as 
pyoverdine, which helps the bacteria to survive and multiply despite the limitation of 
iron in the environment. Pyoverdine is a small molecule iron chelator, which is 
necessary for the metabolism and regulation of the secretion of some virulence factors 
(exotoxin A, proteases). In addition, the Quorum Sensing system (QS) is one of the 
regulation systems which control the expression of virulence factors (Ben et al., 2011). 
There are two types of QS population density-dependent system which are expressed in 
P. aeruginosa: LasI-LasR and RhlI-RhlR. Both systems have a role in pathogenicity by 
regulating the expression of virulence factors; such as exotoxin A (ToxA) and ExoS 
which could induce apoptosis in lymphocytes (Pastar et al., 2013). 
2.1.3  Acanthamoeba 
The wide distribution of Acanthamoeba in the environment gives a high risk of this 
organism using deep wounds as a gateway to the human body to go through the blood 
stream and then to the Blood Brain Barrier (BBB), potentially causing AGE in 
Chapter 2 
   
  
68 
immunocompromised patients. However, there are no reports to show the presence of 
Acanthamoeba in infected wounds in healthy individuals. The presence of 
Acanthamoeba in infected wounds will be discussed in detail in (Chapter 5). Some 
studies have shown that Acanthamoeba is the Trojan horse for a variety of microbes 
including MRSA and P. aeruginosa as they can survive and multiply inside both 
Acanthamoeba trophozoite and cyst stages, then burst the Acanthamoeba (Cardas et al., 
2012; Yousuf et al., 2013). Hence, three Acanthamoeba strains were selected to 
performe this study. 
Here, the ability of MRSA and Pseudomonas strains isolated from wound infection to 
bind with, invade, survive and multiply inside human skin cell line and different 
pathogenic and non-pathogenic strains of Acanthamoeba were investigated. 
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2.2 Materials and Methods 
All chemicals were purchased from Sigma, unless otherwise stated. 
2.2.1 Cell lines and cell culture 
Human KB epithelial cells isolated from human epidermal carcinoma of the mouth were 
kindly provided by the University College of London (UCL). KB epithelial cell line was 
provided as proliferating cells in T-25 flask. Cells were cultured and maintained in 
Eagle's Minimum Essential Medium (EMEM) supplemented with 10 % (v/v) foetal calf 
serum, 0.1 % (w/v) (1000 U/mL, 1 mg/mL) penicillin/streptomycin and 1 % non-
essential amino acids. Cells were transferred into three T25 flasks and incubated at 37 
oC in humidified 95 % air, 5 % CO2. Theoretically, cells become confluent within 2 
days (~3x106 cells). All transfers, used in experiments, were between transfer numbers 
4 to 10. 
2.2.1.1 Transfer cells into T25 flask 
To transfer cells, growth medium was aspirated off from the confluent flask. Growing 
cells were washed by phosphate-buffered saline (PBS) once. Then, 0.5 mL Trypsin- 
Ethylenediaminetetraacetic acid (EDTA) (1X) was added into the tissue culture flask 
and rocked them for 1-2 min, and then the flask was tapped. Once the cells detached 
from the tissue culture flask, the trypsin was immediately inactivated by adding 5 mL of 
growth medium. The flask contents were transferred to a 15 mL centrifuge tube. The 
sample was centrifuged for 4 minat 1000 x g. The supernatant was discarded and the 
pellet was re-suspended in warm growth medium. In the end, the suspended cells were 
transferred to three other flasks and incubated at 37 oC in humidified 95 % air, 5 % CO2 
incubator.  
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2.2.1.2 Seeding cells in 24 well-plate 
The cells were detached as described earlier.  The suspended cells were seeded in 24-
well plate (~5x105 cells per 0.5 mL in each well) and incubated at 37 oC in humidified 
95 % air, 5 % CO2 incubator. and isolated by Dr J Lorenzo-Morales 
2.2.2 Acanthamoeba culture 
Two clinical isolates of Acanthamoeba castellanii (T1 and T4 genotype), isolated from 
granulomatous encephalitis and keratitis patient, and one environmental isolate (T7 
genotype) used in the study were kindly provided by Dr S Maciver, and isolated by Dr J 
Lorenzo-Morales (University of Edinburgh). The amoebae were grown in 10 mL 
Peptone Yeast Glucose (PYG) medium (0.75 %, w/v, proteose peptone; 0.75 %, w/v, 
yeast extract; 1.5 %, w/v, glucose) in T-75 tissue-culture flasks at 30 oC (Khan 2001, 
Alsam et al. 2006). The medium was refreshed every 17–20 h prior to experiments to 
get 95 % confluence in the trophozoite form. 
2.2.3 Bacterial culture 
Three MRSA strains and three Pseudomonas strains were used in the present study. All 
bacterial strains were obtained from Colchester General Hospital by Dr Tony Elston. 
These strains are clinical isolates from wound infection patients. All strains were 
streaked onto nutrient agar and incubated overnight in 37 oC air incubator, and refreshed 
every week. One or two single colonies of bacteria were grown in Luria-Bertani (LB) 
broth overnight at 37 oC in air incubator. The MRSA strains concentration were 
estimated by Optical Density (OD) measured by spectrophotometer [Cecil CE 2041] at 
wavelength 595 n.m. multiplied by a factor of 0.22 (OD595 0.22 = ~108 CFU/mL), while 
Pseudomonas strains were measured with OD 0.35 (OD595 0.35 = ~108 CFU/mL) at the 
same wavelength. 
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2.2.4 Association assays 
This assay was used to study the interaction of bacterial strains with the human skin cell 
line and Acanthamoeba (Figure 2.1). In brief, human cells or Acanthamoeba were 
cultured and grown in 24-well plates in their own medium [EMEM for KB epithelial 
cells and PYG for Acanthamoeba] (~5x105 cells per 0.5 mL in each well); next, plates 
were incubated till confluency. Then, the growth medium was discarded, and Roswell 
Park Memorial Institute medium 1640 (RPMI 1640) (with Stable Glutamine and Phenol 
Red) was added for Acanthamoeba, and EMEM medium for KB epithelial cell line.  
Next, bacteria (~5x106 CFU/well) were added onto cells with medium and incubated for 
1 h at room temperature for Acanthamoeba, while KB epithelial cells with bacteria were 
incubated 1 h at 37 oC in humidified 95 % air, 5 % CO2 incubator. Then, supernatants 
were discarded and washed by PBS once to remove non-adherent bacteria. Next, 
Acanthamoeba were lysed by adding 0.5 % (v/v) sodium dodecyl sulfate (SDS) final 
concentration with PBS for 20 min, while KB epithelial cell line was lysed by 0.5 mL of 
CelLytic M. In the end, 20 µl of lysed solution was cultured onto Cysteine lactose 
electrolyte deficient (CLED) agar, and incubated overnight at 37 oC in air incubator. 
Then number of recovered bacteria were counted. The bacteria associated with 
epithelial cell lines or Acanthamoeba were calculated as follows: number of bacteria 
recovered (CFU) / number of bacteria inoculated at the start of the experiment × 100 = 
% of bacteria associated with cells (Alsam et al., 2006; Yousuf et al., 2013). 
2.2.5 Invasion assays 
To determine the ability of bacteria to invade or be taken up by A. castellanii and the 
KB epithelial cell line, invasion assays were performed (Figure 2.1). Briefly, 
Acanthamoeba or epithelial cells were grown until confluent in 24-well plates as 
described above. After 1 h incubation with bacteria as detailed above, the wells were 
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washed with PBS, and then antibiotics were added to kill extracellular bacteria 
(vancomycin against MRSA, and ciprofloxacin against Pseudomonas; 100 µg/mL final 
concentration, for 45 min). Finally, cells were washed lysed and then cultured onto 
CLED agar and then, bacteria were counted as described above. The intracellular 
bacteria were calculated as follows: number of bacteria invade each cell or amoeba = 
number of bacteria recovered (CFU) / number of bacteria inoculated at the start of the 
experiment × 100 = % of intracellular bacteria inside cells (Alsam et al., 2006; Yousuf 
et al., 2013). 
2.2.6 Intracellular survival assays 
To determine the long-term fate of bacteria inside A. castellanii and KB epithelial cell 
line, intracellular survival assays were performed (Figure 2.1). Briefly, Acanthamoeba 
or epithelial cell line were incubated with bacteria, followed by the addition of 
antibiotic for 45 min, as described above. After incubation, wells were washed with 
PBS. Then, Acanthamoeba were incubated in 0.5 mL RPMI 1640 for overnight at 30 
oC, while epithelial cell line was incubated in 0.5 mL EMEM medium for overnight at 
37 oC in humidified 95 % air, 5 % CO2 incubator. Finally, Acanthamoeba or epithelial 
cell line were lysed and cultured onto CLED agar and intracellular bacteria were 
counted as described above. The survival of intracellular bacteria after 24 h incubations 
were calculated as follows: number of bacteria recovered (CFU) / number of bacteria 
inoculated at the start of the experiment × 100 = % of intracellular survival bacteria 
inside cells (Alsam et al., 2006; Yousuf et al., 2013). 
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Figure 2.1 Stages of interaction assays. 
Stages of interaction assays (association, invasion and survival) of bacterial strains with host 
cells (A. castellanii or epithelial cells).  
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2.2.7 Software and statistics: 
Microsoft Office Excel programme was used to prepare graphs and to calculate the 
means, standard deviation and standard error. To find the significant differences 
between bacterial strains, two-tail t-Test was applied to calculate P value.  
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2.3 Results 
Association assays were performed to determine the ability of MRSA and Pseudomonas 
to interact with A. castellanii and epithelial cells. Our findings revealed that MRSA 
strains exhibited significantly less association with KB epithelial cell line and 
Acanthamoeba strains than Pseudomonas strains (Figure 2.2. a and b; Figure 2.3. a and 
b). Where the association percentage of MRSA with skin epithelial cells was ~ 0.03 %, 
while the association percentage of Pseudomonas strains with skin epithelial cell line 
was ~ 12.3 %. Furthermore, MRSA strains were associated with Acanthamoeba T1, T4 
and T7 with these percentages ~ 0.41, 0.25 and 0.55 %, respectively, while the 
association percentages of Pseudomonas strains with Acanthamoeba T1, T4 and T7 
were ~ 12.7, 17 and 16.7 %, respectively. Pseudomonas 3 exhibited higher association 
with all Acanthamoeba strains (T1, T4 and T7) compared with P. aeruginosa1 and P. 
aeruginosa2. Interestingly, MRSA3 exhibited significantly higher association with 
Acanthamoeba T1 and T7 compared with MRSA1 and MRSA2 that exhibited similarly 
percentages of association with all Acanthamoeba strains. 
Pseudomonas strains exhibited ~ 281 folds higher growth within epithelial cells 
compared with MRSA, while MRSA strains showed ~ 130 folds higher growth within 
Acanthamoeba compared with epithelial cells. 
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Figure 2.2 Association assays of MRSA and P. aeruginosa with KB epithelial cell line. 
(A) The percentage of associated MRSA strains with KB epithelial cell line. (B) the percentage 
of associated Pseudomonas strains with epithelial cell line. Results are the mean of three 
independent experiments performed in duplicate. Error bars represent standard error. Statistical 
analysis: two-tailed t-test (* = P<0.05).  
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Figure 2.3 Association assays of MRSA and P. aeruginosa with Acanthamoeba T1, T4 and T7. 
(A) The percentage of MRSA strains associated with Acanthamoeba strains. (B) the percentage 
of Pseudomonas strains associated with Acanthamoeba strains. Results are the mean of three 
independent experiments performed in duplicate. Error bars represent standard error. Statistical 
analysis: two-tailed t-test (* = P<0.05).  
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To determine whether Pseudomonas and MRSA strains were engulfed by 
Acanthamoeba or KB epithelial cell line, invasion assays were performed. All bacterial 
strains exhibited recovery from both Acanthamoeba strains and epithelial cells (Figure 
2.4. a and b; Figure 2.5. a and b). MRSA3 exhibited significantly higher recovery from 
epithelial cells compared with MRSA1 and MRSA2 as follows: MRSA3 showed 0.001 
% recovery from epithelial cells whereas MRSA1 and MRSA2 showed 0.0001 %, 
respectively 0.0003 % recovery from the epithelial cells. Similarly, MRSA3 revealed 
significantly higher recovery with all Acanthamoeba strains, particularly T7 as 
compared with other two strains of MRSA (Figure 2.4. a and Figure 2.5. a). 
Interestingly, all Pseudomonas strains showed almost similar percentage of recovery 
from epithelial cells as follows: 0.13 % for P. aeruginosa1, 0.15 % for P. aeruginosa2 
and 0.12 % for Pseudomonas spp1. While Pseudomonas spp1 also exhibited higher 
recovery within all Acanthamoeba strains compared to the other two strains of 
Pseudomonas. Pseudomonas strains exhibited ~ 333 folds higher growth within 
epithelial cells compared with MRSA (Figure 2.4. b and Figure 2.5. b). 
 
 
 
 
 
 
 
 
Chapter 2 
   
  
79 
 
 
 
Figure 2.4 Invasion assays of MRSA and P. aeruginosa with KB epithelial cell line. 
(A) The percentage of MRSA invaded KB epithelial cells, (B) the percentage of Pseudomonas 
strains invaded KB epithelial cells. Results are the mean of three independent experiments 
performed in duplicate. Error bars represent standard error. Statistical analysis: two-tailed t-test 
(* = P<0.05).    
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Figure 2.5 Invasion assays of MRSA and P. aeruginosa with Acanthamoeba T1, T4 and T7. 
(A) The percentage of MRSA strains invaded Acanthamoeba strains, (B) the percentage of 
Pseudomonas strains invaded Acanthamoeba strains. Results are the mean of three independent 
experiments performed in duplicate. Error bars represent standard error. Statistical analysis: 
two-tailed t-test (* = P<0.05).    
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To determine the fate of MRSA and Pseudomonas survival in long term-interactions 
with Acanthamoeba or skin epithelial cell line (Figure 2.6. a and b; Figure 2.7. a and b), 
survival assays were performed by incubation of bacteria with Acanthamoeba or 
epithelial cells for 24 h. The findings showed that all MRSA and Pseudomonas strains 
were able to survive and multiply after 24 h of incubation. Interestingly, higher 
recoveries of MRSA strains were noticed within Acanthamoeba strains than their 
recoveries within epithelial cells. Whereas, Pseudomonas strains displayed higher 
ability to survive inside epithelial cells more than Acanthamoeba strains (Figure 2.6. a 
and b; Figure 2.7. a and b). The survival percentages of MRSA1, MRSA2 and MRSA3 
within skin epithelial cell lines were ~ 0.031, 0.017 and 0.044 %, respectively compared 
with P. aeruginosa1, P. aeruginosa2 and Pseudomonas spp1 recovery after 24 h 
incubation within skin epithelial cell lines were ~ 13, 15 and 12 %, respectively (Figure 
2.6. a and b). However, MRSA and Pseudomonas strains were able to survive within 
Acanthamoeba T7 than other strains of Acanthamoeba. 
Pseudomonas strains exhibited ~ 370 folds higher growth within epithelial cells 
compared with MRSA while MRSA strains showed ~ 500 folds higher growth with 
Acanthamoeba compared with epithelial cells. 
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Figure 2.6  Intracellular survival assays of MRSA and P. aeruginosa with KB epithelial cell 
line. 
(A) The percentage of MRSA survived inside KB epithelial cell line, (B) the percentage of 
Pseudomonas strains survived inside KB epithelial cell line. Results are the mean of three 
independent experiments performed in duplicate. Error bars represent standard error. Statistical 
analysis: two-tailed t-test (* = P<0.05).  
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Figure 2.7 Intracellular survival assays of MRSA and P. aeruginosa with Acanthamoeba T1, T4 
and T7. 
(A) The percentage of MRSA strains survived inside Acanthamoeba strains, (B) the percentage 
of Pseudomonas strains survived inside Acanthamoeba strains. Results are the mean of three 
independent experiments performed in duplicate. Error bars represent standard error. Statistical 
analysis: two-tailed t-test (* = P<0.05).  
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2.4 Discussion 
It is well known that several bacterial pathogens are associated with wound infections 
with severe consequences; however, the pathogenesis and pathophysiology of these 
diseases remain unclear. A fundamental question is how do bacteria interact with the 
epithelial cells, and cause infections. To this end, a skin epithelial cell line was used. 
Three clinical MRSA strains and three Pseudomonas strains isolated from wound 
infections were used in this study. Furthermore, wounds are one of the common route of 
Acanthamoeba to enter and cause encephalitis, therefore, interaction assays were 
performed. 
In vitro interaction assays showed that, S. aureus and Pseudomonas have the ability to 
bind with, invade and survive inside epithelial cells (Ichikawa et al., 2000; Gordon and 
Lowy, 2008). S. aureus has different virulence factors which are responsible for 
adherence and invasion of epithelial cells, such as protein A, elastin-binding protein, 
collagen-binding protein, fibronectin-binding protein and clumping factor (Gordon and 
Lowy, 2008). Pili and LPS in Pseudomonas have a role in binding to and invading 
epithelial cells (Ben et al., 2011). Several lines of evidence have indicated that amoeba 
serve as a host to a number of human pathogens, including Mycobacterium avium 
(Steinert et al., 1998), Legionella pneumophila (Kilvington and Price, 1990), 
Escherichia coli (Alsam et al., 2006), Enterobacter aerogenes, Aeromonas hydrophila 
(Yousuf et al., 2013), P. aeruginosa (Michel et al., 1995) and MRSA (Cardas et al., 
2012) and are able to accommodate bacterial intracellular replication and increase their 
virulence properties pertinent to susceptible hosts (Abd et al., 2010; Sandström et al., 
2010, 2011) Huws et al., (2006) showed MRSA survival and proliferation within A. 
polyphaga. The virulence factors of both bacteria and Acanthamoeba may have the role 
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in the differences between the ability of bacteria to bind with, invade, survive and 
multiply within host cells. 
This is a consequence of the finding that Pseudomonas are more likely to bind with and 
invade Acanthamoeba and epithelial cells, and that probably depends on the virulence 
factors of Pseudomonas, such as pili and LPS, which play important roles in adhesion 
and causing any infections (Hahn, 1997; Ben et al., 2011). However, the ability of 
Pseudomonas to multiply inside Acanthamoeba is very low compared with its ability to 
multiply inside epithelial cells. That would probably rely on the virulence factors of 
Acanthamoeba. Acanthamoeba uptake bacteria by using phagocytosis and then use 
phagolysosomes to lyse them. Although Acanthamoeba feed on both Gram-positive and 
Gram-negative bacteria, they prefer Gram-negative bacteria which are widely used as a 
food source to isolate Acanthamoeba (Khan, 2006). Proteases produced by 
Acanthamoeba are used as significant markers to differentiate between pathogenic and 
non-pathogenic Acanthamoeba species (Khan et al., 2000; Sissons et al., 2006; Dudley 
et al., 2008). Acanthamoeba proteases have antimicrobial effects against different types 
of bacteria including MRSA and Pseudomonas (Iqbal et al., 2014). Our findings show 
that the environmental, non-pathogenic strain of Acanthamoeba (genotype T7), which 
does not produce any type of proteases, is more likely to host MRSA and Pseudomonas 
than other pathogenic strains of Acanthamoeba (genotype T1 and T4). This is 
interesting as this could be a potential route for bacteria to enter into the human body. 
Moreover, bacteria can remain and multiply inside Acanthamoeba within a harsh 
environment, and that may help transmit bacterial pathogens to susceptible hosts and 
also to re-infect wounds again. We demonstrated that the ability of intracellular bacteria 
to survive inside non-pathogenic Acanthamoeba are higher than pathogenic 
Acanthamoeba. In addition, Pseudomonas were appropriate food for Acanthamoeba. In 
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conclusion, non-pathogenic Acanthamoeba may play role in protecting bacteria during 
the treatment.  
MRSA and P. aeruginosa are multidrug resistant; and treatment of infected wounds 
with these strains are problematic (Gardner et al., 2001). Moreover, Acanthamoeba are 
resistant to many of antimicrobial agents as they protect themselves via encystment 
process and that would be crucial if there any bacteria inside amoebae (Aksozek et al., 
2002). Therefore, the need for alternative active treatment methods is increased. Iron 
chelators showed antimicrobial activity against range of different bacterial strains 
(Hider and Kong, 2010), thus, novel iron chelators were used against MRSA, 
Pseudomonas and Acanthamoeba strains. These will be discussed in detail in the next 
chapter (Chapter Three). 
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Chapter Three 
Effects of the iron(III)- selective hexadentate-ligands of 
iron chelators as antimicrobial agents against MRSA and 
Pseudomonas strains and Acanthamoeba spp.
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Chapter 3 : Effects of the iron(III)- selective hexadentate-ligands of 
iron chelators as antimicrobial agents against MRSA and 
Pseudomonas strains and Acanthamoeba spp. 
3.1 Introduction 
Nosocomial infections caused by antibiotic-resistant bacteria are becoming more 
common (Hogan and Kolter, 2002). The severity of these infections is variable, between 
superficial only, such as cellulitis, and severe infection, such as Staphylococcal Scalded 
Skin Syndrome (SSSS) (Plowman, 2000). The healthcare associated infections (HAI) 
are amongst the important factors which would lead to prolonged stays in hospital, 
therefore increasing the cost of wound care (Talan et al., 2011). It is a big task 
nowadays for clinicians to manage and keep wound infections under control. Wound 
infections involve a complex interaction between host, pathogens and the environment. 
However, the molecular mechanisms of the interaction of host and pathogen are crucial 
and not completely understood (Cooper, 2005). Both MRSA and P. aeruginosa are 
multi-drug resistant bacteria because of the over use and misuse of antibiotics. MRSA 
has been directly associated with severe wound infections and has resulted in an 
increase in morbidity and mortality rates (Gardner et al., 2001). Treatment is 
problematic, because of their increased virulence factors, such as penicillin-binding 
protein 2A (PBP2A) in MRSA that is responsible for antibiotic resistance. Therefore, 
the need for alternative treatment methods has become very important. 
Iron is an essential cofactor of many biochemical pathways in both prokaryotic and 
eukaryotic species (Thompson et al., 2012). Hence, decreasing the availability of iron 
should, in principle, inhibit microbial growth (Lewin, 1984). There are many strategies 
used by many different microorganisms to absorb and scavenge iron from their 
environment, such as producing and secreting siderophores, which have a high affinity 
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and selectivity for iron(III) (Hider and Kong, 2010). S. aureus use two types of 
carboxylate family siderophores, which are staphyloferrin A and staphyloferrin B, via 
the transporters Hts and Sir, respectively, to access the transferrin iron pool (Beasley et 
al., 2011). Pseudomonas aeruginosa produces two types of siderophores, which are 
pyoverine and pyochelin. Moreover, P. aeruginosa uses a large number of 
xenosiderophores to uptake the iron molecule by a mechanism known as siderophore 
piracy (Youard et al., 2011). The presence of the high-affinity iron-selective chelating 
agents can interrupt the iron uptake (Bergan et al., 2001). The affinity of these agents 
must be extremely high to be able to efficiently out-compete the native siderophores for 
iron. Therefore, siderophores would not be able to scavenge iron molecules when the 
high affinity hexadentate hydroxypyridinone binds with iron (Hider and Kong, 2010). 
The design of iron chelators for an antimicrobial purpose should not have one of the 
structures which bind with siderophores, including hydroxamate, catecholate and a-
hydroxycarboxylate, otherwise the iron chelator’s complex may well be able to supply 
iron to the microorganism via the iron-siderophore transporter (Ji et al., 2012). Three 
recent studies have shown the antimicrobial effect of hexadentate 3-hydroxypyridin-4-
ones (HPO) on both Gram-positive and Gram-negative bacteria (Qiu et al., 2011; Xu et 
al., 2011; Ma et al., 2014). All compounds which have been developed and used in 
those studies have a different structure from all other known siderophores; therefore, the 
iron complex cannot gain access to the bacteria by receptor mediated transport.  
Herein the antimicrobial activity of HPO with high affinity for iron (III) against MRSA 
and P. aeruginosa isolates alone, against Acanthamoeba strains (T4 and T7), and the 
intracellular bacterial strains inside Acanthamoeba and KB epithelial cell line are 
described. Furthermore, the cytotoxic effect of bacterial strains in the presence and 
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absence of HPO, and whether these chelators would stop or reduce Acanthamoeba 
proteases expression were tested.  
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3.2 Materials and Methods 
All chemicals were purchased from Sigma, unless otherwise stated. 
3.2.1 Cell lines and cell culture 
KB epithelial cell line was grown and culture as described in section 2.2.1.   
3.2.2 Acanthamoeba culture 
Acanthamoeba strains (T4 and T7 genotypes) were grown and cultured as described in 
section 2.2.2. 
3.2.3 Bacterial culture 
MRSA and Pseudomonas strains were cultured, inoculated in LB broth and OD were 
measured by spectrophotometer as described in section 2.2.3. 
3.2.4 Preparation of antimicrobial agents 
Three novel iron chelators (13a, 13l, and 13i) were designed and synthesised for this 
study by Dr Tao Zhou from Zhejinag Gongshang University, China. The iron chelator 
3-Hydroxy-1,2-dimethyl-4(1H)-pyridone (deferiprone) was used as a control. All 
compounds were tested in five concentrations for their antimicrobial effects against 
MRSA and Pseudomonas strains. The solutions of these compounds were prepared by 
dissolving the chelator in destil sterile water (dsH2O).  
The chemical structures of compounds are shown in Figure 3.1. 
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Chemical structure of the four iron chelators 
 
 
 
 
 
 
 
 
 
 
Figure 3.1 Chemical structure of deferiprone and the novel iron chelators. 
Figure adapted from (Zhou et al., 2015). 
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3.2.5 Antimicrobial assays 
3.2.5.1 Antibacterial assay 
To determine the antimicrobial activity of the iron (III)- selective HPO chelators to 
inhibit the bacterial growth, antimicrobial assays were performed. Bacterial strains were 
grown in LB broth overnight at 37 oC. Then ODs were measured by spectrophotometer 
as described above. After measuring, each strain was diluted (1:1) in dsH2O to give 
final number of bacteria (~0.5×108 CFU/mL). Five different final concentrations of iron 
chelators (100, 200, 300, 400 and 500 µg/mL) were used in this assay. 96-well plates 
were used to perform this assay. All wells contained 80 µL of antimicrobial agent in 
sterilized water and 20 µL of bacteria (~1×107 CFU/well), except wells of controls that 
contained 80 µL of sterilized water with 20 µL (~1×107 CFU/well) of bacteria. Then, 
bacteria with iron chelators were incubated at 37 oC for 6 and 24 h. The number of 
viable bacteria in each well was determined by plating onto CLED agar using 20 µL 
volumes in duplicate. The bactericidal rate was calculated as follows: 
R=
X0 – Xt
X0
 ×100  
where R is the bactericidal rate, X0 the number of bacteria without chelator (control), 
and Xt the number of bacteria after the treatment with chelator (Qiu et al., 2011). 
3.2.5.2 Antiamoebic assays 
To determine the antimicrobial activity of the iron (III)- selective HPO chelators on 
Acanthamoeba, antiamoebic assays were performed. In brief, Acanthamoeba were 
cultured and grown in 96-well plates in PYG (~1x105 cells per 0.150 mL in each well); 
next, plates were incubated until confluent. Then, the growth medium was discarded 
and wells washed with PBS once to remove floating Acanthamoeba. Five different final 
concentrations of iron chelators (100, 200, 300, 400 and 500 µg/mL) were added to 
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different wells. All wells contained 150 µL of antimicrobial agent in dsH2O, except 
wells of controls that contained only 150 µL of sterilised water. Then Acanthamoeba 
with iron chelators were incubated at 30 oC for 6 and 24 h. The number of viable and 
unviable Acanthamoeba in each well was determined by adding 150 µL of 0.4 % 
Trypan blue in each well and incubating for 15 min. The numbers of viable and 
unviable Acanthamoeba, as judged by dye exclusion or staining, were counted by a 
haemocytometer. 
3.2.5.2.1 Conditioned medium (CM) 
To determine the effects of iron chelators on the extracellular proteases released from 
intact Acanthamoeba, CM was produced by inoculating Acanthamoeba with and 
without iron chelators in serum free medium (RPMI) for 24 h. Next day, CM was 
collected by centrifugation and used for zymography (Alsam et al., 2005b; Dudley et 
al., 2008). 
3.2.5.2.2 Zymography 
Zymographic assays were performed to visualise and begin to characterise 
Acanthamoeba extracellular proteases. Briefly, CM was mixed (1:1) with sample buffer 
(containing 4 % sodium dodecyl sulfate (SDS)) and electrophoresed on SDS-
polyacrylamide gels (SDS-PAGE) containing gelatin (1 mg/mL). After electrophoresis, 
gels were soaked in 2.5 % Triton X-100 (w/v) for 60 minto remove the SDS. Finally, 
the gels were incubated in a developing buffer (50 mM Tris-HCl, pH 7.5, containing 10 
mM CaCl2) at 37 °C overnight, rinsed, and stained with Coomassie brilliant blue. Areas 
of gelatin digestion indicating protease activities are seen as non-staining regions in the 
gel (Alsam et al., 2005b; Dudley et al., 2008).  
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3.2.6 Intracellular antimicrobial assays 
3.2.6.1 Acanthamoeba intracellular uptake 
In brief, Acanthamoeba were cultured in 96-well plates in PYG (~1x105 cells per 0.150 
mL in each well); and plates were incubated until confluency. Then, the growth medium 
was discarded and wells washed with PBS once to remove floating Acanthamoeba. 
Next, bacterial strains (~1.2x106 CFU/well) were added onto Acanthamoeba with RPMI 
medium and incubated for 1 h at room temperature. Then, supernatants were discarded 
and wells washed by PBS once to remove non-adherent bacteria. Next, the wells were 
washed once again with PBS, and then antibiotics were added to kill extracellular 
bacteria (vancomycin against MRSA, and ciprofloxacin against Pseudomonas; 100 
µg/mL final concentration, for 45 min). Then   the supernatants were discarded and 
wells washed once with PBS. The final five different concentrations of iron chelators 
(100, 200, 300, 400 and 500 µg/mL) were used in this assay. All wells contained 150 
µL of antimicrobial agent in sterilized water, except wells of controls that contained 
only 150 µL of sterilized water. Then, Acanthamoeba with bacteria inside and iron 
chelators were incubated at 30 oC for 6 and 24 h. Next, Acanthamoeba were lysed by 
adding 0.5 %SDS final concentration for 10 min. Finally, 20 µl of lysed solution was 
cultured onto CLED agar, and incubated overnight at 37 oC in air incubator. The 
bactericidal rates of iron chelators on intracellular bacteria within Acanthamoeba were 
calculated as follows: 
R=
X0 – Xt
X0
 ×100  
Where R is the bactericidal rate, X0 is the number of intracellular bacteria without 
chelator (control), and Xt represent the number of intracellular bacteria after the 
treatment with chelator. 
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3.2.6.2 KB epithelial intracellular uptake 
To investigate the effects of the iron (III)- selective HPO chelators on the intracellular 
bacteria within KB epithelial cell line, antimicrobial assays were performed. In brief, 
KB epithelial cells were cultured and grown in 96-well plates in EMEM (~1x105 cells 
per 0.150 mL in each well); then plates were incubated until confluency. Then, the 
growth medium was discarded and wells washed with PBS once to remove floating cell. 
Next, bacterial strains (~1.2x106 CFU/well) were added onto cells with EMEM medium 
and incubated for 1 h in CO2 Incubator (37 oC in humidified 95 % air, 5 % CO2). Then, 
supernatants were discarded and cells were washed with PBS once to remove non-
adherent bacteria. Next, antibiotics were added to kill extracellular bacteria 
(vancomycin against MRSA, and ciprofloxacin against Pseudomonas; 100 µg/mL final 
concentration, for 45 min). Then the supernatants were discarded and wells washed 
once with PBS. Following this, five different concentrations of iron chelators (as 
mentioned above in section 3.2.6.1.) were used in this assay. All wells contained 150 
µL of antimicrobial agent in EMEM medium, except wells of controls that contained 
only 150 µL of EMEM medium. The KB epithelial cell line with bacteria inside and 
iron chelators were incubated in CO2 incubator (37 oC in humidified 95 % and, 5 % 
CO2) for 6 and 24 h. Then, KB epithelial cells were lysed by adding 150 µL of CelLytic 
M® for 10 min. In the end, 20 µl of lysed solution was cultured onto CLED agar, and 
incubated for overnight at 37 oC in air incubator. 
3.2.7 Cytotoxicity assays 
This assay was performed to determine the cytotoxic effect of MRSA and Pseudomonas 
on KB epithelial cell line. In brief, the method used here is as previously described in 
section (2.6.). After the incubation time, the supernatants were collected in centrifuge 
tubes to determine the cytotoxic effect of these bacteria on KB cells. In addition, the 
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cytotoxic effect was assessed in three methods. The first method was by staining the 
cells with hematoxylin stain and assessing visually. The second method was by staining 
with Trypan blue and by counting viable and dead cells, which will be mentioned in the 
next section. The third method was by measuring Lactate DeHydrogenase (LDH) by 
using a specific kit (Alsam et al., 2003). 
3.2.7.1 Cell visualising 
Cytotoxic effects were assessed visually by hematoxylin staining. Briefly, the 
supernatants were collected to use for the LDH assay in the next section (3.2.7.2.); then 
cells were fixed by acetone and methanol 1:1 for 15 min. Then, hematoxylin stain was 
added to the cells to stain for 30 min. In the end, the stained cells were assessed visually 
under the microscope (Alsam et al., 2003). 
3.2.7.2 Measurements of lactate dehydrogenase (LDH) 
LDH is an enzyme that is released when cells damaged. Cytotoxic effects were 
determined by measuring LDH release into the supernatants (Cytotoxicity detection 
kitplus; Roche). Briefly, the supernatants which had been collected, were centrifuged 
(10000 x g for 5 min). Next, 50 µl of supernatants were loaded in 96-well plates. 
Moreover, high and low controls were prepared as follows:  lysis buffer was added onto 
the control cells with growth medium to release a high amount of LDH, while the low 
control was just control cells with growth medium. Then 50 µl of reaction mixture were 
added to each sample and incubated for 15 min at room temperature in the dark. Next, 
the stop solution was added to stop the reactions (Alsam et al., 2003). Finally, the 96-
well plates were shaken for 10 seconds and read by multiplate reader [FLUOstar 
Omega] at wavelength 600. The percentage cytotoxicity was calculated as follows:  
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% Cytotoxicity=
Sample value – Low control value
[High control value- Low control value]
 ×100  
3.2.8 Software and statistics: 
All graphs and data analysis were done as describe in section (2.2.7.). Microsoft Office 
PowerPoint was used to adjust the contrast and brightness of photos.  
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3.3 Results 
3.3.1 Iron chelators as antimicrobial agents 
The viable bacteria were determined after incubation of bacteria for 6 and 24 h in the 
presence or absence of the novel iron chelators (13a, 13i and 13l) compared with 
deferiprone. 13l was found to exhibit the strongest inhibitory activity against MRSA1 
amongst the tested chelators after both 6 and 24 h incubation (Figure 3.2.). At 6 h 
incubation, hexadentate chelators 13a and 13i showed stronger inhibition on MRSA1 
than deferiprone (Figure 3.2.). Compared with deferiprone, 13a exhibited similar 
inhibitory activity after 24 h incubation, while 13i was much weaker. In the cases of 
MRSA2 and MRSA3, similar results were found, chelator 13l exhibiting the strongest 
inhibitory activity throughout. After 24 h incubation, the inhibition rates of 13l at a 
concentration of 400 mg/mL against MRSA1, MRSA2 and MRSA3 were determined to 
be 96.8 %, 95.6 % and 97.2 %, respectively, while the inhibition rates of the control 
chelator (deferiprone) at the same concentration against MRSA1, MRSA2 and MRSA3 
were determined as 80.1 %, 83.1 % and 87.6 %, respectively (Table 3.1). Overall, the 
Pseudomonas strains were found to be more sensitive to the iron chelators than the 
MRSA strains. Surprisingly, at concentrations less than 200 µg/mL, all three 
compounds (13a, 13i and 13l) failed to exhibit superior inhibitory activity against the 
three strains of Pseudomonas when compared with deferiprone (Figure 3.3.). However, 
at higher concentrations, these three compounds were found to exhibit a stronger 
inhibitory effect compared with deferiprone. After incubation for 24 h, all three strains 
of Pseudomonas were killed when the concentration of hexadentate chelator (13a, 13i 
and 13l) was over 400 µg/mL, while the bacterial inhibition rates of deferiprone at a 
concentration of 400 µg/mL against P. aeruginosa1, P. aeruginosa2 and Pseudomonas 
spp1. were determined to be 93.1 %, 92.3 % and 92.1 %, respectively (Table 3.2).  
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Figure 3.2 The growth inhibition of MRSA strains after treatment with different concentrations 
of novel iron chelators compared with deferiprone. 
(a, b and c) growth of MRSA1, MRSA2 and MRSA3, respectively, after 6 h incubation. (d, e and 
f) growth of MRSA1, MRSA2 and MRSA3, respectively, after 24 h incubation. Results are the 
mean of three independent experiments performed in duplicate. Error bars represent standard 
error. Statistical analysis: two-tailed t-test (* = P<0.05). 
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Figure 3.3 The growth inhibition for Pseudomonas strains after treatment with different 
concentrations of novel iron chelators compared with deferiprone. 
(a, b, and c) growth of P. aeruginosa1, P. aeruginosa2 and Pseudomonas spp1, respectively, 
after 6 h incubation. (d, e, and f) growth of P. aeruginosa1, P. aeruginosa2 and Pseudomonas 
spp1, respectively, after 24 h incubation. Results are the mean of three independent experiments 
performed in duplicate. Error bars represent standard error. Statistical analysis: two-tailed t-test 
(* = P<0.05). 
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MRSA1 MRSA2 MRSA3 
6 h 24 h 6 h 24 h 6 h 24 h 
Deferiprone (3.60 mM) 38.8 80.1 37.4 83.1 33.2 87.6 
13a (0.62 mM) 85.5 84.4 86.6 80.0 89.4 92.1 
13l (0.44 mM) 87.3 96.8 88.1 95.6 89.7 97.2 
13i (0.48 mM) 88.0 56.6 78.2 46.9 75.8 74.0 
 
Table 3.1 Bacterial inhibition rate (%) of iron chelators on MRSA strains after 6 and 24 h 
incubation at concentration of 500 µg/mL. 
 
 
P. aeruginosa1 P. aeruginosa2 Pseudomonas spp.1 
6 h 24 h 6 h 24 h 6 h 24 h 
Deferiprone (2.88 mM) 78.1 93.1 75.4 92.3 78.7 92.1 
13a (0.50 mM) 97.5 100 99.2 100 94.1 100 
13l (0.35 mM) 98.7 100 99.2 100 94.2 100 
13i (0.38 mM) 97.8 100 98.2 100 96.1 100 
 
Table 3.2 Bacterial inhibition rate (%) of iron chelators on Pseudomonas strains after 6 and 24 h 
incubation at concentration of 400 µg/mL. 
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3.3.2 Iron chelators as antiamoebic agents  
Antiamoebic assays were performed to determine whether the iron chelators such as 
13a, 13l, 13i and deferiprone have amoebicidal activities against Acanthamoeba T4 and 
T7 in trophozoite stage. The results showed that after 6 h incubation, 13a at 100 µg/mL 
had 100 % amoebicidal (trophozoites were killed) activity against both strains of 
Acanthamoeba [T4 and T7], while 13l and 13i had 100 % at 300 and 400 µg/mL, 
respectively, compared with deferiprone which did not show a significant activity 
against both genotypes (Figure 3.4.). As shown in (Figure 3.4.), 13l decreased the 
number of viable Acanthamoeba T4 trophozoites at 100 µg/mL after 6 h incubation 
from 18 ×104 trophozoite/mL to 9 ×104 trophozoite/mL with a amoebicidal rate 52 %, 
while 13i at the same concentration after 6 h number of viable Acanthamoeba T4 
trophozoites decreased to be 11 ×104 trophozoites/mL with a amoebicidal rate 3 %. 
However, deferiprone at 500 µg/mL did not have a real effect on Acanthamoeba T4 
trophozoites after 6 and 24 h, whereas, this chelator decreased the viable trophozoites 
from 18 ×104 trophozoite/mL to be about 16 ×104 trophozoites/mL and 13 ×104 
trophozoite/mL, respectively, with amoebicidal rates 13 and 20 %. Moreover, 100 
µg/mL of 13l and 13i chelators decreased the number of viable Acanthamoeba T7 
trophozoites after 6 h incubation from 24 ×104 trophozoite/mL to 15 ×104 
trophozoites/mL and 24 ×104 trophozoite/mL, with amoebicidal rate 36 and 12 %, 
respectively. Furthermore, 200 µg/mL of same chelators after 6 h incubation time 
decreased the number of viable cells from 24 ×104 trophozoite/mL to 9 ×104 
trophozoite/mL and 16 ×104 trophozoite/mL, respectively, with amoebicidal rates 61 
and 32 % respectively. As shown in (Figure 3.5.), all novel iron chelators at 500 µg/mL 
had antiamoebic activity on Acanthamoeba trophozoites compared with deferiprone 
which did not show any activity at the same concentration.   
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Figure 3.4 The antiamoebic effect of iron chelators on Acanthamoeba (T4 and T7) trophozoites 
after treatment with different concentrations of iron chelators. 
(a and b) Number of viable Acanthamoeba T4 after 6 and 24 h incubation, respectively. (c and 
d) Number of viable Acanthamoeba T7 after 6 and 24 h incubation, respectively. Results are the 
mean of three independent experiments performed in duplicate. Error bars represent standard 
error. Statistical analysis: two-tailed t-test (* = P<0.05). 
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Figure 3.5 Trypan blue viability test. 
Trypan blue viability test of Acanthamoeba T4 trophozoite after treated with 500 µg/mL of the 
novel iron chelators compared with deferiprone. (Acanthamoeba trophozoites, bars = 50 µm). 
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3.3.3 Effect of iron chelators on the intracellular bacteria inside Acanthamoeba 
Antimicrobial assays were performed to determine whether the iron(III)- selective 
hexadentate ligands of 3-hydroxypyridine-4-one chelators have bactericidal activities 
against MRSA and Pseudomonas within pathogenic and non-pathogenic Acanthamoeba 
trophozoites. Our findings revealed that all iron chelators almost inhibit the growth of 
intracellular MRSA at the lowest concentration (100 µg/mL) for 6 h. However, after 24 
h incubation the number of remaining viable MRSA multiplied. All novel iron chelators 
including 13a, 13l and 13i and the control chelator had antimicrobial activity after 6 h 
incubation against intracellular MRSA within Acanthamoeba T4 trophozoites at 100, 
300, 300 and 300 µg/mL, respectively. Concentrations of 13a, 13l, and 13i (100, 200, 
and 200 µg/mL, respectively), were sufficient to eliminate both Acanthamoeba T7 and 
intracellular MRSA. In order to determine whether any bacteria remained inside 
Acanthamoeba which could multiply significantly, the experiments were repeated and 
96-well plates incubated for 24 h. The Minimum Bactericidal Concentration (MBC) of 
13a, 13l and 13i after 24 h incubation were 100, 500 and 500 µg/mL, respectively, 
against MRSA inside Acanthamoeba T4, compared with deferiprone that showed viable 
MRSA at 500 µg/mL. While the MBC values for them against MRSA inside 
Acanthamoeba T7 were 100, 300 and 500 µg/mL, respectively, with bactericidal rate of 
100 % for all; by comparison deferiprone did not show activity against intracellular 
MRSA at 500 µg/mL (Figure 3.6.).  
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Figure 3.6 The antimicrobial effect of iron chelators on intracellular MRSA inside 
Acanthamoeba T4 and T7 trophozoites after treatment with different concentrations of iron 
chelators. 
(a and b) Number of recovered MRSA from within Acanthamoeba T4 after 6 and 24 h 
incubation, respectively. (c and d) Number of recovered MRSA from within Acanthamoeba T7 
after 6 and 24 h incubation. Results are the mean of three independent experiments performed in 
duplicate. Error bars represent standard error. Statistical analysis: two-tailed t-test (* = P<0.05). 
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The inhibitory effect of the chelators against the growth of intracellular P. aeruginosa is 
illustrated in (Figure 3.7.). As shown previously in this chapter, 13a had the highest 
effect on Acanthamoeba trophozoites and bacteria within. All the novel iron chelators 
showed antimicrobial activity compared with deferiprone which had no significant 
effect against intracellular P. aeruginosa. The lowest concentration (100 µg/mL) of 13a 
completely eliminated intracellular P. aeruginosa, with bactericidal rate 100 %. The 
MBC values of 13l and 13i after 6 h incubation against P. aeruginosa inside the 
trophozoite of Acanthamoeba T4 were 300 and 400 µg/mL, respectively, while the 
MBC for both chelators were 400 µg/mL against P. aeruginosa inside the T7 
trophozoite. The results after 24 h incubation showed that 13l and 13i had antimicrobial 
effect against P. aeruginosa inside both T4 and T7 trophozoite, whereas 400 and 500 
µg/mL of 13l and 13i, respectively, completely inhibit the growth of P. aeruginosa 
within T4 trophozoites. About 400 µg/mL of 13l and 13i for 24 h incubation completely 
inhibited the growth of P. aeruginosa within T7 trophozoites (Figure 3.7.). 
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Figure 3.7 The antimicrobial effect of iron chelators on intracellular P. aeruginosa inside 
Acanthamoeba T4 and T7 trophozoites after treatment with different concentrations of iron 
chelators. 
(a and b) Number of recovered P. aeruginosa from within Acanthamoeba T4 after 6 and 24 h 
incubation, respectively. (c and d) Number of recovered P. aeruginosa from within 
Acanthamoeba T7 after 6 and 24 h incubation. Results are the mean of three independent 
experiments performed in duplicate. Error bars represent standard error. Statistical analysis: 
two-tailed t-test (* = P<0.05). 
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3.3.4 Effect of iron chelators on the intracellular bacteria inside KB epithelial cell 
line and their cytotoxic effect 
Antimicrobial assays for intracellular bacteria were performed to determine if the iron 
(III)- 3-hydroxypyridine-4-one chelators have antimicrobial activities against MRSA 
and Pseudomonas within KB epithelial cell line. These findings revealed that all the 
iron chelators tested had different ranges of antimicrobial effect on the intracellular 
MRSA and P. aeruginosa after 24 h with the lowest concentration used. Deferiprone, 
13a and 13l showed similar inhibition effect at 500 µg/mL after 6 h incubations, with 
bactericidal rate 74.25 %, 74.25 % and 77.67 %, while 13i showed the lowest activity at 
the same conditions with 60.36 % bactericidal rate. After 24 h incubation, the chelators 
13l and 13i exhibited a large effect on MRSA at low concentrations (100 and 300 
µg/mL, respectively), with bactericidal rates of 95.82 % and 94.90 %, respectively 
(Figure 3.8.). While 13a and the control chelator showed low activity against 
intracellular MRSA after 24 h incubation at 500 µg/mL, with bactericidal rate 38.10 % 
and 44.57 % respectively. 
The antimicrobial activities of all iron chelators against intracellular P. aeruginosa 
within KB the epithelial cell line after 6 h were low. However, the bactericidal effect of 
all chelators on intracellular P. aeruginosa were high at 200 µg/mL after 24 h 
incubation, with a bactericidal rate ranging between 95.04 – 97.22 % (Figure 3.8.). The 
MBC for all iron chelators on the intracellular bacteria for both MRSA and P. 
aeruginosa is over 500 µg/mL, as they did not completely eliminate at this 
concentration.  
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Figure 3.8 The antimicrobial effect of iron chelators on intracellular MRSA and P. aeruginosa 
inside KB epithelial cell line. 
(a) Number of recovered MRSA within KB epithelial cell line after 6 h incubation. (b) Number 
of recovered P. aeruginosa within KB epithelial cell line after 6 h incubation. (c) Number of 
recovered MRSA within KB epithelial cell line after 24 h incubation. (d) Number of recovered 
P. aeruginosa within KB epithelial cell line after 24 h incubation. Results are the mean of three 
independent experiments performed in duplicate. Error bars represent standard error. Statistical 
analysis: two-tailed t-test (* = P<0.05). 
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An LDH cytotoxicity detection kit was used to determine the toxic effect of the 
chelators on the KB cell line and the cytotoxic effect of bacteria on the cell line in the 
presence and absence of the chelators. Cytotoxicity results showed <10 % toxicity for 
the chelators on the cells after 6 and 24 h, which is very low (Figure 3.9.). In addition, 
iron chelators did not show a real reduction of bacterial toxicity after 6 h incubation, 
whereas the cytotoxic effect of MRSA and P. aeruginosa in the presence and absence of 
chelators were <10 % (Figure 3.10.a and Figure 3.11.a). However, MRSA showed the 
highest cytotoxic effect on KB cells after 24 h, of approximately 54.3 %. The lowest 
concentration (100 µg/mL) of 13a, 13l and 13i had reduced the cytotoxicity 13.1 %, 
54.8 % and 37.7 % (respectively) to make MRSA toxicity around 47.2 %, 24.5 % and 
33.8 % (respectively), while the toxicity was reduced 5.9 % by deferiprone at the same 
concentration. Moreover, 500 µg/mL of 13a, 13l and 13i had reduced MRSA toxicity of 
49.2 %, 94.7 % and 59.1 % (respectively), compared with deferiprone which reduced 
the toxicity to 44.6 % (Figure 3.10.b). P. aeruginosa’s cytotoxicity on untreated KB 
epithelial cells was approximately 41.8 %. The toxic effect of P. aeruginosa on the cell 
line was decreased gradually by chelators, and at 100 µg/mL 13l had proportionately the 
greatest effect as it reduced the toxicity 81.8%, compared with deferiprone which just 
reduced the toxicity 8.8% at the same concentration. The highest concentration (500 
µg/mL) of 13a, 13l and 13i showed 48.1 %, 87.9 % and 90.3 % (respectively) reduction 
rate of P. aeruginosa’s toxicity, compared with deferiprone that showed 42.3 % 
reduction rate (Figure 3.11.b).  
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Figure 3.9 The cytotoxic effect of iron chelators on KB epithelial cell line after treatment with 
different concentrations of iron chelators. 
(a) Percentage of iron chelators’ cytotoxicity on KB epithelial cell line after 6 h incubation. (b) 
Percentage of iron chelators’ cytotoxicity on KB epithelial cell line after 24 h incubation. 
Results are the mean of three independent experiments performed in duplicate. Error bars 
represent standard error. Statistical analysis: two-tailed t-test (* = P<0.05). 
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Figure 3.10 The effect of iron chelators on the cytotoxic effect of MRSA on KB epithelial cell 
line after treatment with different concentrations of iron chelators. 
(a) Percentage of MRSA cytotoxicity on KB epithelial cell line after 6 h incubation. (b) 
Percentage of MRSA cytotoxicity on KB epithelial cell line after 24 h incubation. Results are 
the mean of three independent experiments performed in duplicate. Error bars represent 
standard error. Statistical analysis: two-tailed t-test (* = P<0.05).  
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Figure 3.11 The effect of iron chelators on the cytotoxic effect of P. aeruginosa on KB 
epithelial cell line after treatment with different concentrations of iron chelators. 
(a) Percentage of P. aeruginosa cytotoxicity on KB epithelial cell line after 6 h incubation. (b) 
Percentage of P. aeruginosa cytotoxicity on KB epithelial cell line after 24 h incubation. 
Results are the mean of three independent experiments performed in duplicate. Error bars 
represent standard error. Statistical analysis: two-tailed t-test (* = P<0.05).  
C
yt
ot
ox
ic
ity
 (%
)
6 h
24 h
*
*
*
*
*
*
*
*
*
**
**
*
*
a)
b)
0
10
20
30
40
50
60
70
80
90
100
Untreated 100 200 300 400 500
0
10
20
30
40
50
60
70
80
90
100
Untreated 100 200 300 400 500
Concentration of Chelators (µg/mL)
P. aeruginosa Deferiprone 13a 13l 13i
Chapter 3 
 116 
 
To determine the efficacy of the chelators as potent treatments, cell visualising assays 
were performed. Control KB cells uninfected and untreated showed intact monolayers 
without damages or spaces between cells, while the other controls that had been 
infected with MRSA or P. aeruginosa showed large damaged areas and disruption in 
the monolayer of KB epithelial cells (Figure 3.12.a and Figure 3.13.). Furthermore, the 
disruption caused by both MRSA and P. aeruginosa in the monolayer of KB epithelial 
cell was decreased gradually with increasing iron chelator concentrations (Figure 3.12.b 
and Figure 3.13.). The disruption of the monolayer of epithelial cell line infected by P. 
aeruginosa was higher than that infected by MRSA. Disruption amelioration was dose 
dependent; it decreased gradually with the increase in concentration of iron chelators 
(Figure 3.13.). 
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Figure 3.12 The efficacy of the chelators as potent treatments against MRSA. 
(a) Positive control untreated and uninfected KB epithelial cell (Left); and negative control 
MRSA infected KB epithelial cells after 24 h but untreated. (b) Infected KB epithelial cell 
monolayer by MRSA and treated with different concentrations of deferiprone, 13a, 13l and 13i 
chelators. Disruption in epithelial cells by MRSA was decreased gradually with increasing 
concentration of the chelators. (Disruption area in the monolayer caused by MRSA are referred 
by arrows; bars = 50 µm). 
 
(A) 
Chapter 3 
 118 
 
Figure 3.13 The efficacy of the chelators as potent treatments against P. aeruginosa. 
Top image represents positive control KB epithelial cell uninfected and untreated; negative 
control infected KB epithelial cells by P. aeruginosa but untreated (Left image in the second 
row); and then different concentrations of 13l chelators. Disruptions on the monolayer of 
epithelial cell caused by P. aeruginosa were decreased gradually with increasing concentration 
of the chelators. 
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3.3.5 The effect of iron chelators on the expression of Acanthamoeba extracellular 
proteases 
To detect the inhibitory effect of the iron (III)- selective HPO chelators on 
Acanthamoeba proteases, zymographic assays were performed. Deferiprone showed the 
greatest inhibition of Acanthamoeba proteases at 500 µg/mL compared with the other 
novel iron chelators. It was found that deferiprone inhibits the proteases at 115 and 100 
kDa; other proteases were increased by 13l (Figure 3.14a). Four other zymographic gels 
were prepared to investigate the dose dependency of the iron chelators on the expression 
of Acanthamoeba proteases (Figure 3.14b, 3.14c, 3.14d and 3.14e). Increasing the 
concentration of 13l enhanced Acanthamoeba protease production (Figure 3.14c); but 
there was no difference between concentrations for other iron chelators. 
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Figure 3.14 Condition media (CM) of Acanthamoeba T4 incubated in RPMI overnight to 
determine the ability of iron chelators to inhibit Acanthamoeba proteases. 
(a) Control untreated, then CM of Acanthamoeba in presence of the chelators at 500 µg/mL, 
lane1: deferiprone, lane2: 13a, lane3: 13l, and lane4: 13i. Deferiprone were decreased proteases 
expression. (b) CM 5 different concentrations of deferiprone. (c) 5 different concentrations of 
13l. (d) 5 different concentrations of 13a. (e) 5 different concentrations of 13i. 
(A)	
(B)	
(C)	
(D)	
(E)	
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3.4 Discussion 
Microorganisms face a continuous struggle for iron using acquisition and assimilation 
strategies which share several functional and mechanistic principles. One common 
theme is the utilization of high-affinity chelators for extracellular iron mobilization, 
generally known as siderophore-dependent iron acquisition. The other strategy is to 
release the mobilized iron from extracellular sources to allow its transfer and 
incorporation into metabolically active proteins. A variety of mechanisms which are 
often coupled with high-affinity uptake have evolved to facilitate the removal of iron 
from siderophore ligands; however, they differ in many key aspects including substrate 
specificities and release efficiencies (Hassett et al., 1998; Miethke, 2013). Although 
heme is a valuable nutrient source for invading pathogens, the intracellular 
accumulation of heme is toxic due to the molecule's reactivity. Therefore, organisms 
that acquire exogenous heme to satisfy nutrient iron needs must have adaptable 
mechanisms to avoid surplus heme accumulation (Torres et al., 2007). Catecholate 
siderophores are common in Gram-negative bacteria, such as Pseudomonas, and that 
depends on several reasons, including complex stability, high environmental pH and a 
weak capability for nitrogen metabolism (Winkelmann, 2002). MRSA as a Gram-
positive bacterium produces two siderophores: staphyloferrin A and staphyloferrin B, 
and these both are synthesised via the nonribosomal peptide synthetase independent 
pathway (NIS) (Hammer and Skaar, 2011). 
Previous studies with iron chelators have demonstrated their bactericidal effect (Qiu et 
al., 2011; Xu et al., 2011; Thompson et al., 2012).  Although N,N’-bis(2-
hydroxybenzyl) ethylenediamine-N,N’-diacetic acid, possesses very high affinity for 
iron, it was found to be a weak inhibitor of bacterial growth (Chew et al., 1985). In an 
attempt to develop drugs with comparable iron binding capacity but reduced bacterial 
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virulence-enhancing properties, we have investigated the effect of three novel iron 
chelators based on the structure of deferiprone.  
Because of structurally different siderophores and different cell wall types, it can be 
expected that iron selective chelators will have a differential influence on a range of 
bacteria. The high efficacy of hydroxypyridinone iron-chelators against Pseudomonas 
strains is consistent with the outer membrane of Gram-positive bacteria. The penetration 
of compounds is expected to be limited by molecular mass above about 500–600 Dalton 
(Hancock and Nikaido, 1978). The molecular mass for deferiprone, 13a, 13i and 13l are 
139.15, 739.35, 941.51 and 1025.61 Da, respectively. 
Deferiprone is a very small, neutral molecule, and these properties are known to 
facilitate its transfer across host cell membranes and may be bacterial membranes as 
well. However, wound tissue is already disrupted, therefore, compounds with higher 
molecular mass can probably pass through cell membranes by different mechanisms, 
such as endocytosis (Sohn et al., 2012). The compounds 13a, 13i, and 13l feature three 
moieties of (3-Hydroxypyridine-4-one), allowing them to form hexadentate ligands with 
high affinity to iron (III) by comparison with deferiprone which forms a bidentate iron 
complex. These novel iron chelators possess stronger inhibitory activities against the 
growth of both MRSA and Pseudomonas than deferiprone. Compound 13l conferred the 
highest growth inhibition, exceeding 13a and 13i. The higher efficacy of 13l could be 
due to its increased hydrophobicity. Compound 13l was designed with not only a 
diethylenglycole chain, similar to 13i compound but also has a longer hydrocarbon 
chain, 6(CH2). Compound 13i has a shorter hydrocarbon chain, 4(CH2) and compound 
13a lacks either (Zhou et al., 2015). Balanced hydrophobic compounds could intensify 
their binding characters toward protein transporting iron complexes, and also their 
intracellular uptake mechanisms (Górska et al., 2014).  
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The Minimum Inhibitory Concentrations (MIC) of deferiprone on S. aureus and P. 
aeruginosa are (>512 µg/mL) (Thompson et al., 2012); and that agrees with these 
results for deferiprone against MRSA and Pseudomonas (>500 µg/mL). There are two 
recent studies that used three novel iron chelators, possessing three moieties of (3-
Hydroxypyridine-4-one) (Qiu et al., 2011; Xu et al., 2011). These compounds vary in 
their cores to our novel compounds. The MICs of CP251 (Qiu et al., 2011) on S. aureus 
and P. aeruginosa are 500 and 100 µg/mL, respectively, compared to our novel chelator 
13l, >500 and 400 µg/mL. 
Notably, there are antiamoebic activities for all three novel iron chelators against 
pathogenic and non-pathogenic Acanthamoeba. This is the first report showing the use 
of iron chelation against Acanthamoeba. However, the use of iron chelators against 
amoebae had been investigated in 1983 with Naegleria fowleri. Antiamoebic effect of 
desferrioxamine B and rhodotorulic acid on Naegleria fowleri was found at 1000 µg/mL 
after 96 h and at 2000 µg/mL after 48 h as these concentrations completely eliminated 
Naegleria (Newsome and Wilhelm, 1983). Another study demonstrated that the survival 
of Entamoeba histolytica was affected by using iron chelators which interrupt a 
fermentative pathway (Espinosa et al., 2009). We propose that iron chelation therapy 
could be used to treat Acanthamoeba. 
Acanthamoeba T4 has the ability to protect intracellular bacteria from drugs (Abd et al., 
2010). However, all novel iron chelators that were used in this study have antimicrobial 
effect against intracellular MRSA and P. aeruginosa inside Acanthamoeba and the KB 
epithelial cell line. The intracellular growth of Chlamydia psittaci, C. trachomatis, and 
Legionella pneumophila inside macrophage were inhibited by using deferiprone and 
desferasirox (Paradkar et al., 2008). 3-hydroxy-4-pyridinone hexadentate iron chelators 
were reported to have antimycobacterial activity against intracellular Mycobacterium 
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avium inside macrophages (Nunes et al., 2010). The present findings show that MRSA 
and P. aeruginosa have toxic effects on the KB epithelial cell line. The chelators 
ameliorated this toxicity in a dose dependent manner. Since these chelators could have 
shown a toxic effect on mammalian cells, the cytotoxicity assays were performed. 
Fortunately, all iron chelators used in this research showed very low toxic effect on KB 
cells (<10%) after 24 h. However, they could be toxic on KB epithelial cell line or other 
types of cells if exposed for long time to these chelators. Therefore, further investigation 
is needed to investigate their toxicity on the same cell line and other cell lines after 24, 
48 and 72 h. However, this is clearly advantageous for the use of iron chelation strategy 
for wound infection. 
Iron could be important for Acanthamoeba protease production as iron has an important 
role in microorganism pathogenicity. However, these findings showed that there is no 
significant effect of iron chelators on the expression of Acanthamoeba proteases. In 
addition, deferiprone showed no effect on the viability of Acanthamoeba, however, it 
showed slightly reduction on proteases expression, which is mean that deferiprone 
might has an inhibitory effect on the production of proteases. 
Both microorganisms themselves and their products have roles in causing infections and 
the induction of the immune system response. Cell death is one of these responses, 
which has been classified as two forms: apoptosis and necrosis. The investigation of the 
ability of these microorganisms to induce one or both forms of cell death, and whether 
cysteine-aspartic proteases (caspases) have a role in that process, is the subject of the 
fourth chapter. 
 
  
4 
 
 
 
 
 
 
 
 
 
 
Chapter Four 
The role of caspase pathway in cell death of mesenchymal 
stem cells and skin epithelial cells induced by MRSA, 
Pseudomonas and Acanthamoeba 
Chapter 4 
 126 
Chapter 4 : The role of caspase pathway in cell death of mesenchymal 
stem cells and skin epithelial cells induced by MRSA, 
Pseudomonas and Acanthamoeba 
4.1 Introduction 
Chronic wounds are a serious problem around the world. The wounds which fail to heal 
within one month are considered as chronic wounds. Infection and vascular failure play 
roles in non-healing wounds. Infection caused by MRSA and P. aeruginosa cause 
complications in wounds, which lead to a prolonged inflammatory response, interfere 
with collagen synthesis and epithelialization, and cause damage in the tissue (Reyes-
López et al., 2015).  Acute infection in chronic wounds can lead to biofilms forming, 
which could be one of the main reasons behind treatment failure (Clinton and Carter, 
2015; Rondas et al., 2015). 
A combination of factors work together to enhance wound healing, which include 
growth factors such as Epidermal Growth Factor (EGF) and Vascular Endothelial 
Growth Factor (VEGF), Extracellular Matrix (ECM) proteins, viable epithelial cells, 
fibroblasts and mesenchymal stem cells (MSCs). MSCs have roles in all wound healing 
phases, thus their presence would support the successful healing for chronic wounds via 
secreting anti-inflammatory factors such as interleukin (IL-1RA) (Maxson et al., 2012; 
Hu et al., 2015). In addition, MSCs have antimicrobial activity against bacteria in 
wounds via two mechanisms: (i) direct by producing antimicrobial factors such as 
antimicrobial peptides called (LL-37) and neutrophil associated gelatinase (N-Gal), and 
(ii) indirect via producing immune-modulating factors which stimulate phagocytosis in 
the immune cells to kill bacteria (Mei et al., 2010). The presence of MSCs in the skin 
and their important role in wound healing and the role of their antimicrobial production 
against bacteria suggest that using external MSCs could be a promising solution to treat 
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infected non-healing wounds (Paquet-Fifield et al., 2009; Krasnodembskaya et al., 
2010; Sellheyer and Krahl, 2010).  
Although cell death is a fundamental regulator of development in eukaryotic cells, it is 
also considered as a critical immune defence mechanism in multicellular organisms by 
removing infected cells to save other uninfected cells. Two main cell death modes are 
known: apoptosis and necrosis (Bergsbaken et al., 2009; Lamkanfi and Dixit, 2010; 
Zitvogel et al., 2010). Apoptosis induced by bacterial infections is considered as an 
innate immune response, as this type of cell death has two defensive roles in bacterial 
infections. The first role is to get rid of bacteria in the early stage of infections; while 
the second role is to induce immune cells to pick up apoptotic bodies which contain 
bacteria, then induce a protective immune response (Elliott and Ravichandran, 2010). 
By contrast necrosis induced by bacterial infections would allow the bacteria to go out 
of necrotic cells and infect neighbouring cells. The bacterial pathogens which are able 
to invade and multiply within host cells, use different mechanisms to control survival 
and death pathways of host cells to support their own ability to survive and replicate 
(Behar et al., 2010; Kim et al., 2010; Lamkanfi and Dixit, 2010). The apoptosis process 
is mainly mediated by intracellular cysteine-aspartic proteases (caspases), which 
interfere with different cellular proteins leading to demise of the cell (Haslinger-Löffler 
et al., 2005). 
4.1.1 Cysteine-aspartic proteases (Caspases) 
Caspases are a family of proteases which regulate cell death and inflammation. 
Caspases are endoproteases which break down peptide bonds on active sites at cysteine 
residues (Riedl and Shi, 2004). Caspases have been classified into two groups 
depending on their roles. The first group contains caspases which have roles in 
apoptosis, including caspase-3, 6, 7, 8, and 9 in mammals. The other group contains 
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those which have roles in inflammation, including caspase-1, 4, 5, 12 in humans and 
caspase-1, 11, and 12 in mice. Moreover, those caspases, which have roles in apoptosis, 
have been sub-classified with regard to their mechanisms of action: either as 
executioner caspases (caspase-3, 6, and 7) or initiator caspases (caspase-8 and 9) 
(McIlwain et al., 2013). 
4.1.2 The extrinsic pathway of apoptosis 
The extrinsic pathway is so called as it is the responsible pathway causing apoptosis by 
external causative agents such as, microorganisms. This pathway is stimulated by 
extracellular signals in the form of ligands binding to Death Receptors (DRs). These 
receptors are members of the Tumour Necrosis Factor (TNF) family, including TNF 
receptor-1 (TNFR1), Death Receptor 3 (DR3), TNF-Related Apoptosis-Inducing 
Ligand Receptor-1 (TRAIL-R1), and TRAIL-R2. Death receptor ligands such as TNF, 
TRAIL (also known as Apo2-L), and TNF-like ligand 1A (TL1A), bind to DR 
activating the monomeric procaspase-8 protein via death domain, and then activate 
caspase-8 monomers, which activate caspase-3 which induce programmed cell death 
(McIlwain et al., 2013). 
4.1.3 MRSA-induced cell death 
MRSA induce apoptosis and necrosis by producing haemolysin α-toxin (Essmann et al., 
2003; Haslinger-Löffler et al., 2005). The ability of S. aureus to induce apoptosis was 
investigated in different types of cells such as epithelial cells, endothelial cells, 
keratinocytes, lymphocytes and macrophages (Jonas et al., 1994; Kahl et al., 2000; 
Menzies and Kourteva, 2000; Nuzzo et al., 2000; da Silva et al., 2004). In order for S. 
aureus to invade host cells, they produce toxins (e.g. α-toxin) forming pores in the host 
cell membrane prior to invasion. However, apoptosis might not be triggered by a single 
staphylococcal virulence factor, but requires combinations of factors together such as 
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Fibronectin-Binding Proteins (FnBPs) (Peacock et al., 2002). Toxic Shock Syndrome 
Toxin-1 (TSST-1) produced by S. aureus and MRSA has been demonstrated to induce 
apoptosis in T lymphocytes via stimulating the release of IL-1, IL-2 and TNF (Mateo et 
al., 2007). 
4.1.4 Pseudomonas aeruginosa-induced cell death 
The ability of P. aeruginosa to induce apoptosis in host cells has been shown by several 
studies. Direct interaction of P. aeruginosa with host cells and secreted factors (e.g. 
pyocyanin) seem able to induce cell death in macrophages, neutrophils and epithelial 
cells (Broquet and Asehnoune, 2015). The major known virulence factor of P. 
aeruginosa-induced apoptosis in eukaryotic host cells is type III secretion system 
(T3SS). The T3SS is activated during contact with host cells membrane resulting in cell 
death or alterations in the host immune responses. This secretion system is responsible 
for producing four effector toxins of P. aeruginosa including ExoS, ExoT, ExoU and 
ExoY. Each exotoxin has a specific function: ExoS causes cell death and ExoU causes 
cell lysis. It is rare to find one strain producing all these four toxins (Galle et al., 2012a, 
2012b). Quorum sensing molecules which regulate virulence factors such as toxins, 
exotoxin A and pyocyanin, play a role in apoptosis (Rutherford and Bassler, 2012). In 
conclusion, T3SS along with other virulence factors produced by P. aeruginosa are 
involved in apoptosis by different mechanisms such as the generation of Reactive 
Oxygen Species (ROS) and the activation of the caspase pathways (Broquet and 
Asehnoune, 2015). 
4.1.5 Acanthamoeba-induced cell death 
A few studies reviewed the ability of Acanthamoeba to induce apoptosis in the host 
cells. Both Acanthamoeba and host determinants (e.g. IL-8 and TNF-a) play a role in 
inducing apoptosis in host cell (Siddiqui and Khan, 2012). The ability of Acanthamoeba 
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trophozoites or their lysate to induce apoptosis in human corneal epithelial cells have 
been demonstrated (Zheng et al., 2004). In another study, the co-cultivation of 
Acanthamoeba with mouse neuroblastoma cells showed signs of apoptosis including 
cell shrinkage, nuclear condensation and DNA fragmentation. Caspase enzymes and 
mitochondrial pro-apoptotic proteins (Bax and Bcl-2) were determined in 
Acanthamoeba-mediated apoptosis (Chusattayanond et al., 2010). Ecto-ATPases are 
one of the direct virulence factors produced by Acanthamoeba. These enzymes 
hydrolyse the extracellular ATP to ADP which have toxic effects on the host cells. Once 
Acanthamoeba binds the host cells, ADP will be released causing caspase-3 activation 
and then apoptosis (Khan, 2009). 
Herein the role of caspase pathway in KB epithelial cells and MSC cell death induced 
by live, heat-killed and conditioned medium of MRSA and P. aeruginosa, and also 
Acanthamoeba conditioned medium is described. 
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4.2 Materials and Methods 
4.2.1 Cell Lines and cell culture 
Human KB epithelial cell line and murine Mesenchymal Stem Cells (mMSCs) were 
used in this study. mMSCs primary cells was provided by Dr Ralf Zwacka (School of 
Biological Science, University of Essex). Dulbecco's Modified Eagle Medium 
(DMEM)-low glucose supplemented with 20% FBS (Invitrogen) was used for mMSCs 
culturing and seeding. Both cell types were cultured and seeded as described in section 
(2.2.1). 
4.2.2 Bacterial culture and conditioned media 
4.2.2.1 Live bacteria 
MRSA and P. aeruginosa were cultured onto CLED plates overnight. A few colonies 
were inoculated in LB broth and the ODs were measured using spectrophotometer as 
described in section (2.2.3). 
4.2.2.2 Heat-killed bacteria 
Heat-killed bacteria were prepared to investigate whether the bacterial body has role on 
cell death. Both strains were refreshed onto CLED plates and incubated overnight. 
Then, a few colonies were inoculated in LB broth and incubated for overnight at 37 oC 
in air incubator. OD was measured using spectrophotometer as described in section 
(2.2.3). Then, 1 mL of bacterial broth (containing 108 CFU) was heated in a water bath 
at 65 oC for 90 min. About 20 µL of heat-killed bacteria were cultured onto CLED 
plates and incubated overnight at 37 oC in air to determine whether bacterial strains 
were still alive, and no bacterial growth was detected after incubation (Worgall et al., 
2002). 
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4.2.2.3 Conditioned medium from bacteria 
Bacterial conditioned media (BCM) were prepared to investigate the ability of enzymes, 
toxins and proteases which were produced by MRSA and P. aeruginosa to have any 
role in apoptosis. Bacterial strains were inoculated in the cell media (EMEM for KB 
epithelial cell line; and DMEM for mMSCs) in tubes. Then, the tubes were incubated at 
37 oC in air overnight. After incubation, tubes were centrifuged at 5000 x g for 10 min 
and then supernatants were filtered by using syringe and filter pore size (0.20 µm) to get 
conditioned media which contained the proteins and external virulence factors from 
both strains. BCMs were stored at -20 oC till required (Iqbal et al., 2014). 
4.2.3 Conditioned medium (CM) of Acanthamoeba 
Acanthamoeba Conditioned Medium (CM) was prepared as described in section 
3.2.6.2.1 (Sissons et al., 2006; Iqbal et al., 2014). 
4.2.4 General caspase inhibitor 
In order to investigate the role of caspase pathway in cell death induced by infection, an 
irreversible caspase-3 inhibitor (Z-VAD-FMK) (1 mg, purchased from BD Pharmingen) 
was used to inhibit caspase pathways. Stock solution (10 mM) of Z-VAD-FMK was 
prepared by adding 214 µL of dimethyl sulfoxide (DMSO) into the original tube 
containing 1 mg of the inhibitor (Worgall et al., 2002).  
4.2.5 Induction of cell death 
To study the ability of live, heat-killed and BCM of MRSA and P. aeruginosa, and CM 
of Acanthamoeba to induce cell death, fluorescence (flow cytometry assays) and 
colorimetric (LDH assays) techniques were performed. In brief, cells were seeded and 
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grown in two 24 well-plates until confluent as described in sections 2.2.1.2 and 2.2.4. 
Then, the growth medium was discarded, and cells were washed once with PBS. To 
analyze whether bacteria and Acanthamoeba induced cytotoxicity can be influenced by 
caspase inhibition, one of the plates was used with caspase inhibitor (15 µM, final 
concentration for 60 min pre-induction), but the other was not. Next, live, heat-killed 
and BCM for bacteria and Acanthamoeba CM were added to different wells to induce 
cell death. Plates were incubated for 60 min at 37 oC in humidified 95 % air, and 5 % 
CO2 incubator. Next, wells with live bacteria were treated with antibiotics as described 
in section (2.2.6) to kill extracellular bacteria. Then plates were incubated for 24 h at 37 
oC in humidified 95 % air, and 5 % CO2 incubator. After cell death induction, cells were 
harvested and collected with the supernatants in 1.5 mL centrifuge tubes for flow 
cytometry assays. While supernatants only were collected in 1.5 mL centrifuge tubes for 
LDH measurement (Worgall et al., 2002). 
4.2.6 Flow cytometry assays (apoptosis) 
Samples containing supernatants and cells were centrifuged at 1500 x g for 5 min. Then, 
cells were stained according to recommended method by manufacturer. Annexin V 
method were used to detect apoptosis and necrosis. The fixable Zombi NIR were used 
instead of Propidium Iodide (PI) and 7-AAD in these assays. Briefly, pellets of cells 
were washed twice with 200 µL of cold cell staining buffer (BioLegend). Then, cells 
(1.0x105) were resuspended in 100 µL of Annexin V binding buffer (BioLegend) 
containing 5 µL of Annexin V FITC (BioLegend) and 1 µL of Zombie NIR 
(BioLegend). Samples were gently vortexed and incubated at room temperature (RT) 
for 20 minin the dark. Next, samples were washed once with cell staining buffer and 
fixed with 4% paraformaldehyde (PFA) on ice for 20 min. Then, all samples were 
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centrifuged and supernatants were discarded. Pellets were washed once with cell 
staining buffer and then resuspended in 400 µL of Annexin V binding buffer. Next, 
cells were analysed by flow cytometry [The BD Accuri™ C6] and each run was 
restricted to 10000 moments. 
4.2.7 Lactate dehydrogenase (LDH) assays (necrosis) 
LDH assays were performed to detect the role of caspase pathway in cell damage 
caused by live, heat-killed and BCM of MRSA and P. aeruginosa, and CM of 
Acanthamoeba on both KB cell line and mMSC cells. Samples prepared in section 
(4.2.5) were used for these assays. LDH assays were performed as described earlier in 
section (3.2.8.2) (Worgall et al., 2002; Chan et al., 2013). 
4.2.8 Software and statistics 
FlowJo software (v10.1) was used to analyse and prepare flow cytometry graphs.  In 
addition, Microsoft office Excel programme was used to prepare all bar charts and 
analyse data, as described in section (2.2.7).  
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4.3 Results 
4.3.1 Induction of cell death by bacteria at different time intervals 
To study the effects of MRSA and P. aeruginosa in wound healing, cell death induction 
by MRSA and P. aeruginosa was determined. Cell death induced by MRSA and P. 
aeruginosa was determined at different time intervals to investigate the induction of 
apoptosis and then necrosis. KB and mMSC were infected with ~10 CFU/cell for 4, 6 
and 12 h. Cells were stained with annexin V-FITC and Zombie NIR and analysed by 
flow cytometry. Cells with double positive for both annexin V-FITC and Zombie NIR 
were dead cells, while cells staining positive for annexin V-FITC and negative for 
Zombie NIR were apoptotic cells. Live cells are those cells with low Zombie NIR and 
negative for annexin V-FITC. Percentages of apoptotic and necrotic cells of KB 
epithelial cell line were slightly and gradually increased after being infected with 
MRSA, while they significantly increased in mMSC to be 23±10 % for necrotic cells 
and 8±3 % for apoptotic cells at 12 h post-infection. Cell death induced by P. 
aeruginosa was somewhat higher than cell death induced by MRSA in both KB 
epithelial and mMSC cells. The percentage of necrotic KB epithelial cells induced by P. 
aeruginosa was 35±2 % at 12 h post-infection, while for the apoptotic cells it was 
13±1.5 % at the same time. In mMSC, P. aeruginosa were able to induce both cell 
death forms, the percentage of necrotic cells after 12 h infection was about 28±2 % and 
apoptotic cells about 8±2 % (Figure 4.1 and Figure 4.2). 
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Figure 4.1 Evaluation of apoptosis in KB epithelial and mMSC cells after exposure to MRSA 
and P. aeruginosa. 
Both cell types KB and mMSC were infected with 10 CFU/cell for 4, 6 and 12 h. Cells were 
stained with annexin V-FITC and Zombie NIR and analysed by flow cytometry. Cells with 
double positive for both annexin V-FITC and Zombie NIR were dead cells, while cells with 
positive annexin V-FITC and negative Zombie NIR were apoptotic cells. Live cells were those 
cells with low Zombie NIR and negative for annexin V-FITC. Controls (cells only) showed high 
percentage of viable cells with very low apoptotic and necrotic cells. Apoptotic and necrotic 
cells increased gradually in both host cells types after increasing exposure time to bacterial 
strains. The data shown are representative of four experiments. 
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Figure 4.2 Evaluation of apoptosis and necrosis in KB epithelial cell line and mMSC cells after 
exposure to MRSA and P. aeruginosa. 
Both cell types were infected with 10 CFU/cell for 4, 6 and 12 h. Cells were stained with 
annexin V-FITC and Zombie NIR and analysed by flow cytometry. Controls (cells only) 
showed low percentages of low apoptotic and dead cells. Apoptotic and necrotic cells increased 
gradually in mMSC cells after increasing exposure time to both bacterial strains, while 
apoptotic cells were increased then decrease in KB epithelial cells at 12 h post-infection. Results 
are the mean of three independent experiments performed in duplicate. Error bars represent 
standard error. Statistical analysis: two-tailed t-test (* = P<0.05). 
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4.3.2 Role of caspase pathway in MRSA-induced cell death 
The Role of the caspase pathway in MRSA-induced cell death was determined by 
fluorescence and colorimetric techniques. Cells with and without Z-VAD-FMK 
inhibitor were infected by one of three different conditions of MRSA: including live, 
heat-killed bacteria, and BCM for 24 h. Then, cell death was determined by flow 
cytometry after staining with annexin V-FITC and Zombie NIR. To quantify the 
necrotic cells, LDH released from necrotic cells was measured by colorimetric assay. 
The percentage of viable KB epithelial cells after being infected with live MRSA was 
10±2 %, while with caspase inhibitor the viable cells increased to 34±5 % (Figure 4.3 
and Figure 4.4a). The reduction of necrosis-induced by live MRSA after using caspase 
inhibitor was 16 %, whereas they dropped from 79±5 % to 66±5 % (Figure 4.4b). The 
total apoptotic cells induced by heat-killed MRSA was about 86.1 % without Z-VAD-
FMK inhibitor, while the percentage dropped to 55.5 % after inhibiting caspase 
pathway (Figure 4.3). Necrosis was inhibited as well under the same conditions, with 
their percentage about 55 % lower after using inhibitor (Figure 4.4b), while the viable 
cells jumped over 40 % from 14±1.5 % to be 44±1.5 % (Figure 4.4a). Cell death 
induced by BCM was about 90 % without inhibiting caspase pathway, while this 
number decreased to be about 60 % with caspase inhibitor (Figure 4.3). The viable cells 
of the KB epithelial line were increased by inhibiting caspase pathway from 12±5 % to 
be 37±3 % (Figure 4.3 and Figure 4.4a), while the necrotic cells decreased 
approximately 12 % by using the inhibitor to be 55±6 % (Figure 4.4b). 
The percentage of viable mMSC cells were increased with using Z-VAD-FMK inhibitor 
from 8±1.5 % to 31±5 % after infected by live MRSA (Figure 4.3 and Figure 4.4a), 
while necrotic cells were slightly decreased from 68±3 % to 57±10 % (Figure 4.4b). 
mMSC cells infected by heat-killed MRSA showed reduction in the apoptotic cells 
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when the caspase pathway inhibited to be 31 %, while they were about 49 % without 
inhibitor (Figure 4.3). The necrotic cells after inhibiting caspase pathway were 
decreased from 15±1 % to 8±2 %; nevertheless, the viable cells were increased 15 % to 
be 78±2 %.  The MRSA BCM showed cell death induction on the mMSC cells after 24 
h post-infection. Caspase inhibitor reduced cell death from 70 % to 60 %. The viable 
cells were increased when caspase pathway inhibited to be 39±4 %, compared with 
24±3 % without inhibitor (Figure 4.3 and Figure 4.4a). 
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Figure 4.3 Evaluation of caspase pathway role in apoptosis induced by MRSA on KB epithelial 
cell line and mMSC cells. 
Both cell types were infected with live or heat-killed bacteria (10 CFU/cell) or BCM of MRSA 
for 24 h. Cells were stained with annexin V-FITC and Zombie NIR and analysed by flow 
cytometry. Cells with double positive for both annexin V-FITC and Zombie NIR were dead 
cells, while cells with positive annexin V-FITC and negative Zombie NIR were apoptotic cells. 
Live cells were those cells with low Zombie NIR and negative annexin V-FITC. Controls (cells 
only) showed high percentage of viable cells with very low apoptotic and dead cells. Cells 
infected by live bacteria and BCM showed very low number of viable cells with increasing on 
the number of apoptotic and dead cells compared with those cells infected with heat-killed. Live 
cells were increased after using Z-VAD-FMK inhibitor in both host cells types. Shown is a 
representative of four experiments. 
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Figure 4.4 Evaluation of caspase pathway role in cell death induced by MRSA on KB epithelial 
cell line and mMSC cells. 
Both cell types were infected with live or heat-killed bacteria (10 CFU/cell) or BCM of MRSA 
for 24 h. (A) Quantification of viable cells following exposure to live or heat-killed bacteria (10 
CFU/cell) or BCM of MRSA for 24 h with and without Z-VAD-FMK inhibitor assessed by 
annexin V-FITC and Zombie NIR by flow cytometer (- annexin V-FITC/ - Zombie NIR). (B) 
Quantification of necrotic cells following exposure to live or heat-killed bacteria (10 CFU/cell) 
or BCM of MRSA for 24 h with and without Z-VAD-FMK inhibitor assessed by measuring 
LDH release into the supernatant using a colorimetric assay. Viable cells were increased as a 
result of apoptotic cells reduction by inhibit caspase pathway. Necrotic cells were slightly 
decreased when caspase pathway inhibited. Results are the mean of three independent 
experiments performed in duplicate. Error bars represent standard error. Statistical analysis: 
two-tailed t-test (* = P<0.05). 
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4.3.3 Role of caspase pathway in P. aeruginosa-induced cell death 
Role of caspase pathway in P. aeruginosa-induced cell death was determined by 
fluorescence and colorimetric techniques. Caspase inhibitor (Z-VAD-FMK) had been 
used to investigate caspase pathway role in P. aeruginosa infections. Three different 
conditions of P. aeruginosa: including live, heat-killed bacteria, and BCM for 24 h were 
used in this study. Viable and apoptotic cells were determined by flow cytometer after 
stained with annexin V-FITC and Zombie NIR, while necrotic cells were measured by 
determine the amount of LDH released from necrotic cells by colorimetric assays. 
The percentage of viable KB epithelial cells post-infected with live P. aeruginosa was 
5±3 %, while the percentage of viable cells with using caspase inhibitor was increased 
to be 30±3 %. At the same condition, the percentage of apoptotic cells was decreased 
when caspase inhibitor was used from 94 % to be 39 %, while necrotic cells was 
decreased from 80±5 % to be 37±8 % after inhibiting caspase cascade (Figure 4.5 and 
Figure 4.6a). Necrotic cells were dropped from 80±5 % to 37±8 % after using caspase 
inhibitor (Figure 4.6b). Z-VAD-FMK inhibitor reduced apoptotic KB epithelial cells 
induced by heat-killed P. aeruginosa from 44 % to 25 % (Figure 4.5), while the necrotic 
cells was slightly decreased from 18±1 % to 8±3 % (Figure 4.6b). Therefore, the viable 
cells were jumped from 34±4 % to 73±6 % (Figure 4.5 and Figure 4.6a). Apoptosis 
induced by BCM of P. aeruginosa was about 73 % without inhibiting caspase pathway, 
while this number decreased to be about 38 % with caspase inhibitor (Figure 4.5). The 
percentage of necrotic KB epithelial cells was decreased by inhibiting caspase pathway 
from 44±7 % to be 25±3 % (Figure 4.5 and Figure 4.6a), while the viable cells were 
increased from 33±4 % to 52±6 % (Figure 4.6b). 
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Percentage of viable mMSC cells was slightly increased with using Z-VAD-FMK 
inhibitor from 13±3 % to 22±5 % after infected by live P. aeruginosa (Figure 4.5 and 
Figure 4.6a), while necrotic cells was decreased from 70±7 % to 43±7 % (Figure 4.6b). 
While heat-killed P. aeruginosa showed significantly reduction on the apoptotic cells 
when the caspase cascade blocked to be 25 %, which it was 70 % without inhibitor 
(Figure 4.5). The necrotic mMSC cells after inhibiting caspase pathway and infected 
with heat-killed P. aeruginosa was decreased 50 % to be 21±2 %, while the viable cells 
was increased from 30±5 % to 78±2 % (Figure 4.6a,b).  The P. aeruginosa BCM 
showed increasing in the viable mMSC cells when the caspase cascade inhibited from 
72±2 % to 80±3 %. Caspase inhibitor reduced cell death induced by BCM, whereas the 
dead cells was 20 % to be 11 %. The percentage of necrotic cells was decreased when 
caspase pathway inhibited to be 12±2 %, compared with 30±7 % without inhibitor 
(Figure 4.5 and Figure 4.6a). 
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Figure 4.5 Evaluation of caspase pathway role in apoptosis induced by P. aeruginosa on KB 
epithelial cell line and mMSC cells. 
Both cell types were infected with live or heat-killed bacteria (10 CFU/cell) or BCM of P. 
aeruginosa for 24 h. Cells were stained with annexin V-FITC and Zombie NIR and analysed by 
flow cytometry. Cells with double positive for both annexin V-FITC and Zombie NIR were 
dead cells, while cells with positive annexin V-FITC and negative Zombie NIR were apoptotic 
cells. Live cells were those cells with low Zombie NIR and negative annexin V-FITC. Controls 
(cells only) showed high percentage of viable cells with very low apoptotic and dead cells. Cells 
infected with live bacteria showed very low number of viable cells with increasing on the 
number of apoptotic and dead cells compared with infected cells by heat-killed bacteria and 
BCM of P. aeruginosa. Apoptotic and dead cells were decreased after using Z-VAD-FMK 
inhibitor in both host cells types. Shown is a representative of four experiments. 
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Figure 4.6 Evaluation of caspase pathway role in cell death induced by P. aeruginosa on KB 
epithelial cell line and mMSC cells. 
Both cell types were infected with live or heat-killed bacteria (10 CFU/cell) or BCM of P. 
aeruginosa for 24 h. (A) Quantification of viable cells following exposure to live or heat-killed 
bacteria (10 CFU/cell) or BCM of P. aeruginosa for 24 h with and without Z-VAD-FMK 
inhibitor assessed by annexin V-FITC and Zombie NIR by flow cytometer (- annexin V-FITC/ - 
Zombie NIR). (B) Quantification of necrotic cells following exposure to live or heat-killed 
bacteria (10 CFU/cell) or BCM of P. aeruginosa for 24 h with and without Z-VAD-FMK 
inhibitor assessed by measuring LDH release into the supernatant using a colorimetric assay. 
Viable cells were increased as a result of apoptotic cells reduction by inhibit caspase pathway. 
Necrotic cells were slightly decreased when caspase pathway inhibited. Results are the mean of 
three independent experiments performed in duplicate. Error bars represent standard error. 
Statistical analysis: two-tailed t-test (* = P<0.05). 
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4.3.4 Role of caspase pathway in CM of Acanthamoeba-induced cell death 
Caspase cascade role in CM of Acanthamoeba-induced cell death was determined by 
fluorescence and colorimetric techniques, and using Z-VAD-FMK inhibitor. KB 
epithelial cell line and mMSC cells were infected by CM of Acanthamoeba for 24 h in 
the presence and absence of caspase inhibitor. Percentages of necrotic cells were 
measured by detecting the amount of LDH released from necrotic cells by colorimetric 
assays, while viable and apoptotic cells were determined by flow cytometry after 
staining with annexin V-FITC and Zombie NIR. 
Apoptosis induced by Acanthamoeba CM in KB epithelial cells was extremely high, at 
96 %, and that was slightly reduced by using caspase inhibitor to be 83 % (Figure 4.7). 
Necrotic KB epithelial cells decreased from 62±8 % to 40±3 %, while the percentage of 
viable cells was increased from 10±2 % to 22±4 % (Figure 4.7 and Figure 4.8a,b). 
mMSC cells treated with caspase inhibitor showed a lower percentage of apoptotic cells 
(38 %), while those untreated with the inhibitor showed 96 % apoptotic cells (Figure 
4.7). The percentage of viable cells increased from 8±3 % to 57±8 %; while necrosis 
decreased from 61±5 % to 21±7 % (Figure 4.7 and Figure 4.8a,b). 
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Figure 4.7 Evaluation of caspase pathway role in apoptosis induced by CM of Acanthamoeba on 
KB epithelial cell line and mMSC cells. 
Both cell types were treated with Acanthamoeba CM for 24 h. Cells were stained with annexin 
V-FITC and Zombie NIR and analysed by flow cytometry. Cells double positive for both 
annexin V-FITC and Zombie NIR were dead cells, while cells with positive annexin V-FITC 
and negative Zombie NIR were apoptotic cells. Live cells were those cells with low Zombie 
NIR and negative annexin V-FITC. Controls (cells only) showed high percentage of viable cells 
with very low apoptotic and dead cells. Cells treated with CM of Acanthamoeba showed a very 
low number of viable cells with increased numbers of apoptotic and dead cells compared with 
untreated cells. Live cells increased after using Z-VAD-FMK inhibitor in both host cells types. 
Shown is a representative of four experiments.  
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Figure 4.8 Evaluation of caspase pathway role in cell death induced by CM of Acanthamoeba 
on KB epithelial cell line and mMSC cells. 
Both cell types were treated with Acanthamoeba CM for 24 h. (A) Quantification of viable cells 
following exposure Acanthamoeba CM for 24 h with and without Z-VAD-FMK inhibitor 
assessed by annexin V-FITC and Zombie NIR by flow cytometer (- annexin V-FITC/ - Zombie 
NIR). (B) Quantification of necrotic cells following exposure to Acanthamoeba CM for 24 h 
with and without Z-VAD-FMK inhibitor assessed by measuring LDH release into the 
supernatant using a colorimetric assay. Viable cells were increased as a result of apoptotic cells 
reduction by inhibiting the caspase pathway. Necrotic cells were slightly decreased when the 
caspase pathway was inhibited. Results are the mean of three independent experiments 
performed in duplicate. Error bars represent standard error. Statistical analysis: two-tailed t-test 
(* = P<0.05). 
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4.4 Discussion 
Wound healing includes a sequence of specific phases which enhance cells in tissue 
remodelling and increase the population of the cells to repair the injured area by 
rebuilding new matrices then maturing the wound. Different cells are recruited to 
wounds to complete these stages, including MSCs. When this process is completed, 
unwanted cells in the wound are eliminated via a fundamental biological process which 
provides tissue homeostasis, which is cell death. Two forms of cell death are involved 
in wound healing and wound infections: apoptosis and necrosis. Cell death forms are 
involved in wound infection as an immune response to infection to eliminate infected 
cells and to clear the wound by macrophages (Serra et al., 2015). In addition, it is well 
known that microorganisms have a role in cell death. However, each microorganism has 
different virulence factors, including contact-dependent factors (e.g. FnBPs, pili and 
flagella) and contact-independent factors (e.g. α-toxin, ExoS and Ecto-ATPases) 
(Worgall et al., 2002; Haslinger-Löffler et al., 2005; Khan, 2009). This chapter studied 
the overall effect of these factors in inducing cell death in skin epithelial cells and 
mesenchymal stem cells (MSC), and also the role of caspase cascade in cell death 
induced by live or heat-killed bacteria or CM of both bacteria and Acanthamoeba. 
The present study showed that both primary culture of mMSC and KB epithelial cell 
line are sensitive to MRSA-, P. aeruginosa- and Acanthamoeba-induced cell death. In 
addition, the caspase cascade has a role in both forms of cell death (apoptosis and 
necrosis). Cell death of KB epithelial cell line induced by P. aeruginosa was higher 
than that induced by MRSA at early times post-infection. Apoptotic and necrotic 
responses of mMSC and KB epithelial cells to MRSA and P. aeruginosa were 
dependent on live bacteria and BCM, as they were higher than heat-killed bacteria. 
Inhibition of caspase reduced the degree of host cell death. Importantly, CM of 
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Acanthamoeba-induced cell death was significantly decreased in mMSC when caspase 
inhibitor was used, presenting a higher percentage of viable cells compared with KB 
epithelial cells. Together, these observations support the concept that toxins, enzymes 
and proteases produced by pathogens may have a major role in delaying wound healing, 
in part, by inducing cytotoxic effects on cells. Although caspase-3 has a regulated role 
in apoptosis, while caspase-8 has a role in both apoptosis and necrosis (Hetz et al., 
2002; Haslinger-Löffler et al., 2005; McIlwain et al., 2013), our findings showed the 
ability of caspase-3 inhibitor (Z-VAD-FMK) to modify the necrotic effect on cells. In 
necrosis, ROS are produced as a result of external or internal signals, such as bacterial 
toxins, while apoptotic bodies result from apoptosis induced by an external agent (Behar 
et al., 2010; Kim et al., 2010). In vivo, macrophages phagocytose apoptotic bodies with 
intracellular bacteria. However, in vitro this process is completely different as no 
phagocytosis happened, thus, apoptotic bodies would be burst and necrosis will take 
place as a result of multiplication of the intracellular viable bacteria or via prolonged 
exposure times to lytic toxins and enzymes produced by microorganisms. As a result, 
inhibiting apoptosis could indirectly inhibit necrosis. 
Several studies indicated that S. aureus were able to induce cell death in different types 
of cells such as epithelial cells and endothelial cells, using different virulence factors 
e.g. haemolysin α-toxin, TSST-1 and FnBPs (Kahl et al., 2000; da Silva et al., 2004; 
Essmann et al., 2003; Mateo et al., 2007). S. aureus use their factors in order to invade 
and colonise host cells (Peacock et al., 2002). Furthermore, P. aeruginosa have the 
ability to induce cell death in different cell types, such as lung epithelial cell line, as 
demonstrated by several studies (Worgall et al., 2002; Losa et al., 2014; Wood et al., 
2015). Different virulence factors produced by P. aeruginosa have been proved to be 
cell death inducers. T3SS effector proteins ExoT, ExoS and ExoU have an important 
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role in cell death induction. In addition, pyocyanin factor produced by P. aeruginosa 
within the direct interaction of P. aeruginosa with host cells might have the ability to 
induce cell death in epithelial cells (Losa et al., 2014; Broquet and Asehnoune, 2015).  
Different studies have proved the ability of Acanthamoeba trophozoites and their lysate 
to causecell death (Zheng et al., 2004; Chusattayanond et al., 2010). Acanthamoeba 
trophozoites produce Ecto-ATPases, which hydrolyse the extracellular ATP to ADP. 
ADP will be released as a result of Acanthamoeba binding with host cells causing 
caspase-3 activation and then apoptosis (Khan, 2009). However, the role of 
Acanthamoeba in wound infections is not very well understood due to the uncommon 
incidence of such disease. As mentioned in the introduction, one case study has been 
published showing the presence of Acanthamoeba in a lung transplant patient who died 
a few days later from developing AGE. This is the first study to isolate Acanthamoeba 
from clinical wound samples from healthy individuals. This will be explained in details 
in the next chapter when 140 samples were checked for the presence of Acanthamoeba 
in Colchester.  
 
 
  
5 
 
 
 
 
 
 
 
 
 
 
Chapter Five 
Investigation of the presence of Acanthamoeba 
in wound samples
Chapter 5 
 153 
Chapter 5 : Investigation of the presence of Acanthamoeba in wound 
samples 
5.1 Introduction 
FLA are widely distributed in the environment. They can be isolated from soil, water 
and other environmental sources. A few species, including Acanthamoeba spp., were 
found as causative agents for fatal infections of the CNS called, in the case of 
Acanthamoeba, AGE, especially in immunocompromised patients. However, cutaneous 
diseases such as non-healing skin lesions in the absence of CNS involvement are 
increasingly recognized (Torno et al., 2000). One of the entry routes for Acanthamoeba 
is through skin lesions, then via bloodstream to the BBB. The nature of wounds provide 
an open source for microorganisms to enter and cause an infection. A case report has 
shown the presence of Acanthamoeba trophozoites and cysts in punch biopsy of skin 
nodule from a 62-year-old male who had history of lung transplant (D’Auria et al., 
2012). However, till now, there has not been a single study to isolate Acanthamoeba 
from wound samples published. 
Not only immunocompromised patients at risk of Acanthamoeba, healthy individuals 
whom wearing contact lens are at the risk as well of gaining Acanthamoeba keratitis 
(AK). The number of diagnosed cases of AK has increased dramatically within the last 
two decades. The relation between contact lens wearer and AK has been well 
established, and spotlighted on contact lens and their containers. The wide distribution 
of Acanthamoeba in the environment gave them high chance to contaminate contact 
lens and containers, which may be resulting AK (Gomes et al., 2016). Other recent 
study had detected Acanthamoeba in ocular surface of healthy individuals. All those 
patients were non-contact lens wearer (Rocha-Cabrera et al., 2015). 
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Genus of Acanthamoeba comprises about 20 genotypes. This classification based on 
sequences of Diagnostic Fragment 3 (DF3) of 18S rDNA of the genus Acanthamoeba 
(Siddiqui and Khan, 2012; Fuerst, 2014; Corsaro et al., 2015). Before the year 2000, 
genetically cloned materials were used to obtain most Acanthamoeba sequences. In the 
same time, a number of PCR primers were tested to produce partial products of 18S 
rRNA gene to diagnose infections involving Acanthamoeba. In 2001, a series of PCR 
primers were designed and developed by a group from Ohio State University (OSU). 
Some of those primers become widely used to identify and sequence clinical and 
environmental isolates of Acanthamoeba (Schroeder et al., 2001). This pair of PCR 
primers used to amplify a region of Acanthamoeba-specific amplimer S1 (ASA.S1) 
with size approximately 400-460 base pairs (bp). The ASA.S1 amplimer sequences 
showed variation between different strains within 18S rDNA and then was used for 
genotyping (Stothard et al., 1998). There is another PCR primers pair which was 
designed to amplify a large region that was called genotype-specific amplimer B1 
(GTSA.B1). In this amplimer, three variable diagnostic fragments (DF1, DF2 and DF3) 
can be sequenced. While only DF3 can be found in ASA.S1 amplimer. A specific 
primer called (892C) can be used to sequence DF3 within ASA.S1 amplimer giving 
approximately 200-250 bp in size that includes most of the highly variable portions of 
the ASA.S1 region. Sequences of both ASA.S1 and DF3 regions from 18S rDNA can 
be used for the phylogenetic signal (Figure 5.1.). The partial sequences can be 
misleading with phylogenetic relationships especially in the less frequently reported 
Acanthamoeba isolates. However, phylogenetic analysis of Acanthamoeba which rely 
on the almost complete sequences show very accurate results (Schroeder et al., 2001). 
Herein the presence of Acanthamoeba has been investigated, within clinical wound 
swabs which had already been collected for routine bacterial investigation in Colchester 
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General Hospital, by culturing on 3 % Non-Nutrient Agar (NNA). Then the variable 
specific region ASA.S1 and sequence DF3 were amplified to identify the genotype of 
positive samples. Thus the phylogenetic relationships between positive samples could 
be compared with other different genotypes from the database. 
 
Chapter 5 
 156 
 
 
 
Figure 5.1 Sequenced regions, Variable regions, and primers used for PCR and sequencing of 
ASA.S1 and GTSA.B1. 
(A) Shows ASA.S1 amplimer, JDP1-JDP2 primers pair and primer 892C, primers indicated by 
the arrows. The black box represents DF3. (B) Black boxes represent the diagnostic regions 
(DF1, DF2 and D3) within GTSA.B1. The locations and directions of the amplification primers 
and the sequencing primers are indicated by arrows.  
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5.2 Materials and Methods 
5.2.1 Ethical approval and forms 
Ethical approval was required for this study. Application for ethical approval had three 
phases. Firstly, the ethical approval application was reviewed by research and enterprise 
office at the University of Essex to obtain a sponsor confirmation letter. Then, the 
ethical approval application was submitted online through Integrated Research 
Application System (IRAS) website [https://www.myresearchproject.org.uk] to NHS 
Research Ethics (London-Chelsea Committee) for proportionate review, where a 
favourable opinion subject was issued (reference no. 14/LO/1538). Finally, NHS 
Research and Development (NHS R&D) approval form and Site-Specific Information 
(SSI) form were completed through the IRAS website and sent with all supporting 
documents to Colchester General Hospital NHS Trust’s Research and Development 
office for approval The NHS R&D approval was issued (reference no. 2014/039). 
5.2.2 Clinical samples 
Clinical swabs from different sites of wounds and ulcers from patients at Colchester 
General Hospital were collected by the microbiology unit at Colchester General 
Hospital for routine bacterial investigation; these were then tested for the presence of 
Acanthamoeba at the medical microbiology laboratory, School of Biological Sciences, 
University of Essex, Colchester. A total of 140 wound swabs were tested. To determine 
the presence of Acanthamoeba, specimens were inoculated on to 3 % NNA (Oxoid) 
plates seeded with E. coli K12. Plates were incubated at 30 °C and observed daily for 
the presence of amoebae. Acanthamoeba were monoxencally subcultured onto other 
NNA plates and then axenically cultivated in PYG medium at 30 °C as described 
previously (Khan and Paget, 2002). 
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5.2.3 Xenic culture of Acanthamoeba 
To determine the presence of Acanthamoeba, specimens were cultured by monoxenic 
growth on NNA plates seeded with a lawn of E. coli (NNA-E. coli) (Page, 1988). The 
NNA medium was comprised of 1.5 % plain agar (Agar No. 1, Oxoid, U.K.) in Page’s 
Amoeba saline (PAS) [Sodium Phosphate 0.0142 g, Potassium Phosphate 0.0136 g, 
Sodium Chloride 0.012 g, Magnesium Sulfate 0.0004 g, Calcium Chloride 0.0004 g, 
and Agar 15 g] in 1 L of deionized water] and the final pH was 7.0 ± 0.2. The agar mix 
was autoclaved at 121 oC for 15 min, and allowed to cool to 50 oC before being poured 
into Petri dishes, and left to gel overnight at 37 oC. 
Once set, the agar surface was seeded with 5 mL of a dense suspension of E. coli K12 
(ATCC 33876) (see 5.2.4.). Approximately 5 mL of late log phase cultures of E. coli 
were poured onto NNA plates and left for 5 min, after which excess culture fluid was 
removed and plates were left to dry before their inoculation with clinical specimens. 
For routine maintenance of Acanthamoeba, plates were cultured in air incubator at 30 
oC. All plates were observed daily for the presence of amoebae. To isolate and clone 
single cysts from a mixed culture, cultures were refreshed weekly by excising a piece 
region of agar from the leading edge of the plaque, containing trophozoites, and placing 
it face down onto the centre of a fresh NNA-E. coli plate and incubated as described 
above. 
5.2.4 Preparation of E. coli food source stock 
To make the stock suspension, E. coli was streaked on to a CLED agar plate using a 
sterile disposable loop. Once inoculated, the CLED plates were incubated overnight at 
37 oC allowing colonies to form. 
Distinct single colonies were picked with a loop, and transferred to a sterile glass bottle 
with 100 mL of LB broth, and propagated overnight at 37 oC in air incubator. The 
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suspension of E. coli was pelleted by centrifugation at 2,000 x g for 30 min, and the 
supernatant was discarded and the pellet washed by resuspension in PAS. This step was 
repeated three times, with the final pellet being resuspended in 50 mL of PAS. The 
stock of E. coli to be used as a food source can be stored at 4 oC for up to two weeks. 
5.2.5 Axenic culture of Acanthamoeba 
Where possible, strain was adapted to axenic growth in PYG medium supplemented 
with Penicillin/Streptomycin (to a final concentration of 100 U/mL and 0.1 mg/mL, 
respectively) (Hughes and Kilvington, 2001). The complete medium can be stored at 4 
oC, and used within one month. 
Before axenic culture could be obtained, superfluous bacteria surrounding the 
Acanthamoeba were removed by treating cysts with 2 % (v/v) hydrochloric acid (HCl) 
for 24 h (Kilvington and White, 1994). All traces of HCl were then removed by washing 
the cysts with sterile deionised water and pelleting with centrifugation at 3,000 x g for 5 
min, this wash step was repeated three times. Washed cysts were inoculated into flat-
sided NunclonTM Surface tissue culture 6 well-plate (Fisher Scientific UK) containing 
3 mL of culture media, and incubated in air at 30 oC. Under these conditions, 
excystation should occur and any emergent trophozoites can adapt and replicate in the 
media. Then, axenic strain was successfully maintained in 25 cm2 tissue culture flasks 
after six months of the main swab was collected (Nunc- Fisher Scientific UK). 
5.2.6 DNA extraction 
The growing amoebae were harvested from culture plates and collected in centrifuge 
tubes. Then, amoeba were washed twice with 100 µl of PBS 1X. The DNA was 
extracted by using the QIAamp DNA Micro Kit (QIAGEN Ltd., Crawley, UK) 
following manufacturer’s guidelines. Briefly, approximately 103 amoeba (counted using 
a haemocytometer) were suspended with 180 µl of Tissue Lysis Buffer (ATL). Tubes 
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were incubated into the water bath at 56 oC for 4-6 h. Then, mixed solution of 200 µl of 
Buffer AL with 1 µl Carrier RNA were added to each tube; and they were vortexed until 
the pellet completely dissolved. About 200 µl Ethanol (95-100 %) were added to each 
sample and mixed well. The sample tubes were lifted for 5 min at room temperature. 
Samples were transferred to QIAamp MinElute columns and centrifuged for 1 min at 
8000 x g. The collection tubes were discarded and replaced with new collection tubes. 
The sample tubes were washed by adding 500 µl of the first washing buffer (AW1) and 
centrifuged for 1 min at 8000 x g. The collection tubes were discarded and replaced 
with new collection tubes. Samples were washed again by adding 500 µl of second 
washing buffer (AW2) and centrifuged for 1 min 8000 x g. Next, the collection tubes 
were discarded and replaced with new tubes, and centrifuged for 3 min 14000 x g, to 
dry the membrane. The DNA sample extracts were collected in 1.5 centrifuge tubes by 
adding 50 µl of elution buffer (AE) in the centre of the membrane and left on the bench 
for 1-5 min at room temperature, then centrifuged for 1min 14000 x g. The DNA 
extractions were loaded onto 1 % agarose gel, to detect the DNA extraction. 
5.2.7 PCR methods analysis 
A standard PCR method was used for the detection of Acanthamoeba. PCR reactions 
were performed following the cycling structure and conditions described by Schroeder 
et al 2001. Sequencing forward and reverse primers JDP1 (5′-
GGCCCAGATCGTTTACCGTGAA) and JDP2 (5′-
TCTCACAAGCTGCTAGGGGAGTCA) which amplify a fragment of approximately 
500 bp of the ASA.S1 amplimer that included DF3 was used to amplify amplicons of 
the isolates for genotyping purposes as described previously (Schroeder et al., 2001). 
PCR was performed in a volume of 50 µl containing 1.25 U Taq polymerase (Thermo 
Scientific), 1–10 ng DNA, 200 µM dNTPs, 4 mM MgCl2 and 0.5 µM primer.  The PCR 
Chapter 5 
 161 
cycle profile was as follows: initial denaturation at 95 °C for 5 min, followed by 35 
cycles of denaturation at 95 °C for 30 sec, annealing at 50 °C for 30 sec and extension at 
72 °C for 30 sec, with a final extension at 72 °C for 7 min. As a negative control for 
amplification (non-target), reaction mixtures containing only reagents and sterile 
distilled water were prepared and included simultaneously with the unknowns in each 
PCR run. The total PCR product was visualized on Safe view DNA-stained 1  % agarose 
gels (Fisher). After detecting the PCR product in the gel, the DNA-containing fragment 
was cut from the agarose gel with a clean, sharp scalpel and the size of the gel slice 
minimized by removing extra agarose, and put in 1.5 mL centrifuge tubes to purify. 
5.2.8 Purification of PCR product 
The PCR product was purified with the QIAquick Gel Extraction Kit (QIAGEN Ltd., 
Crawley, UK) following manufacturer’s guidelines. Briefly, the gel slice containing 
DNA fragments were transferred to colourless tube containing 200 µl of QG buffer. 
Next, tubes were incubated at 50 oC in water bath until the gel slice had completely 
dissolved and the color changed to be yellow. Then, about 200 µl of isopropanol was 
added to each sample and mixed. Samples were transferred to QIAquick spin column 
and centrifuged for 1 min at 13000 x g. Then, about 500 µl of QG buffer were added to 
the column after the content of the collection tubes were discarded and centrifuged for 1 
min at 13000 x g. Next, samples were washed once with 750 µl of PE buffer and 
centrifuged for 1 min at 13000 x g. Then, the washings were discarded and the 
QIAquick columns were centrifuged for an additional 1 min at ~13,000 g to dry the 
membrane. The QIAquick columns were then placed into a clean 1.5-mL microfuge 
tube to elute the DNA by adding 30 µl of EB buffer to the center of the QIAquick 
column. All the columns were left to stand for 1 min, and then centrifuged for 1 min at 
14000 x g. 
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5.2.9 18s rDNA gene sequencing 
The DF3 fragment of positive control and positive samples were commercially 
sequenced using Sanger Sequencing services (SourceBioscience; Birmingham, UK).  
One way 892C primer was used to obtained DF3 sequences. 
5.2.10 Phylogenetic analysis and Blast 
Genotype assignment was based on sequence analysis of the 18S rDNA gene including 
the DF3 fragment. Multiple sequences of the different Acanthamoeba genotypes of the 
same region were performed by using ClustalW via MEGA (version 6.06). Sequences 
were identified via a Basic Alignment Search Tool (BLAST), by using nucleotide blast 
to locate the highly similar sequences for comparison. Nucleotide sequences of the 
homologous gene fragments from all genotypes were retrieved from GenBank (see table 
5.1 and table 5.2 for accession numbers). Phylogenetic analysis based on the sequences 
obtained was performed using MEGA. Distance-based analyses were conducted using 
the maximum composite likelihood method, and trees were constructed using a 
Neighbour-Joining algorithm. Bootstrap proportions were calculated by analysing 1000 
replicates (Cabello-Vílchez et al., 2014b). Maximum composite likelihood method was 
selected to estimate evaluation distances between DNA sequences of Acanthamoeba 
genotypes with their differences by a bootstrap approach. The advantage of using this 
method is to reduce errors, as a single set of parameters estimated from all sequence 
pairs is applied to each distance estimation. When distances are estimated with lower 
errors, distance-based methods for inferring phylogenies are expected to be more 
accurate. Therefore, this method will be giving high bootstrap values for the estimated 
phylogenetic tree. 
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Table 5.1 Different Acanthamoeba genotypes which were used to obtain phylogenetic tree.  
 
 
 
 
Genotype Isolate Genbank (accession #) 
T1 A. castellanii [ATCC 50494] (U07400) 
T2 A. palestinensis [ATCC 30870] (U07411) 
T3 A. griffini  [ATCC 30731] (U07412) 
T4 A. castellanii [ATCC 30011] (U07413) 
T5 A. lenticulata [ATCC 50428] (U94739) 
T6 A. palestinensis  [ATCC 50708] (AF019063) 
T7 A. astronyxis [ATCC 30137] (AF019064) 
T8 A. tubiashi [ATCC 30867] (AF019065) 
T9 A. comandoni [ATCC 30135] (AF019066) 
T10 A. culbertsoni [ATCC 30171] (AF019067) 
T11 A. hatchetti BH-2 [ATCC 30730] (AF019068) 
T12 A. healyi [ATCC 30866] (AF019070) 
T13 A. spp. UWC9 [ATCC PRA-3] (AF132134) 
T14 A. spp. PN13 (AF333609) 
T15 A. jacobsi [ATCC 30732] (AY262360) 
T16 A. spp.  U/HC1 (AY026245) 
T17 A. spp.  Ac E1a (GU808277) 
T18 A. spp. CDC:V621 (KC822461) 
T19 A. spp. USP-AWW-A68 (KJ413084) 
T20 A. spp. OSU 04-020 (DQ451161) 
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Table 5.2 Different subtypes isolate of Acanthamoeba belonging to T4 genotype which were 
used to obtain phylogenetic tree. 
 
 
 
 
Genotype Isolate name Genbank (accession #) 
T4A A. castellanii  [ATCC 30011] (U07413) 
T4B A. castellanii Ma [ATCC 50370] (U07414) 
T4C A. spp. Fernandez [ATCC 50369] (U07409) 
T4D A. rhysodes Singh [ATCC 30973] (AY351644) 
T4E A. polyphaga Page-23 [ATCC 30871] (AF019061) 
T4F A. triangularis SH621  [ATCC 50254] (AF346662) 
T4-Neff A. castellanii Neff [ATCC 30010]  (U07416) 
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5.3 Results 
One out of 140 wound swab samples was positive for Acanthamoeba spp., beside 
positive control A. castellanii (T4 genotype). The positive sample was isolated from an 
85 year-old female with leg wound. Her first episode was treated with flucloxacillin 
however, recovery was followed by an acute episode which was treated with 
trimethoprim. Both positive sample and positive control were cloned to obtain pure 
isolations for axenification and further molecular investigation (Figure 5.2.). DNA 
extracted from those samples, and ASA.S1 region were successfully amplified (Figure 
5.3.). DF3 region in both sample and control were sequenced and aligned alongside the 
other Acanthamoeba species obtained from the database and shown in (table 5.1.) 
(Figure 5.4.). The alignment results show the differences in the variable region, 
however, both sample and control showed some similarity with the T4 genotype that 
was used in the alignment (Figure 5.5.). To find the relationships between these strains a 
phylogenetic tree was obtained (Figure 5.6.). Further alignment was done for both 
sample and control with 7 different subtypes of Acanthamoeba T4 genotype. Both of 
them belong to T4A subtype genotype (Figure 5.7.). After employing nucleotide 
BLAST, it became clear the positive sample was identified as A. castellanii (Figure 
5.8.). 
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Figure 5.2 Presence of Acanthamoeba spp. in the only positive wound samples. 
Image (A) show Acanthamoeba trophozoites and their feed tracks on NNA; and image (B) show 
clumped Acanthamoeba cysts on NNA. X40 objective (bars = 50 µm). 
 
Figure 5.3 ASA.S1 amplimer was present in both sample and positive control with size 
approximately 500 bp. 
Lane 1: 1kb DNA ladder (Thermo scientific #SM0311), Lane 2: Positive control A. castellanii, 
Lane 3: sample (OS102), and Lane4: Negative control (water). 
 
+ -
Marker        Control OS102 Control
500 bp
(A) (B)
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Figure 5.4 Sequence of DF3 fragment of the positive wound swab sample (OS102). 
One single primer (892C) was used to obtain DF3 sequences. 
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Figure 5.5 Primary sequence alignment of a variable region of DF3 of 18S rDNA. 
Primary sequence alignment of a variable region of DF3 of 18S rDNA of sample OS102 beside 
positive control and 20 genotypes of Acanthamoeba (T1-T20) by MEGA 6.06. The alignment 
shown (red box) is a subset of DF3 that contains the highly variable and informative section of 
this fragment. Arrows refer to T4 genotype from the database (4), positive control which is A. 
casteallanii (21), and positive sample (OS102) (22). 
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Figure 5.6 18S rDNA DF3 phylogenetic neighbour-joining tree. 
18S rDNA DF3 phylogenetic neighbour-joining tree obtained by using two-parameter distance 
algorithm, produced in MEGA 6.06. The isolate and positive control obtained in this study are 
identified in the tree (red box). Bootstrap value is 46%. 
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Figure 5.7 The comparison of both isolate and positive control with other 7 subtypes of T4 
genotype. 
(A) Sequence alignment of a variable region of DF3 of 18S rDNA. The highly variable part of 
DF3 was shown within red box. (B) 18S rDNA DF3 phylogenetic tree obtained by using 
MEGA 6.06. The isolate and positive control obtained in this study are identified in the tree (red 
box). Bootstrap value is 49%. 
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Figure 5.8 Sequence of DF3. 
Sequence of DF3 was identified via a basic alignment search tool (BLAST, 
https://blast.ncbi.nlm.nih.gov), by using nucleotide blast to locate the highly similar sequence 
for comparison. The isolate from wound was identified as A. castellanii.  
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5.4 Discussion 
This is the first study to look at the genomic characterisation of Acanthamoeba strains 
from wounds in the worldwide, and the first report of Acanthamoeba in Colchester and 
whole Essex. The world-wild distribution of Acanthamoeba gives them the opportunity 
to be one of the microorganism which could be colonise an open wound. Acanthamoeba 
species were isolated from both clinical and environmental sources, including soil, 
waste dumps, cooling towers of air conditioning systems, humidifiers, aquaria, dialysis 
machines, dental equipment, as well as bottled, tap, and sea waters (Siddiqui and Khan, 
2012). Moreover, Acanthamoeba were isolated from the nasal samples of healthy 
people indicating that subclinical infections might be common (Cabello-Vílchez et al., 
2014b). 
There are two main clinical infections caused by Acanthamoeba: AK in healthy people 
who wear contact lenses and AGE in immunosuppressed people. One of Acanthamoeba 
entry routes for CNS is through a skin lesion (cutaneous acanthamoebiasis) (Torno et 
al., 2000). The importance of AGE in the literature has been emphasised, especially in 
immunocompromised patients, such as AIDS patients and patients who have organ 
transplant (Marciano-Cabral and Cabral, 2003). In 2012, D’Auria et al. reported a 66-
year-old male who had a double lung transplant, after which he was diagnosed with 
cutaneous acanthamoebiasis which was then followed by AGE. In the literature, about 
20 cases of transplant patients got Acanthamoeba spp. infections, and only 8 of them 
presented with skin lesions. Those lesions were nodules, ulcers and cellulitis (D’Auria 
et al., 2012). However, there is not a single study to report isolation of Acanthamoeba 
from a wound in an immunocompetent person. 
In the present study, swabs were obtained from different wounds, including abscess, 
ulcer, and other skin wounds. One out of 140 samples was positive, and that was from a 
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right-leg-wound. The number of positive samples in this study is very low compared 
with other studies. The recommended samples for amoeba clinical isolations are 
cerebrospinal fluid (CSF), biopsy, or tissue specimens (Centers for Disease Control and 
Prevention, 2014). In a very recent study, about 28 % of the total samples from nasal 
swabs were positive for Acanthamoeba (Cabello-Vílchez et al., 2014b). However, some 
other previous studies had shown very low percentages of positive samples (Cerva et 
al., 1973; Michel et al., 1982; Badenoch et al., 1988). In another study which tried to 
isolate Acanthamoeba spp. from conjunctiva swabs, no single sample out of 286 
samples was positive for Acanthammoeba (Anisah et al., 2005). Therefore, swabs may 
not be the best sampling method for clinical Acanthamoeba isolations compared with 
biopsy or tissue specimens. 
Based on the inconsistencies in classifying Acanthamoeba spp. according to their 
morphology, PCR was used to identify Acanthamoeba spp. based on the sequence of 
ASA.S1amplimer (Schuster and Visvesvara, 2004). Genus Acanthamoeba is divided 
into 20 genotypes based on the sequences of 18s rDNA (Corsaro et al., 2015). 
Nevertheless, only some of these genotypes are associated with human infections, other 
genotypes have been found only in the environment; however, T4 genotype was found 
in both clinical and environmental samples (Booton et al., 2005; Khan, 2006; Ledee et 
al., 2009; Magnet et al., 2012). Moreover, the T4 genotype has been identified as a 
main one associated with both AK and AGE. More than 90 % of AK cases are caused 
by T4 genotype; and that genotype has been linked with AGE and cutaneous infections 
(Siddiqui and Khan, 2012). The virulence properties of T4 genotype are greater than 
other genotypes, and that could be the reason behind the propagation of T4 genotype. It 
contains seven subtypes including T4A, T4B, T4C, T4D, T4E, T4F and T4-Neff. In 
addition, the T4 genotype secretes serine protease with different molecular weights. 
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Some of them produce extracellular serine proteases with approximately 33, 36, 49 and 
66 kDa; and 107 kDa; however, other studies showed the presence of 27, 47, 60, 
75,100, and 110 kDa serine proteases (Khan, 2009). This variation in the molecular 
weight of serine proteases might correlate with the subtypes of T4 genotype. Thus, it 
would be very important to identify the serine proteases produced by using zymography 
gels. This is the first study in worldwide to report the presence of Acanthamoeba in 
wound infections. 
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Chapter 6 : General discussion  
6.1 Overview 
Skin is the first protective barrier of the body, however, when it is compromised, 
bacteria and other microorganisms may invade and colonise superficial and deep tissue 
(Lacey et al., 2016). It has been estimated that wound infections are the most common 
nosocomial diseases, mostly caused by MRSA and P. aeruginosa (Eardley et al., 2011). 
Several studies showed the presence of these bacteria in non-healing wounds, such as 
pressure sores, and diabetic foot ulcers. In addition, many other studies showed that the 
presence of MRSA and P. aeruginosa lead to the formation of resistant biofilms (Pfaller 
et al., 1989). The pathogenicity of bacteria depends on their virulence factors including 
the ones responsible for binding, invasiveness and toxicity. Pathogenesis involves the 
beginning of the inflammation process which leads to the in part to the signs and 
symptoms of infection (Beceiro et al., 2013). In order to investigate the reason behind 
episodes of wound re-infection, clinical isolates of MRSA and Pseudomonas isolated 
from wounds were used in this study, together with KB epithelial cell line and 
mesenchymal stem cells. Steps were taken to test if the presence of the ubiquitous 
Acanthamoeba in wounds is one of the key factors for such re-infections, as they feed 
on bacteria. 
6.1.1 Pathogenicity of MRSA and P. aeruginosa in wounds 
In this study, the interaction of MRSA and Pseudomonas with human KB epithelial cell 
line were first studied. Although both MRSA and Pseudomonas showed their ability to 
bind with, invade, survive and multiply inside these cells, Pseudomonas were more 
likely to interact with cells. The findings showed that the number of Pseudomonas bind 
with epithelial cells were higher compared with MRSA after 60 min incubation. The 
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ability of intracellular Pseudomonas to survive and then multiply was higher than that 
of MRSA. The differences in bacterial structure and their virulence factors could be the 
reason behind these findings. 
It is well known that MRSA have some virulence factors responsible for binding to 
cells, such as FnBPs, protein A, elastin-binding protein and collagen-binding protein. In 
addition, MRSA produce different toxins and enzymes, such as Haemolysin α-toxin 
(Hla) and Panton-Valentine leukocidin (PVL) to invade host cells (Sinha et al., 1999; 
Gordon and Lowy, 2008; Yang and Ji, 2014). Both Hla and PVL have multiple 
functions including pore-formation, utilizing iron from haemoglobin and causing cell 
death (Otto, 2010; Pishchany et al., 2010; Lipinska et al., 2011).  
Pseudomonas as Gram-negative bacteria have other special molecules, such as pili and 
LPS, which are responsible for adherence to the surface of the host cells (Ben et al., 
2011). Adding to that, type III system- secretion (T3SS) is one of the major systems in 
P. aeruginosa responsible for secreting and delivering toxins, such as ExoS, ExoT, 
ExoY and ExoU (Schaber et al., 2004; Galle et al., 2012a, 2012b; Pastar et al., 2013). 
Quorum sensing (QS) systems of Pseudomonas, including LasI-LasR and RhlI-RhlR, 
are responsible for wound infection and biofilm formation (Rumbaugh et al., 1999; 
Nakagami et al., 2011). Exotoxin A is the most toxic protein compound produced by P. 
aeruginosa and is regulated by QS. It is secreted as an inactive pro-toxin which 
specifically interacts with the receptor present on the surface of the host cell causing a 
shutdown of protein synthesis resulting in cell death (Ben et al., 2011). 
Cytotoxic effects of MRSA and P. aeruginosa on KB epithelial cell line were 
determined by two different techniques: flow cytometry and colorimetric assays. 
Cytotoxic effects lead to cell death, induced by bacterial toxins and their multiplication 
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inside cells. In this study, live and heat-killed bacteria and BCM of MRSA and P. 
aeruginosa were used to investigate the role of the caspase-3 pathway in cell death. As 
expected, findings showed that the ability of live bacteria to induce cell death was 
higher compared with heat-killed bacteria and BCM. It may be because viable bacteria 
are able to multiply and produce toxins. Cell death induced by P. aeruginosa was 
greater than cell death induced by MRSA. The inactive form (heat-killed) of bacteria 
and BCM were able to induce cell death. However, the exact trigger for the cell death of 
KB epithelial cells in this study is unknown. This process was followed and apoptosis 
and necrosis were found following exposure to MRSA and P. aeruginosa. This may be 
due to secondary necrosis following apoptosis, or may reflect direct cytotoxic effect as 
well as apoptosis (Worgall et al., 2002). In addition, these bacteria have the ability to 
decrease the expression of Keratinocyte Growth Factor 1 (KGF1), which is one of the 
important responsible factors needed in the wound healing process. A recent study 
showed that increased expression of pro-inflammatory cytokines TNFα and IL-1β has 
been associated with polymicrobial biofilm formation by MRSA and P. aeruginosa 
(Pastar et al., 2013). This is responsible for prolonging the inflammatory stage of the 
healing process. 
6.1.2 Presence and role of Acanthamoeba in wounds 
Several lines of evidence had been published, suggesting the probability of the presence 
of Acanthamoeba in wounds. First, the wide distribution of Acanthamoeba spp. in the 
environment (Lorenzo-Morales et al., 2006; Chomicz et al., 2010), which could lead to 
contaminated wounds. Secondly, skin lesions may provide the direct entry route for 
Acanthamoeba to enter the bloodstream and then interact with the BBB causing AGE 
(Alsam et al., 2005b; Khan, 2009). Finally, the relationship between bacteria associated 
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with wound infections and Acanthamoeba (Cardas et al., 2012). These lines of evidence 
suggest that Acanthamoeba could be present in wounds and therefore have a role in 
their infection. 
In this study, the presence of Acanthamoeba in wounds was investigated. 140 wound 
swabs were collected from different sites including feet (heels and toes), knees, hips, 
lips, hands, breasts and thighs. Only one sample was positive for Acanthamoeba spp. As 
expected, this Acanthamoeba isolate was from one patient who had more than one 
episode of inflammation. This supports the hypothesis of this study: presence of 
Acanthamoeba in wounds might have a role in the increasing of incidence of wound 
reinfection. Sequencing of the highly variable DF3 region of the 18S rRNA gene of the 
isolate showed that this was very similar to genotype T4 subtype A. A study showed the 
presence of Acanthamoeba trophozoites and cysts in a skin nodule biopsy from a patient 
who had recently undergone lung transplantation (D’Auria et al., 2012). 
To investigate whether Acanthamoeba could interact with the most common bacteria in 
wounds, interaction assays were performed. Clinical isolates of MRSA and 
Pseudomonas were used with three different Acanthamoeba species, including T1, T4 
and T7. Findings of this study showed that both MRSA and Pseudomonas were able to 
bind with, invade, survive and multiply inside all Acanthamoeba species. The nature of 
the relationship between bacteria and amoebae depends on bacterial virulence and 
amoebic virulence and also on the environmental conditions. It is interesting to mention 
that the number of bacteria which survived and multiplied inside the pathogenic 
Acanthamoeba T1 was very low compared with the intracellular bacteria inside 
Acanthamoeba T7. The limitation of bacterial survival inside pathogenic species 
compared with non-pathogenic ones may be due to proteases and toxins produced by 
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pathogenic Acanthamoeba. A study showed that, in vitro, clinical and non-clinical 
isolates belonging to genotypes, T1, T2, T3, T4 and T7 showed ecto-ATPase activities. 
Acanthamoeba binds to host cells using their mannose-binding protein and binding can 
be blocked using exogenous α-mannose (Alsam et al., 2003). It has been demonstrated 
that α-mannose significantly increased ecto-ATPase activities of pathogenic 
Acanthamoeba belonging to T1, T2, T3 and T4 genotypes but not the non-pathogenic 
species belonging to T7 genotype (Sissons et al., 2004). In addition, pathogenic 
Acanthamoeba belong to T1 and T4 genotypes were found producing extracellular 
proteases, such as serine and metalloproteases, which were not produced by non-
pathogenic T7 genotype (Khan et al., 2000; Alsam et al., 2005b). Another study showed 
the antimicrobial activity of A. castellanii conditioned medium on MRSA and P. 
aeruginosa (Iqbal et al., 2014). Several studies have reported the ability of bacteria to 
interact with amoeba, such as Escherichia coli (Alsam et al., 2006), Enterobacter 
aerogenes, Aeromonas hydrophila (Yousuf et al., 2013), Pseudomonas aeruginosa 
(Michel et al., 1995) and MRSA (Cardas et al., 2012). The relationship between 
bacteria and amoebae could be symbiotic or destructive of either the bacterium or the 
amoeba (Jeon, 1995). It has been reported that in the absence of food, pathogenic 
Escherichia coli strain K1 was able to remain viable and even multiply inside 
Acanthamoeba compared with non-pathogenic strain E. coli K12 which was killed. 
However, in the presence of variable conditions, E. coli K1 lysed amoebae and grew 
exponentially whereas E. coli K12 exhibited minimal growth (Alsam et al., 2006). 
Overall, these findings suggest that Acanthamoeba facilitate bacterial survival and 
provide protection from unfavourable conditions. 
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6.1.3 Role of microorganisms in wound healing 
Wound healing requires specific factors to interact together, including cells, growth 
factors, and extracellular matrix proteins. Endogenous MSC are required to accelerate 
wound healing by recruiting other host cells and secreting growth factors and matrix 
proteins. Self-renewal is the most important feature of MSC along with their ability to 
differentiate to other cell types (Maxson et al., 2012; Ma et al., 2014). However, 
microorganisms have the ability to delay wound healing by producing toxins and 
enzymes (Pastar et al., 2013; Losa et al., 2014). 
Live, heat-killed bacteria and BCM of MRSA and P. aeruginosa, and Acanthamoeba 
CM were used against human skin cells and MSC to determine the effective agent of 
cell death. In this study, findings showed that all microorganisms induced cell death in 
both KB epithelial and MSC cells. As mentioned earlier, live bacteria showed a greater 
effect on host cells compared with heat-killed bacteria and BCM. Unfortunately, clinical 
isolates of MRSA and P. aeruginosa were not characterised as to the level of virulence 
factors they produce. Therefore, it is impossible to ascribe the cytotoxicity to specific 
virulence factors. A previous study showed that incubating inactivated (heat-killed) P. 
aeruginosa with dendritic cells for 3 h induced apoptosis (Worgall et al., 2002). In this 
study, cell death induced by P. aeruginosa was less effective in KB epithelial cell line at 
the same conditions. In addition, BCM of both MRSA and P. aeruginosa were toxic on 
both KB epithelial and MSC cells. T3SS of P. aeruginosa were demonstrated to have a 
direct role in cell death (Losa et al., 2014; Broquet and Asehnoune, 2015; Wood et al., 
2015). Furthermore, TSST-1 and FnBPs produced by MRSA are able to induce cell 
death in different cell types, such as epithelial and endothelial cells (Essmann et al., 
2003; Mateo et al., 2007). The ability of Acanthamoeba trophozoites to induce 
Chapter 6 
 182 
apoptosis in human corneal epithelial cells has been confirmed (Zheng et al., 2004). In 
this study, Acanthamoeba CM were highly induced cell death in both KB epithelial and 
MSC cells. Acanthamoeba produce different enzymes which are able to induce 
apoptosis or necrosis, such as ecto-ATPases and extracellular serine proteases (Sissons 
et al., 2004; Alsam et al., 2005b; Lorenzo-Morales et al., 2015). In addition, 
Acanthamoeba activates Phosphatidylinositol 3-Kinase (PI3ks) which induce brain 
endothelial cell death (Sissons et al., 2005). 
The mechanism of caspase-mediated cell death has been detected in different cell types, 
including epithelial cells and stem cells. Among the caspases, activation of caspase-3 
plays an important role in infections as it is activated by both the intrinsic and extrinsic 
pathways (Hurt et al., 2003; Alaoui-El-Azher et al., 2006; Maxson et al., 2012; Tripathi 
et al., 2012; Soong et al., 2015). Findings of this study confirmed the role of caspase-3 
pathways in cell death mediated by MRSA, P. aeruginosa and Acanthamoeba. 
6.1.4 Alternative efficient treatment strategy 
The overuse and misuse of antibiotics result in mutations of bacteria, which lead to 
antibiotic resistance. Both MRSA and P. aeruginosa are multi-drug resistant. MRSA 
and P. aeruginosa have been directly associated with severe and chronic wound 
infections which result in increased morbidity and mortality rates (Gardner et al., 2001; 
Pastar et al., 2013). Treatment of multi-drug resistant bacteria is difficult, because of 
their increased virulence factors, such as penicillin-binding protein 2A (PBP2A) in 
MRSA (Peacock and Paterson, 2015). In addition to bacteria, Acanthamoeba cysts are 
very difficult to treat (Aksozek et al., 2002). Therefore, there is an urgent need for novel 
and alternative treatment methods, such as iron chelation therapy. The antimicrobial 
activity of iron chelation therapy has been studied against different types of bacteria, 
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such as S. aureus, E. coli and P. aeruginosa (Hider and Kong, 2010; Qiu et al., 2011). 
The chemical structure of iron chelators plays an important role in chelation. For 
examples, deferiprone is a small molecule which forms a bidentate ligand with one iron 
molecule, but iron chelators which are able to form a hexadentate ligand with one iron 
molecule have been demonstrated as high affinity and more effective on the viability of 
bacteria (Qiu et al., 2011; Xu et al., 2011; Thompson et al., 2012; Zhou et al., 2015). 
In this study, three novel hexadentate iron chelators together with deferiprone were used 
to determine whether iron chelation is a promising method in the treatment of mutli-
drug resistant microorganisms. All novel iron chelators showed antimicrobial activity 
against both extracellular and intracellular bacteria inside host cells and Acanthamoeba. 
Iron chelators investigated in previous studies vary in their core and novel compounds 
(Qiu et al., 2011; Xu et al., 2011; Thompson et al., 2012; Zhou et al., 2015).  In one 
study, the MIC of deferiprone against S. aureus and P. aeruginosa was over 500 µg/mL 
(Thompson et al., 2012) which is in agreement with our findings. The most effective 
iron chelator against MRSA and P. aeruginosa in this study was 13l, with MIC of >500 
and 400 µg/mL, respectively. By comparison the MICs of another novel hexadentate 
iron chelator CP251 against MRSA and P. aeruginosa were 500 and 100 µg/mL, 
respectively (Qiu et al., 2011). As well as that, all iron chelators used in this study 
showed very low toxicity on host cells, which was determined by LDH assays. 
This was the first report showing the use of iron chelation against Acanthamoeba. 
However, the use of iron chelators against Naegleria fowleri and Entamoeba histolytica 
has been investigated (Newsome and Wilhelm, 1983; Espinosa et al., 2009). Our 
findings showed that the MIC of 13a, 13l and 13i on both Acanthamoeba T4 and T7 
were 100, 300 and 400 µg/mL, respectively, after 24 h incubation. The MIC of 
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desferrioxamine B against Naegleria fowleri was found to be 1000 µg/mL after 96 h 
(Newsome and Wilhelm, 1983). 
Chapter 6 
 185 
6.2 Limitations of the study 
The use of two types of cell lines, three Acanthamoeba species, three MRSA and three 
Pseudomonas, was a unique feature of this study. Several techniques were used in this 
project including interaction assays, antimicrobial activity (MBC and MIC), LDH 
cytotoxicity colorimetric assays, zymographic assays, flow cytometry, PCR and 
bioinformatics. On the other hand, there were limitations of this study. 
One of the limitations of this study was that the KB epithelial cell line was derived from 
a cancerous tissue and does not represent the skin tissue of a healthy individual. This 
cell line may not express the same receptors as normal skin epithelial cells, therefore the 
interaction of bacteria with the KB epithelial cell line may not be representative of the 
interaction which would take place in a healthy individual. Another type of cell which 
could be considered for use would be the normal human keratinocyte cells which are 
derived from a healthy individual foreskin. In addition, mMSC cell which was used in 
this study was isolated from murine bone marrow, which could be different from human 
MSC.  
Clinical isolates of MRSA and Pseudomonas were used in this study. The virulence 
factors of individual strains have not been characterised. To study individual virulence 
factors, inhibitors or mutant strains lacking one or more virulence factors could be used.
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6.3 Recommendations for future work 
The findings presented in this thesis highlighted some aspects of Acanthamoeba role in 
wound infections, along with the pathogenesis of MRSA and P. aeruginosa, and the 
promise of using iron chelation as an alternative therapeutic method. There are, 
however, needs for further investigations to give a better picture for Acanthamoeba’s 
role in wounds. 
1. Further investigations of the virulence factors most responsible for cytotoxicity could 
be worth studying. To assess that, a few cell types derived from healthy human skin 
tissue are required, such as keratinocytes, fibroblasts and endothelial, or a skin tissue 
model. In addition, different bacterial strains lacking one or more of the virulence 
factors could be used on the above-mentioned cells. Many techniques would be helpful 
to assess that: at proteins level, such as flow cytometry, fluorescence microscopy, and 
western blot using antibodies; and at the gene level, such as PCR, sequencing and 
bioinformatics. 
2. Another matter would be using human MSC to study the effect of different virulence 
factors in cell death. As well as that, understanding the pathways of cell death will shed 
some more light in this field. 
3. It is well known that biopsies from infected wounds are better samples compared 
with swabs for isolation of any microorganisms (Central Disease Control and 
Prevention, 2014). Therefore, collecting biopsies to detect the presence of 
Acanthamoeba in infected wounds could be a future study. 
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Appendix 1: List of reagents and chemicals 
 
7.1 List of reagents and chemicals 
7.1.1 Reagents and media for bacterial, amoebal and cell culture 
Minimum Essential Medium Eagle (EMEM)  (Sigma M0644) 
Dulbecco’s Modified Eagle’s Medium (DMEM) (Gibco™ 61965026) 
MEM Non-Essential Amino Acid Solution (100×) (Sigma 7145) 
Fetal Bovine Serum      (Fisher Scientific10117272) 
Phosphate buffered saline (PBS)   (Sigma P4417) 
Nutrient agar      (Sigma N9405) 
Bacteriological agar     (Sigma A5306) 
CLED Agar      (Sigma 55420) 
Ringers solution     (Sigma 96724) 
D-(+)-Glucose      (Sigma G8270) 
Peptone Water      (Sigma 70179) 
Yeast Extract      (Sigma 92144) 
Trypsin-EDTA solution    (Sigma T4174) 
Sodium chloride (NaCl)    (Sigma S7653) 
Tryptone      (Sigma T7293) 
Accutase® solution     (Sigma A6964) 
Sodium phosphate dibasic – potassium phosphate monobasic solution  
(Sigma 71653) 
Magnesium sulfate heptahydrate    (Sigma M1880) 
Calcium chloride dihydrate     (Sigma 223506) 
 
7.1.2 Antibiotics and antimicrobial agents 
Vancomycin      (Sigma V2002) 
Ciprofloxacin      (Sigma17850) 
Deferiprone      (Sigma 379409) 
 
7.1.3 Reagent for Zymography 
Triethylamine hydrochloride (Tris)    (Sigma T8521) 
Bis/ acrylamide solution for electrophoresis  (Sigma A3574) 
Sodium dodecyl sulfate (SDS)    (Sigma L3771)  
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Glycine      (Sigma G8898) 
Glycerol      (Sigma G5516) 
2-mercaptoethanol     (Sigma M6250) 
Bromophenol blue     (Sigma B0126) 
Coomassie brilliant blue    (Sigma B0149) 
TEMED      (Sigma T9281) 
Ammonium persulphate    (Sigma A3678) 
Acetic acid      (Fisher Scientific 10375020) 
Methanol      (Fisher Scientific 10093880) 
Triton X-l00      (Sigma X-100) 
Calcium chloride (CaCl2)    (Sigma C1016) 
Gelatin       (Sigma 48723) 
 
7.1.4 Kits 
QIAamp DNA Micro Kit    (QIAGEN 56304) 
QIAquick Gel Extraction Kit    (QIAGEN 28704) 
Cytotoxicity Detection Kit (LDH)   (ROCHE 11644793001) 
 
7.1.5 Inhibitors 
Phenylmethanesulfonyl fluoride (PMSF)  (Sigma P7626) 
General caspase inhibitor (Z-VAD-FMK)  (BD 550377) 
 
7.1.6 Reagents for flow cytometry 
Annexin V FITC     (BioLegend 640906) 
Annexin V Binding Buffer    (BioLegend 422201) 
Cell staining buffer     (BioLegend 420201) 
Zombie NIR      (BioLegend 423106) 
 
7.1.7 Reagents for PCR and gel electrophoresis 
Agarose      (Fisher Scientific 10776644) 
GeneRuler 1 kb DNA Ladder    (Thermo Scientific™ SM0311) 
dNTP Mix      (Thermo Scientific™ R0241) 
Taq DNA Polymerase     (Thermo Scientific™ EP0401) 
SafeView Nucleic Acid Stain    (NBS-Biologicals NBS-SV1) 
 
7.1.8 General reagents 
Ethylenediaminetetraacetic acid (EDTA) (10×) (Sigma E9884) 
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Acetone      (Fisher Scientific 10045800) 
Hematoxylin      (Sigma H9627) 
CelLytic™ M      (Sigma C2978) 
Virkon       (Fisher Scientific 12358667) 
Ethanol      (Fisher Scientific BP2818) 
Dimethyl Sulfoxide (DMSO)    (Sigma D2650) 
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Appendix 2: List and preparation of buffers and cultured 
medium 
 
7.2 List and preparation of buffers and cultured medium  
7.2.1 Saline 
Page's Amoeba Saline: 
Solution1: 
• Sodium phosphate dibasic (Na2HPO4)     0.142 g 
• Potassium phosphate monobasic (KH2PO4)   0.136 g 
• DI Water       500.0 mL 
Autoclave at 121ºC for 15 min 
Solution2: 
• Magnesium Sulfate Heptahydrate (MgSO4.7H2O)  4.0 mg 
• Calcium chloride dehydrate (CaCl2.2H2O)   4.0 mg 
• Sodium chloride (NaCl)      0.120 g 
• DI Water       500.0 mL 
Autoclave at 121ºC for 15 min 
Combine solutions 1 and 2 when cooled to room temperature. 
 
Ringers solution 1/4 strength tablets: One tablet is sufficient for 500mL contained: 
• calcium chloride,      0.12 g/l  
• potassium chloride,      0.105 g/l  
• sodium bicarbonate,      0.05 g/l 
• sodium chloride,      2.25 g/l 
Phosphate buffered saline (PBS) tablets: One tablet dissolved in 200 mL of deionized water 
giving 0.01 M phosphate buffer contained: 
• potassium chloride,       0.0027 M 
• sodium chloride,       0.137 M 
Autoclave at 121ºC for 15 min. pH 7.4, at 25 °C 
 
7.2.2 Human cell, amoebal, and bacterial culture medium 
EMEM for KB epithelial cell line (v/v): EMEM 89 %, NEAA 1 %, and FBS 10 %. 
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DMEM for MSC cell (v/v): DMEM 80 %, and FBS 10 %. 
PYG (w/v): proteose peptone 0.75 %, yeast extract 0.75 %, and glucose 1.5 % distilled water 
prior to autoclaving 121ºC for 15 min. 
Luria Bertani broth (w/v): 10g tryptone, 5g yeast extract and 10g NaCl in water to a final 
volume of 1000 mL, adjusting the pH to 7.5 before autoclaving at 121ºC for 15 min. 
CLED (w/v): 36.15 g of CLED agar dissolved up to 1000 mL distilled water prior to 
autoclaving 121ºC for 15 min. 
Nutrient agar (w/v): 23 g of nutrient agar dissolved up to 1000 mL distilled water prior to 
autoclaving 121ºC for 15 min. 
Non-nutrient agar (w/v): 30 g bacteriological agar dissolved in to 1000 mL Ringers solution, 
or in Page amoeba saline prior to autoclaving 121ºC for 15 min. 
Trypsin 1x (v/v): 10 mL up to100 mL PBS. 
10 % SDS (w/v): 10 g dissolved up to 100 mL distilled water. 
 
7.2.3 Antibiotics and antimicrobial iron chelator 
Vancomycin (w/v): stock solution: 1 mg/mL dissolved in distilled water 
Ciprofloxacin (w/v): stock solution: 1 mg/mL dissolved in distilled water with 0.05mM HCl 
Deferiprone (w/v): stock solution: 10 mg/mL dissolved in distilled water. 
13a (w/v): stock solution: 10 mg/mL dissolved in distilled water. 
13l (w/v): stock solution: 10 mg/mL dissolved in distilled water. 
13i (w/v): stock solution: 10 mg/mL dissolved in distilled water. 
 
7.2.4 Buffers for electrophoresis: 
SDS-PAGE (Zymography): 
Some of SDS-PAGE reagents and buffers were prepared in the laboratory before using, and 
others were purchased from sigma. pH for all reagents and buffers were adjusted by using either 
HCl or NaCl. SDS-PAGE reagents and buffers were prepared as follows: 
• 30 % (v/v) Bis/acrylamide solution for electrophoresis. 
• Temed solution. 
• Tris: were prepared in two concentrations: 
a) 1.5M Tris (pH 8.8): 18.1g of Tris were dissolved in 100mL of distilled water. 
b) 1M Tris (pH 6.8): 12.05g of Tris were dissolved in 100mL of distilled water. 
• 10 % SDS (w/v): 10g of SDS were dissolved in 100mL of distilled water. 
• 10 % Ammonium persulphate: 0.1g of ammonium persulphate (w/v) were dissolved 
in 1mL of distilled water. 
• Running buffer (pH 8.3): 15g of Tris (v/v), 72g of glycine (v/v) and 5g of SDS (v/v) 
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were dissolved in 1000mL of distilled water. Running buffer was diluted with distilled 
water 1:1. 
• Sample buffer: 4mL of distilled water, 1mL of 0.5M Tris (v/v), 0.8mL of glycerol 
(v/v), 1.6mL of 10 % SDS (v/v), and 0.05 % bromophenol blue (w/v in distilled water) 
were mixed together. 
• Coomassie brilliant blue stain: Coomassie brilliant blue (w/v), methanol (v/v), acetic 
acid (v/v) and distilled water (v/v) were mixed as (1:8:2:10). 
• De-stain: methanol (v/v), acetic acid (v/v) and distilled water (v/v) were mixed as 
(4:1:5). 
• Tris buffer used to prepare triton and developing buffer: 50mM Tris (6.057g/l), adjust 
pH to 7.5. 
a) Triton (v/v): 2 % Triton X-l00 in Tris buffer. 
b) Developing buffer (w/v): l0 mM CaCl2 1.4 g/l in Tris buffer. 
 
Agarose gel: 
0.5 M EDTA: use stirring hotplate to 50-60 ºC for 30-60 mins, pH8 once redissolved. 
 
50X TAE buffer: Stock solution: 
• Tris base (w/v)     242g 
• Glacial Acetic Acid (v/v)   57.1 mL 
• 0.5M EDTA pH8 (v/v)    100 mL  
Dissolve Tris in ~600 mL ddH2O, then EDTA and Acetic Acid were added, up to 1000 mL 
with H2O. 
1X TAE buffer: 20 mL of 50X TAE buffer up to 1000 mL of H2O. 
1 % Agarose gel: 40 g agarose dissolved in 400 mL 1X TAE buffer at 50 ºC then 1mL of 
10 % SDS-PAGE running gels 5 % Stacking gel 
Distilled water 4.2 mL Distilled water 4.3 mL 
30 % Bis/acsrylamide solution 3.3 mL 30 % Bis/acsrylamide solution 0.8 mL 
1.5M Tris (pH 8.8) 2 mL 1.0M Tris (pH 6.8) 0.75 mL 
10 % SDS 100 µL 10 % SDS 60 µL 
10 % Ammonium persulphate 400 µL 10 % Ammonium persulphate 250 µL 
TEMED solution 6 µL TEMED solution 3 µL 
4 % Gelatin 400 µL   
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safeview were added and mixed prior to poured in electrophoresis system tray.   
7.2.5 Primers preparation 
1. Spin the tubes at top speed for 10 minto ensure that there are no lyophilized primers 
stuck to the cap. 
2. To make a typical 100 mM (100X) stock concentration of primers, dissolve the primers 
in a volume of sterile distilled water that is 10X the amount of nmoles in the tube, using 
µL of water. This value is printed on the side of the tube. For example, if your tube 
contains 53.4 nmoles of primer, then you would dissolve using 534 µL of water. This 
will now be at a 100 µM concentration. 
i.e. 53.4 nmoles of primer dissolve in 534 µL of water = 
(53.4 nmoles/l) (x moles/534 x 10-6 l) = 0.0001 mole/l = 0.0001 M = 0.1 mM=100 µM 
3. To prepare primers for use: 
Dilute this stock 1:10, to give a concentration of 10 µM.  
4. Store all sets of primers at -20C. 
5. Typically use 0.1-1.0 µM final concentration in a PCR mix. i.e. if your reaction volume 
is 25 mL, then using 2.5 µL for each separate primer, will give you a final concentration 
of 1µM. 
 
7.2.6 Disinfections used in the laboratory: 
1 % virkon (w/v): 1 mg in 100 mL PBS 
70 % ethanol (v/v): 70 mL in 100 mL H2O 
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Appendix 3: List of cell lines and microorganisms; and 
storage and thawing methods 
 
7.3 List of cell lines and microorganisms; and storage and thawing methods 
7.3.1 List of Cell lines  
KB epithelial (human epidermal carcinoma) cell line was provided from University College 
London. 
mMSCs (murine mesenchymal stem cells) primary cells was provided by Dr Ralf Zwacka from 
University of Essex. 
 
7.3.2 List of Acanthamoeba strains  
Acanthamoeba castellanii T1 (ATCC 50494) 
Acanthamoeba castellanii T4 (ATCC 30234) 
Acanthamoeba astronyxis T7 (ATCC 30317) 
 
7.3.3 Storage method for cells and Acanthamoeba 
Cells and Acanthamoeba were stored as axenic cultures at -80°C and liquid nitrogen. Briefly, 
growing cells or amoebae were re-suspended at a density of 1-5 x 106 cells/mL in the freezing 
medium [90 % FBS, and 10 % DMSO (v/v) for human cells; 90 % PYG, and 10 % DMSO (v/v) 
for Acanthamoeba] and placed into a cryotube. The freezing process were done gradually in ice, 
then -20 °C for 60 minfollowed by their storage at -80°C freezer. Some of cryotubes were 
transferred after overnight incubation in -80 °C to store in liquid nitrogen. 
 
7.3.4 Thawing method for cells and Acanthamoeba 
Thawing and recovery of stored cells and Acanthamoeba from both liquid nitrogen and -80°C 
freezer was done quickly. The cryotubes were placed immediately in the wormer incubator 37°C 
for 3 minafter taken out from liquid nitrogen or -80 °C freezer. Cells or Acanthamoeba were 
transferred into a 15 mL tube with warmed medium (EMEM for KB epithelial cell line, DMEM 
for MSC, and PYG for Acanthamoeba) and centrifuged at 2000 x g for 5 min. Next, supernatants 
were discarded, then pellets were resuspended in owned medium (EMEM for KB epithelial cell 
line, DMEM for MSC, and PYG for Acanthamoeba) and transferred into a T25 tissue flasks. 
Flasks were incubated at 37 °C, 5 % CO2 and 95 % humidity for KB and MSC cells or 30 °C air 
incubator for Acanthamoeba until the cells reached an enough number to transfer. 
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7.3.5 Bacterial strains 
Clinical isolates of MRSA and Pseudomonas were generously provided by Dr Tony Elston from 
Colchester General Hospital. 
E. coli K12 (ATCC 33876) was provided by Dr Terry McGenity from University of Essex. 
 
7.3.6 Storage of bacterial cultures 
By using a disposal sterile loop, about 20-30 isolated colonies of bacteria were picked up from 
the agar plate and inoculated in a 10 mL of bacterial freezing medium [70 % Luria-Bertani broth 
and 30 % glycerol (v/v)]. Then, the mixture of freezing medium with bacteria were divided into 
cryotubes final volume of each tube was 0.5 mL and stored in a -20 °C freezer. 
 
7.3.7 Thawing and re-culturing bacteria 
To re-culture bacteria, a disposable sterile loop was inserted into the frozen cryotube and then 
streaked on fresh agar plate and incubated at 37 °C air incubator overnight. After the incubation, 
the plate was carefully examined if the colonies have similar morphologies such as textures, 
colours and border shapes and stored at 4 °C for up to a month.
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Appendix 4: Approvals documents 
 
7.4 Approvals documents 
7.4.1 Ethical approval latter 
 
  
NRES Committee London - Chelsea 
Research Ethics Committee (REC) Bristol Centre 
Level 3, Block B 
Whitefriars 
Lewins Mead 
Bristol 
BS1 2NT 
 
Telephone: 0117 342 1380 
20 August 2014 
 
Mr Osamah Al Rugai 
3 Saran Court 
Wivenhoe 
Colchester 
CO7 9RS 
 
 
Dear Mr Al Rugai 
 
Study title: Role of Acanthamoeba in wound infections 
REC reference: 14/LO/1538 
Protocol number: N/A 
IRAS project ID: 138584 
 
The Proportionate Review Sub-committee of the NRES Committee London - Chelsea reviewed 
the above application on 18 August 2014. 
 
We plan to publish your research summary wording for the above study on the NRES website, 
together with your contact details, unless you expressly withhold permission to do so. 
Publication will be no earlier than three months from the date of this favourable opinion letter. 
Should you wish to provide a substitute contact point, require further information, or wish to 
make a request to postpone publication, please contact the REC Manager Miss Gemma Oakes, 
nrescommittee.london-chelsea@nhs.net. 
 
Ethical opinion 
 
On behalf of the Committee, the sub-committee gave a favourable ethical opinion of the above 
research on the basis described in the application form, protocol and supporting documentation, 
subject to the conditions specified below. 
 
Conditions of the favourable opinion 
 
The favourable opinion is subject to the following conditions being met prior to the start of the 
study. 
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You confirmed the School of Biological Science in University of Essex followed the Human 
Tissue Authority Code of Practice in disposing of any human materials and methods were 
available if required. 
 
Approved documents 
 
The documents reviewed and approved were: 
 
Document   Version   Date   
Evidence of Sponsor insurance or indemnity (non NHS Sponsors 
only) [(Ref: 5067424) ]  
  06 August 2014  
IRAS Checklist XML [Checklist_11082014]    11 August 2014  
Letter from sponsor [(University of Essex)]    29 July 2014  
REC Application Form    07 August 2014  
Referee's report or other scientific critique report    04 August 2014  
Research protocol or project proposal  1.0  20 May 2014  
Summary CV for Chief Investigator (CI) [Osamah Al rugaie]      
Summary CV for supervisor (student research) [Selwa Alsam]      
Summary, synopsis or diagram (flowchart) of protocol in non 
-technical language  
1.0  04 August 2014  
 
Membership of the Proportionate Review Sub-Committee 
 
The members of the Sub-Committee who took part in the review are listed on the attached 
sheet. 
 
There were no Declarations of Interest. 
 
Statement of compliance  
 
The Committee is constituted in accordance with the Governance Arrangements for Research 
Ethics Committees and complies fully with the Standard Operating Procedures for Research 
Ethics Committees in the UK. 
 
After ethical review 
 
Reporting requirements 
 
The attached document “After ethical review – guidance for researchers” gives detailed 
guidance on reporting requirements for studies with a favourable opinion, including: 
 
x Notifying substantial amendments 
x Adding new sites and investigators 
x Notification of serious breaches of the protocol 
x Progress and safety reports 
x Notifying the end of the study 
 
The HRA website also provides guidance on these topics, which is updated in the light of 
changes in reporting requirements or procedures. 
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User Feedback 
 
The Health Research Authority is continually striving to provide a high quality service to all 
applicants and sponsors. You are invited to give your view of the service you have received and 
the application procedure. If you wish to make your views known please use the feedback form 
available on the HRA website: 
http://www.hra.nhs.uk/about-the-hra/governance/quality-assurance/    
 
HRA Training 
 
We are pleased to welcome researchers and R&D staff at our training days – see details at 
http://www.hra.nhs.uk/hra-training/   
 
With the Committee’s best wishes for the success of this project. 
 
14/LO/1538 Please quote this number on all correspondence 
 
Yours sincerely 
 
Dr Michael Schachter 
pp Alternate Vice Chair 
 
Email: nrescommittee.london-chelsea@nhs.net 
 
Enclosures: List of names and professions of members who took part in the review 
“After ethical review – guidance for researchers” [SL-AR2] 
 
Copy to: Mr Ayres Caldeira, ayres.caldeira@colchesterhospital.nhs.uk 
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NRES Committee London - Chelsea 
 
Attendance at PRS Sub-Committee of the REC meeting on 18 August 2014 
 
  
Committee Members:  
 
Name   Profession   Present    Notes   
Mr Roger A'hern  Senior Statistician, 
Clinical trials and 
statistics unit  
Yes     
Mr Philip Kimberley  Clinical Governance 
Information Manager  
Yes     
Dr Michael Schachter (Chair) Clinical Pharmacologist  Yes     
  
Also in attendance:  
 
Name   Position (or reason for attending)   
Miss Gemma Oakes  REC Manager 
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7.4.2 Research and development approval 
 
 
 
 
         
 
Chief Executive (Interim): Kim Hodgson 
Chair: Dr. Sally Irvine 
 
Colchester General Hospital 
Microbiology Department 
Turner Rd 
Colchester 
CO4 5JL 
 
Tel: 01206 747374 
Dr Selwa Alsam 
Biological Sciences 
University of Essex 
 
 
Date: Wednesday, 28 January 2015 
Your Ref: 
Our Ref: 
 
Dear Selwa, 
 
Re; Osamah Al Rugaie 
 
We would like to give access to Osamah to the laboratory so that he may conduct part of his 
research project. We understand that he will be accompanied by yourself and the impact on our 
staff time will be minimal. 
 
Kind regards 
 
Yours sincerely 
 
 
 
R A Elston 
Consultant Microbiologist 
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Abbate 
“Macromolecular iron-chelators via RAFT-polymerization for the inhibition of 
methicillin-resistant Staphylococcus aureus growth”. Polymer 87, pp. 64-72. 
 
2015 
Ying-Jun Zhou; Mu-Song Liu; Osamah Al Rugaie; Xiao-Le Kong; Selwa Alsam; 
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